TW200948859A - Liquid-crystal alignment material and liquid-crystal display element made with the same - Google Patents
Liquid-crystal alignment material and liquid-crystal display element made with the same Download PDFInfo
- Publication number
- TW200948859A TW200948859A TW098103118A TW98103118A TW200948859A TW 200948859 A TW200948859 A TW 200948859A TW 098103118 A TW098103118 A TW 098103118A TW 98103118 A TW98103118 A TW 98103118A TW 200948859 A TW200948859 A TW 200948859A
- Authority
- TW
- Taiwan
- Prior art keywords
- ring
- liquid crystal
- formula
- crystal alignment
- group
- Prior art date
Links
- 0 CCC(CCCC(C)C(CC1)*2(*)C1C1C=CC(CC(CC3)(c4ccc(C(*)C(C(C)C5)=CC=C5N)cc4)c(cc4)ccc4Oc(cc4)ccc4N)C3(C)C1CC2)C1*C1 Chemical compound CCC(CCCC(C)C(CC1)*2(*)C1C1C=CC(CC(CC3)(c4ccc(C(*)C(C(C)C5)=CC=C5N)cc4)c(cc4)ccc4Oc(cc4)ccc4N)C3(C)C1CC2)C1*C1 0.000 description 5
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1075—Partially aromatic polyimides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1042—Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1075—Partially aromatic polyimides
- C08G73/1078—Partially aromatic polyimides wholly aromatic in the diamino moiety
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Liquid Crystal (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
Description
,200948859 六、發明說明: 【發明所屬之技術領域】 本發明爲有關製作液晶配向膜時所使用之 理劑及使用其之液晶顯示元件之發明。 【先前技術】 目前,液晶顯示元件之液晶配向膜主要係 A 醯胺酸等之聚醯亞胺前驅物或可溶性聚醯亞胺 ❹ 主要成份之液晶配向處理劑(亦稱爲液晶配向 玻璃基板上並經燒成而成之所謂的聚醯亞胺系 〇 液晶配向膜係爲了控制液晶之配向狀態之 者。然而,伴隨著液晶顯示元件之高精細化, 示元件之對比降低之抑制或殘像顯像降低之要 用之液晶配向膜中須提高電壓維持率,或施加 Φ 減少殘留電荷,及/或提早緩和因直流電壓而 電荷之特性亦逐漸變得重要。 聚醯亞胺系液晶配向膜中,作爲使因直流 殘像消失之前之時間縮短者,已知有使用除聚 有醯亞胺之聚醯胺酸以外含有特定結構之三級 向劑者(例如參照專利文獻1 ),或使用於原 吡啶骨架等之特定二胺之可溶性聚醯亞胺之液 (例如參照專利文獻2 )。另外,作爲使電壓 因直流電壓產生之殘像消失之前之時間縮短者 液晶配向處 使用將以聚 之溶液作爲 劑)塗佈於 液晶配向膜 目的而使用 由於液晶顯 求,使得使 直流電壓時 累積之殘留 電壓產生之 醯胺酸或含 胺之液晶配 料使用具有 晶配向劑者 維持率高且 ,已知有使 -5- 200948859 用除聚醯胺酸或其醯亞胺化聚合物等以外含有極少量之選 自分子內含有1個羧基之化合物、分子內含有1個羧酸酐基 之化合物及分子內含有1個三級胺基之化合物之化合物之 液晶配向劑者(例如參照專利文獻3 )。 然而,近年來大畫面且高精細之液晶電視已廣爲實用 化,該等用途之液晶顯示元件中,與迄今爲止主要顯示文 字或靜止畫面之顯示器用途相比較,相對於殘量之要求更 爲嚴苛,且要求有在過度嚴苛之使用環境下之耐長期使用 之特性。據此,所使用之液晶配向膜亦要求有比過去更高 之信賴性,且關於液晶配向膜之電特性不僅亦要求良好之 初期特性,亦要求有例如即使在高溫下長時間暴露後亦可 維持良好之特性。 [專利文獻1]特開平9— 316200號公報 [專利文獻2]特開平10 — 104633號公報 [專利文獻3]特開平8 — 76 1 28號公報 【發明內容】 本發明之目的爲提供一種於作爲液晶配向膜之際,可 得到高電壓保持率,且即使於長時間暴露於高溫下時,也 可及早緩和因直流電壓所蓄積之殘留電荷之液晶配向膜的 液晶配向處理劑,此外,並提供一種使用該液晶配向處理 劑所得之具有液晶配向膜,且於嚴苛使用環境下也可耐長 期使用之具有高信賴性之液晶顯示元件。 本發明者,爲達上述目的而經過深入硏究結果,發現 -6- .200948859 可達成該目的之液晶配向處理劑。本發明爲基於該結果所 得者,其具有以下之特徵。 (1) 一種液晶配向處理劑,其特徵爲’含有包含二 胺化合物(A)及二胺化合物(B)之二胺成份’與四殘酸 二酐成份反應所得之共聚物’ 二胺化合物(A):下述式Π]所表示之二胺化合物、 二胺化合物(B):分子内具有羧基之二胺化合物’ [化4][Technical Field] The present invention relates to a physicochemical agent used in the production of a liquid crystal alignment film and a liquid crystal display element using the same. [Prior Art] At present, the liquid crystal alignment film of the liquid crystal display element is mainly a polyimine precursor of A phthalic acid or a liquid crystal alignment treatment agent of a main component of soluble polyamidiamine (also referred to as a liquid crystal alignment glass substrate). The so-called polyamidene-based liquid crystal alignment film which is fired is used to control the alignment state of the liquid crystal. However, with the high definition of the liquid crystal display element, the suppression or afterimage of the contrast reduction of the element is shown. In the liquid crystal alignment film to be used for image reduction, it is necessary to increase the voltage holding ratio, or to apply Φ to reduce the residual charge, and/or to moderate the characteristics of the charge due to the DC voltage. The polyimine-based liquid crystal alignment film is gradually added. In the case of shortening the time until the disappearance of the DC residual image, it is known that a third-order agent having a specific structure other than polyamine containing polyamidamine is used (for example, refer to Patent Document 1), or used in A solution of a soluble polyimine of a specific diamine such as a pyridine skeleton (for example, see Patent Document 2). Further, as a residual image caused by a DC voltage, the residual image disappears. For the purpose of coating the liquid crystal alignment film with the liquid solution in the liquid crystal alignment, the liquid crystal alignment is used to make the proline acid or the amine-containing liquid crystal compound which is generated by the residual voltage accumulated at the DC voltage. It is known that a compound having a crystal alignment agent has a high retention rate, and it is known that a compound having a carboxyl group selected from a molecule having a minimum amount of a molecule other than poly-proline or a ruthenium imidized polymer thereof is used. A liquid crystal alignment agent containing a compound of one carboxylic acid anhydride group and a compound containing one compound of a tertiary amino group in the molecule (for example, see Patent Document 3). However, in recent years, large-screen and high-definition liquid crystal televisions have been widely put into practical use, and liquid crystal display elements for such applications are more demanding than the remaining ones in comparison with display applications that have mainly displayed characters or still pictures. It is demanding and requires long-term use in an environment of excessively harsh use. Accordingly, the liquid crystal alignment film used also requires higher reliability than in the past, and the electrical characteristics of the liquid crystal alignment film not only require good initial characteristics, but also require, for example, long-term exposure even at high temperatures. Maintain good characteristics. [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. When the liquid crystal alignment film is used as a liquid crystal alignment film, the liquid crystal alignment treatment agent for the liquid crystal alignment film which retains the residual electric charge accumulated by the DC voltage can be used as early as possible when exposed to a high temperature for a long period of time. Provided is a liquid crystal display element which has a liquid crystal alignment film obtained by using the liquid crystal alignment treatment agent and which is resistant to long-term use in a severe use environment. The present inventors have conducted intensive investigations for the above purposes and found that -6-.200948859 can achieve the liquid crystal alignment treatment agent for this purpose. The present invention is based on the results, and has the following features. (1) A liquid crystal alignment treatment agent characterized by 'a copolymer containing a diamine component (A) and a diamine compound (B) and a tetrahydro acid dianhydride component, a diamine compound ( A): a diamine compound represented by the following formula: (II): a diamine compound having a carboxyl group in the molecule '[Chemical 4]
(式[i]中,又!爲選自由一〇—、一 NQ1—、一CONQ1—、 — NQiCO—、— CH20—及—OCO—所成群之至少一種二價 有機基,Q1爲氫原子或碳數1至3之烷基’ I爲單鍵或選自 β 由碳數1至20之脂肪族烴基、非芳香族環式烴基及芳香族 烴基所成群之至少一種二價有機基’ Χ3爲單鍵或選自由 _〇_、一 NQ2-、-CONQ2—、-NQ2C0—、— C00—、 -OCO—及—〇(CH2)m— (m爲1至5之整數)所成群之至少 一種二價有機基’ Q2爲氫原子或碳數1至3之烷基,X4爲含 氮之芳香族雜環,n爲1至4之整數)。 (2)如上述(1)所述之液晶配向處理劑’其中式Π] 爲選自下述式[la]至式[If]表示之化合物所成群之至少一 200948859 Η(In the formula [i], again! is at least one divalent organic group selected from the group consisting of a 〇-, an NQ1-, a CONQ1-, - NQiCO-, -CH20-, and -OCO-, Q1 is a hydrogen atom Or an alkyl group having a carbon number of 1 to 3 'I is a single bond or at least one divalent organic group selected from the group consisting of an aliphatic hydrocarbon group having 1 to 20 carbon atoms, a non-aromatic cyclic hydrocarbon group, and an aromatic hydrocarbon group. Χ3 is a single bond or is selected from the group consisting of _〇_, one NQ2-, -CONQ2—, -NQ2C0—, —C00—, —OCO—and —〇(CH2)m—(m is an integer from 1 to 5) At least one divalent organic group 'Q2 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, X4 is a nitrogen-containing aromatic heterocyclic ring, and n is an integer of 1 to 4). (2) The liquid crystal alignment treatment agent of the above (1) wherein the formula Π is at least one selected from the group consisting of the compounds represented by the following formulas [la] to [If] 200948859 Η
Χ2-Χ3-Χ4) η νη2 ¥〇-χ2-χ3-Χ4) η Χ2-Χ3-Χ4) ηΧ2-Χ3-Χ4) η νη2 ¥〇-χ2-χ3-Χ4) η Χ2-Χ3-Χ4) η
(式中’ Q1爲氫原子或碳數1至3之烷基,χ2爲單鍵或選自 由碳數1至20之脂肪族烴基、非芳香族環式烴基及芳香族 烴基所成群之至少一種二價有機基,Χ3爲單鍵或選自由 —— NQ2—、-CONQ2-、— NQ2CO—、-COO—、 —OCO—及一 〇(CH2)m— ( rn爲1至5之整數)所成群之至少 —種二價有機基,Q2爲氫原子或碳數!至3之烷基,χ4爲含 氮之芳香族雜環,η爲1至4之整數)。 (3) 如上述(2)所述之液晶配向處理劑,其中式 [la]至式[If]中之χ2爲單鍵、碳數1至3之直鏈伸烷基或苯 壞。 (4) 如上述(2)或(3)所述之液晶配向處理劑, 其中式[la]至式[lf]中之χ3爲單鍵、_〇c〇 —或-〇CH2 - 〇 (5) 如上述(2)至(4)中任一項所述之液晶配向 處理劑’其中式[1&]至式[lf]中之χ4爲咪唑環、吡啶環或 嘧啶環。 -8 - .200948859 (6 )如上述(2 )至(5 )中任一項所述之液晶配向 處理劑,其中式[la]至式[if]中之!!爲i或2之整數。 (7)如上述(2)所述之液晶配向處理劑,其中式 [la]至式[If]中之X2爲選自由碳數1至1〇之直鏈或分支伸烷 基、環己烷環、苯環及萘環所成群之至少一種,X3爲選自 由單鍵、一 0-、一 CONH-、一 NHCO-、一COO—、 —OCO—及-0(CH2:U— (m爲1至5之整數)所成群之至少 & —種,X4爲選自由吡咯環、咪唑環、吡唑環、吡啶環、嘧 啶環、嗒畊環、三畊環、三唑環、哌啶環、苯咪唑環及苯 并咪唑環所成群之至少一種,η爲1或2之整數。 (8 )如上述(2 )所述之液晶配向處理劑,其中式 [la]至式[If]中之Χ2爲選自由單鍵、碳數1至5之直鏈或分 支伸烷基及苯環所成群之至少一種,Χ3爲選自由單鍵、 -0— 、 一CONH- 、 一NHCO- 、 一COO- 、 一OCO-及 —0(CH2)m— (m爲1至5之整數)所成群之至少一種,X4 0 爲選自由吡咯環、咪唑環、吡唑環、吡啶環及嘧啶環所成 群之至少一種,η爲1或2之整數。 (9)如上述(2)所述之液晶配向處理劑,其中式 [la]至式[If]中之χ2爲選自由單鍵、碳數丨至3之直鏈伸烷 基及苯環所成群之至少一種,χ3爲選自由單鍵、一 OCO-及—OCH2 —所成群之至少—種,χ4爲選自由咪唑環、吡 陡環及嘧啶環所成群之至少一種,η爲1或2之整數。 (1 〇 )如上述(1 )至(9 )中任一項所述之液晶配向 處理劑’其中,分子内具有羧基之二胺化合物爲下述式[2] 200948859 所表示之二胺, [化5] h2n(wherein Q1 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and χ2 is a single bond or at least selected from the group consisting of an aliphatic hydrocarbon group having 1 to 20 carbon atoms, a non-aromatic cyclic hydrocarbon group, and an aromatic hydrocarbon group. A divalent organic group, Χ3 is a single bond or selected from — NQ2—, —CONQ2-, —NQ2CO—, —COO—, —OCO—and a 〇(CH 2 ) m— ( rn is an integer from 1 to 5) At least one of the groups is a divalent organic group, Q2 is a hydrogen atom or a carbon number! to an alkyl group of 3, χ4 is a nitrogen-containing aromatic heterocyclic ring, and η is an integer of 1 to 4. (3) The liquid crystal alignment treatment agent according to the above (2), wherein the oxime 2 in the formula [la] to the formula [If] is a single bond, a linear alkyl group having 1 to 3 carbon atoms or benzene is bad. (4) The liquid crystal alignment treatment agent according to (2) or (3) above, wherein χ3 in the formula [la] to the formula [lf] is a single bond, _〇c〇- or -〇CH2 - 〇 (5) The liquid crystal alignment treatment agent according to any one of the above (2) to (4) wherein the oxime 4 in the formula [1&] to the formula [lf] is an imidazole ring, a pyridine ring or a pyrimidine ring. The liquid crystal alignment treatment agent according to any one of the above (2) to (5), wherein, in the formula [la] to the formula [if]! ! is an integer of i or 2. (7) The liquid crystal alignment treatment agent according to the above (2), wherein X2 in the formula [la] to the formula [If] is a linear or branched alkyl group selected from a carbon number of 1 to 1 fluorene, and cyclohexane. At least one of a ring, a benzene ring and a naphthalene ring, X3 being selected from the group consisting of a single bond, a 0-, a CONH-, an NHCO-, a COO-, -OCO-, and -0 (CH2:U- (m) At least & of the group of 1 to 5), X4 is selected from the group consisting of a pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a sorghum ring, a three-pound ring, a triazole ring, and a piperidine. And a liquid crystal alignment treatment agent according to the above (2), wherein the formula [la] to the formula [the formula [la] to the formula [2] is a mixture of the pyridine ring, the benzimidazole ring, and the benzimidazole ring. If 2 in If] is at least one selected from the group consisting of a single bond, a straight or branched alkyl group having 1 to 5 carbon atoms, and a benzene ring selected from the group consisting of a single bond, -0-, a CONH-, and At least one of NHCO-, one COO-, one OCO-, and -0(CH2)m- (m is an integer from 1 to 5), X4 0 is selected from the group consisting of a pyrrole ring, an imidazole ring, a pyrazole ring, and a pyridine At least one of a group of a ring and a pyrimidine ring, and η is 1 or 2 (9) The liquid crystal alignment treatment agent according to the above (2), wherein the oxime 2 in the formula [la] to the formula [If] is a linear alkyl group selected from a single bond, a carbon number of 丨 to 3, and a benzene ring. At least one of the groups, χ3 is at least one selected from the group consisting of a single bond, an OCO-, and -OCH2, and χ4 is at least one selected from the group consisting of an imidazole ring, a pyridyl ring, and a pyrimidine ring, η (1) The liquid crystal alignment treatment agent according to any one of the above (1) to (9) wherein the diamine compound having a carboxyl group in the molecule is the following formula [2] 200948859 The diamine represented, [chemical 5] h2n
[2] (式[2]中,X5爲碳數6至30之具有芳香族環之有機基,n 爲1至4之整數。] (1 1 )如上述(1 〇 )項所述之液晶配向處理劑,其中 ,式[2]之二胺化合物爲選自由下述式[3]至式[7]所成群之 至少一種二胺化合物,[2] (In the formula [2], X5 is an organic group having an aromatic ring having 6 to 30 carbon atoms, and n is an integer of 1 to 4.] (1 1 ) The liquid crystal according to the above item (1) An alignment treatment agent, wherein the diamine compound of the formula [2] is at least one diamine compound selected from the group consisting of the following formulas [3] to [7],
-10- 200948859 [化6] Ο H2N-^ -irtCOOH) [3] (CHzWCOOHΗ2Ν"0~{Ό"νΗ2(CH2)m5^〇〇H [5]-10- 200948859 化 H2N-^ -irtCOOH) [3] (CHzWCOOHΗ2Ν"0~{Ό"νΗ2(CH2)m5^〇〇H [5]
(CH2)m6COOH(CH2)m6COOH
[6][6]
(式[3]中,ml爲1至4之整數’式[4]中’ X6爲單鍵、 -CH2- ' -C2H4- ' - C(CH3)2- ' - CF2- ' ❹ _c(cf3)2—、— Ο — ' — CO — ' - ΝΗ—、— N(CH3)— ' —CONH— ' — NHCO— ' — CH2〇— ' — OCH2— ' — COO-、- OCO - 、 - CON(CH3)-,或-N(CH3)CO-,m2及m3分別爲〇至4之整數’且ni2+m3表示1至4之整數 ,式[5]中,m4及m5分別爲1至5之整數’式[6]中’ X?爲碳 數1至5之直鏈或支鏈烷基,m6爲1至5之整數,式[7]中’ χ8爲單鍵、一 CH2 —、一 C2H4 —、一 C(CH3)2 —、一 CF2 一 、一 C(CF3)2-、- 〇-、— CO —、— ΝΗ —、— Ν(CΗ3) 、一 CONH—、— NHCO—、一 CH20—、— OCH2-、 -11 - 200948859 -COO -、一 OCO-、- CON(CH3)-,或一n(ch3)co-,m7爲1至4之整數)。 (12) 如上述(11)項所述之液晶配向處理劑,其中 ,式[3]中,ml爲1至2之整數。 (13) 如上述(11)項所述之液晶配向處理劑,其中 ,式[4]中 ’ X6 爲單鍵、一CH2—、一 C2H4—、 一 C(CΗ3)2 一、一 Ο _ 、_ CΟ —、一 ΝΗ _、一 N(CΗ3)—、 -CONH -、- NHCO -、- COO -,或—OCO-,m2 及 m3同時爲1之整數。 (14) 如上述(11)項所述之液晶配向處理劑,其中 ,式[7]中,X8 爲單鍵、一 CH2—、一 0—、_CO—、 -NH- 、一CONH- 、一 NHCO—、一CH20- 、一OCH2-、—COO—,或—OCO—,m7爲1至2之整數。 (1 5 )如上述(1 )至(1 4 )中任一項所述之液晶配 向處理劑,其中,二胺成份中’相對於式Π]所表示之二胺 之1莫耳,分子内具有羧基之二胺爲0.01至99莫耳。 (16) 如上述(1)至(15)中任一項所述之液晶配 向處理劑,其中,液晶配向處理劑中所含之溶劑中之5至 80質量%爲弱溶劑。 (17) 如上述(1)至(16)中任—項所述之液晶配 向處理劑,其中,液晶配向處理劑中之共聚物爲聚醯胺酸 經脫水閉環所得之聚醯亞胺。 (18) —種液晶配向膜’其特徵爲’使用上述(1) 至上述(1 7 )中任一項之液晶配向處理劑所得者。 -12- 200948859 (19) 一種液晶顯示元件,其特徵爲,具有上述(18 )之液晶配向膜。 本發明之液晶配向處理劑,可以較簡便之方法製得, 使用該液晶配向處理劑時,可得到具有高電壓保持率,且 即使於長時間暴露於高溫下時,可及早緩和因直流電壓所 蓄積之殘留電荷之液晶配向膜。因此,本發明之液晶配向 處理劑所得之具有液晶配向膜之液晶顯示元件,具有優良 之信賴性,而極適合被使用於大畫面且具有高精細度之液 晶電視。 發明實施之最佳型態 以下,將對本發明作詳細之説明。 本發明爲有關含有包含二胺化合物(A)及二胺化合 物(B)之二胺成份與四羧酸二酐反應所得之共聚物的液 晶配向劑,該液晶配向處理劑所得之液晶配向膜,及具有 該液晶配向膜之液晶顯示元件。 此時,二胺化合物(A)爲式[1]所表示之二胺化合物 ,二胺化合物(B)爲分子内具有羧基之二胺化合物。 本發明所使用之二胺化合物(A)爲,支鏈具有含氮 芳香族雜環者。該含氮芳香族雜環,因其共軛結構而具有 電子跳躍(hopping — site)之機能,於液晶配向膜中,可 促進電荷之移動。此外,該含氮芳香族雜環,與二胺化合 物(B)所具有之羧基,經由形成鹽或氫鍵結之靜電相互 作用而連結,而引起電荷於羧基與含氮芳香族雜環之間產 -13- 200948859 生移動。因此’移動至含氮芳香族雜環部位之電荷,可有 效率的於共聚物之分子内、分子間進行移動。 基於以上之理由,本發明之液晶配向處理劑,於作爲 液晶配向膜之際,可得到高電壓保持率,且即使於長時間 暴露於高溫下時,可及早緩和因直流電壓所蓄積之殘留電 荷之效果。 <二胺成份> [二胺化合物(A)] 本發明所使用之二胺化合物(A )爲,下述式[1]所表 示之二胺化合物。 [化7](In the formula [3], ml is an integer from 1 to 4 in the formula [4], 'X6 is a single bond, -CH2- ' -C2H4- ' - C(CH3)2- ' - CF2- ' ❹ _c (cf3 ) 2—, — Ο — ' — CO — ' - ΝΗ —, — N(CH3)— '—CONH— ' — NHCO — ' — CH2〇 — ' — OCH2 — ' — COO-, - OCO - , - CON (CH3)-, or -N(CH3)CO-, m2 and m3 are integers from 〇 to 4, respectively, and ni2+m3 represents an integer from 1 to 4, and in the formula [5], m4 and m5 are 1 to 5, respectively. In the integer 'Formula [6], 'X? is a linear or branched alkyl group having a carbon number of 1 to 5, and m6 is an integer of 1 to 5. In the formula [7], 'χ8 is a single bond, a CH2—, a C2H4 -, a C(CH3)2 -, a CF2, a C(CF3)2-, - 〇-, - CO -, - ΝΗ -, - Ν (CΗ3), a CONH-, - NHCO-, a CH20—, — OCH2-, -11 - 200948859 -COO -, an OCO-, -CON(CH3)-, or an n(ch3)co-, m7 is an integer from 1 to 4. (12) The liquid crystal alignment treatment agent according to the above (11), wherein, in the formula [3], ml is an integer of 1 to 2. (13) The liquid crystal alignment treatment agent according to the above item (11), wherein, in the formula [4], 'X6 is a single bond, a CH2—, a C2H4—, a C(CΗ3) 2 , a Ο _ , _ CΟ —, a ΝΗ _, a N(CΗ3)—, —CONH —, —NHCO —, —COO —, or —OCO—, m2 and m3 are integers of one at the same time. (14) The liquid crystal alignment treatment agent according to the above item (11), wherein, in the formula [7], X8 is a single bond, a CH2-, a 0-, a _CO-, a -NH-, a CONH-, a NHCO-, -CH20-, -OCH2-, -COO-, or -OCO-, m7 is an integer from 1 to 2. The liquid crystal alignment treatment agent according to any one of the above-mentioned (1) to (1), wherein the diamine component has a molar amount of 1 mol relative to the diamine represented by the formula, in the molecule. The diamine having a carboxyl group is from 0.01 to 99 moles. The liquid crystal alignment agent of any one of the above-mentioned (1) to (15), wherein 5 to 80% by mass of the solvent contained in the liquid crystal alignment treatment agent is a weak solvent. The liquid crystal alignment treatment agent according to any one of the above aspects, wherein the copolymer in the liquid crystal alignment treatment agent is a polyimine obtained by dehydration ring closure of polyacrylic acid. (18) A liquid crystal alignment film which is obtained by using the liquid crystal alignment treatment agent according to any one of the above (1) to (7). -12- 200948859 (19) A liquid crystal display element comprising the liquid crystal alignment film of (18) above. The liquid crystal alignment treatment agent of the present invention can be obtained by a relatively simple method, and when the liquid crystal alignment treatment agent is used, a high voltage retention ratio can be obtained, and even when exposed to a high temperature for a long time, the DC voltage can be moderated earlier. A liquid crystal alignment film that accumulates residual charges. Therefore, the liquid crystal display element having a liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention has excellent reliability and is highly suitable for use in a liquid crystal television having a large screen and high definition. BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail. The present invention relates to a liquid crystal alignment agent comprising a copolymer obtained by reacting a diamine component comprising a diamine compound (A) and a diamine compound (B) with a tetracarboxylic dianhydride, the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent, And a liquid crystal display element having the liquid crystal alignment film. In this case, the diamine compound (A) is a diamine compound represented by the formula [1], and the diamine compound (B) is a diamine compound having a carboxyl group in the molecule. The diamine compound (A) used in the present invention is one in which a branched chain has a nitrogen-containing aromatic heterocyclic ring. The nitrogen-containing aromatic heterocyclic ring has a function of hopping-site due to its conjugated structure, and promotes the movement of charges in the liquid crystal alignment film. Further, the nitrogen-containing aromatic heterocyclic ring is bonded to the carboxyl group of the diamine compound (B) via electrostatic interaction forming a salt or a hydrogen bond, thereby causing a charge between the carboxyl group and the nitrogen-containing aromatic heterocyclic ring.产-13- 200948859 生移动. Therefore, the charge moved to the nitrogen-containing aromatic heterocyclic moiety can be efficiently moved intramolecularly or intramolecularly in the copolymer. For the above reasons, the liquid crystal alignment treatment agent of the present invention can obtain a high voltage holding ratio when used as a liquid crystal alignment film, and can repel the residual electric charge accumulated by the DC voltage even when exposed to a high temperature for a long period of time. The effect. <Diamine component> [Diamine compound (A)] The diamine compound (A) used in the present invention is a diamine compound represented by the following formula [1]. [Chemistry 7]
nh2 H2N {·Χι-X2-X3-X4 ) n [ 1 ] 式[1]中,又!爲選自由-〇-、-NQ1-、-CONQ1-、—NQko—、—CH20—及—OCO-所成群之至少一種二 價有機基,Q1爲氫原子或碳數1至3之烷基,X2爲單鍵或選 自由碳數1至20之脂肪族烴基、非芳香族環式烴基及芳香 族烴基所成群之至少一種二價有機基,X3爲單鍵或選自由 一0_、-NQ2-、-CONQ2- ' -NQ2CO- ' -COO- ' —0C0—及—〇(CH2)m- (m爲1至5之整數)所成群之至少 一種二價有機基,Q2爲氫原子或碳數1至3之烷基’ X4爲含 -14- 200948859 氮之芳香族雜環’ n爲1至4之整數。 式[1 ]中之二個胺基(一 ΝΗ2 )之鍵結位置並無限制。 具體而言,η爲1之整數時,舉例爲相對於側鏈之鍵結基( Xj ),爲苯環上之2、3位置’ 2、4位置’ 2、5位置’ 2、ό 位置,3、4位置,3、5位置。η爲2之整數時,舉例爲下列 之位置。相對於側鏈之鍵結基(Χι ),苯環上之2位置上 具有側鏈鍵結基(χι)時’兩個胺基之鍵結位置舉例爲3 、4位置’ 3、5位置’ 3、6位置,4、5位置。另外,相對 於側鏈之鍵結基(Xi),苯環上之3位置上具有側鏈鍵結 基(X,)時,兩個胺基之鍵結位置舉例爲2、4位置,2、5 位置,4、5位置,4、6位置。另外,相對於側鏈之鍵結基 (X!),苯環上之4位置上具有側鏈之鍵結基(X!)時, 兩個胺基之鍵結位置舉例爲2、3位置,2、5位置,2、6位 置,3、5位置。η爲3之整數時,舉例爲下列位置。相對於 側鏈之鍵結基(X!),苯環上之2、3位置上具有側鏈之鍵 結基(Xi)時,兩個胺基之鍵結位置舉例爲4、5位置、4 、6位置。另外,相對於側鏈之鍵結基(X,),苯環上之2 、4位置上具有側鏈之鍵結基(X!)時,兩個胺基之鍵結 位置舉例爲3、5位置、3、6位置,5、6位置。另外,相對 於側鏈鍵結基(X i ),苯環上之3、5位置上具有側鏈之鍵 結基(X!)時,兩個胺基之鍵結位置舉例爲2、4位置。n 爲4之整數時,舉例爲下列位置。相對於側鏈之鍵結基( Χι ),苯環上之2、3、4位置上具有側鏈之鍵結基(Xi ) 時,兩個胺基之鍵結位置舉例爲5、6位置。又,相對於側 200948859 鏈之鍵結基(Xi),苯環上之2、4、5位置上具有側鏈之 鍵結基(X!)時,兩個胺基之鍵結位置舉例爲3、6位置。 另外,相對於側鏈之鍵結基(X!).,苯環上之2、4、6位 置上具有側鏈之鍵結基(X!)時,兩個胺基之鍵結位置舉 例爲3、5位置。該等之中,就合成聚醯胺酸時之反應性之 觀點,以及加上合成二胺化合物時容易性而言,η爲1之整 數時,兩個胺基之鍵結位置最好爲2、4位置、2、5位置、 3、5位置,或η爲2之整數時相對於側鏈之結合基(Xi ), 苯環上之3位置上具有側鏈鍵結基(X〇時,兩個胺基之 鍵結位置最好爲4、6位置。 式[1]中 Χι 爲選自由一 〇—、一 NQ1-、一 CONQ1—、 一 NQkO—、— CH20—及—OCO—所成群之至少一種二價 有機基。其中,以 _〇_、一NQ1—、— CONQ1—、 一;KQkO—較佳。而且,Q1係與式[1]之定義相同。 X!更具體之結構舉例爲下述式[la]至式[If]。 [化] H2丨Nh2 H2N {·Χι-X2-X3-X4 ) n [ 1 ] In the formula [1], again! Is at least one divalent organic group selected from the group consisting of -〇-, -NQ1-, -CONQ1-, -NQko-, -CH20-, and -OCO-, and Q1 is a hydrogen atom or an alkyl group having 1 to 3 carbon atoms X2 is a single bond or at least one divalent organic group selected from the group consisting of an aliphatic hydrocarbon group having 1 to 20 carbon atoms, a non-aromatic cyclic hydrocarbon group, and an aromatic hydrocarbon group, and X3 is a single bond or is selected from a 0-, - NQ2-, -CONQ2-'-NQ2CO-'-COO-'-0C0- and -〇(CH2)m- (m is an integer from 1 to 5) of at least one divalent organic group, Q2 is a hydrogen atom Or an alkyl group having a carbon number of 1 to 3 'X4 is an aromatic heterocyclic ring having a nitrogen content of from 14 to 200948859, and n is an integer of from 1 to 4. The bonding position of the two amine groups (mono-2) in the formula [1] is not limited. Specifically, when η is an integer of 1, it is exemplified by a bonding group (Xj) with respect to a side chain, 2, 3 positions on the benzene ring, 2, 4 positions, 2, 5 positions '2, ό position, 3, 4 position, 3, 5 position. When η is an integer of 2, the following positions are exemplified. With respect to the bonding group of the side chain (Χι ), when the side of the benzene ring has a side chain bonding group (χι), the bonding position of the two amine groups is exemplified by 3, 4 positions '3, 5 positions'. 3, 6 position, 4, 5 position. Further, when the side chain bonding group (X,) is present at the 3 position on the benzene ring with respect to the bonding group (Xi) of the side chain, the bonding position of the two amine groups is exemplified by 2, 4 positions, 2 5 position, 4, 5 position, 4, 6 position. Further, when the bonding group (X!) having a side chain at the 4-position on the benzene ring is bonded to the bonding group (X!) of the side chain, the bonding positions of the two amine groups are exemplified by the positions 2 and 3, 2, 5 position, 2, 6 position, 3, 5 position. When η is an integer of 3, the following positions are exemplified. With respect to the bonding group (X!) of the side chain, when the bonding group (Xi) having a side chain at the positions 2 and 3 on the benzene ring, the bonding positions of the two amine groups are exemplified by 4, 5 positions, 4 , 6 positions. Further, when the bonding group (X!) having a side chain at the positions 2 and 4 on the benzene ring is bonded to the bonding group (X,) of the side chain, the bonding position of the two amine groups is exemplified as 3, 5 Position, 3, 6 position, 5, 6 position. Further, when the side chain bonding group (X i ) has a side chain bonding group (X!) at the 3 and 5 positions on the benzene ring, the bonding positions of the two amine groups are exemplified by 2 and 4 positions. . When n is an integer of 4, the following positions are exemplified. With respect to the bonding group of the side chain ( Χι ), when the bonding group (Xi) of the side chain is present at the 2, 3, and 4 positions on the benzene ring, the bonding positions of the two amine groups are exemplified by the 5 and 6 positions. Further, when the bonding group (X!) of the chain is present at the 2, 4, and 5 positions on the benzene ring with respect to the bonding group (Xi) of the chain of the 200948859 chain, the bonding position of the two amine groups is exemplified as 3 , 6 positions. Further, when the bonding group (X!) having a side chain at the positions 2, 4, and 6 on the benzene ring is bonded to the bonding group (X!) of the side chain, the bonding position of the two amine groups is exemplified as 3, 5 position. Among these, the viewpoint of the reactivity in synthesizing poly-proline, and the ease of synthesizing the diamine compound, when η is an integer of 1, the bonding position of the two amine groups is preferably 2 , 4 position, 2, 5 position, 3, 5 position, or η is an integer of 2 with respect to the binding group (Xi) of the side chain, and has a side chain bonding group at the 3 position on the benzene ring (X〇, The bonding position of the two amine groups is preferably 4 and 6. The formula [1] is selected from the group consisting of a 〇-, an NQ1-, a CONQ1-, an NQkO-, a CH20-, and an -OCO. At least one divalent organic group of the group, wherein _〇_, one NQ1-, -CONQ1-, one; KQkO- is preferred. Moreover, the Q1 system is the same as the definition of the formula [1]. X! More specific structure For example, the following formula [la] to formula [If]. [Chemical] H2丨
H2H2
X2-X3-X*) n Η,X2-X3-X*) n Η,
-Χ2-Χ3-Χ4)η [1 f] 〇-Χ2-Χ3-Χ4)η [1 f] 〇
H2IH2I
ΓΓ2气 [lc]ΓΓ2 gas [lc]
-16- 200948859 其中,以式[la]、式[lb]、式[〗c]及式[Id]較佳。且, Q1係與式[1]之定義相同。 式[1]中,x2爲單鍵、碳數1至20之脂肪族烴基、非芳 香族環式烴基,或芳香族烴基。 碳數1至20之脂肪族烴基可爲直鏈狀,亦可爲分支。 又,亦可具有不飽和鍵。較佳爲碳數1至10之脂肪族烴基 〇 非芳香族環狀烴基之具體例舉例爲環丙烷環、環丁烷 環、環戊烷環、環己烷環、環庚烷環、環辛烷環、環壬烷 環、環癸烷環、環十一烷環、環十二烷環、環十三烷環、 環十四烷環、環十五烷環、環十六烷環、環十七烷環、環 十八烷環、環十九烷環、環二十烷環、三環二十烷環、三 環癸烷環、雙環丁烷環、十氫萘環、原冰片烯環、金剛烷 環等。 芳香族烴基之具體例舉例爲苯環、萘環、四氫萘環、 奧環、節環、苟環、惠環、菲環、非那稀(Phenalene)環 等。 式[1]中’較佳之X2爲單鍵、碳數1至10之直鏈或分支 伸烷基、碳數1至10之不飽和伸烷基、環丙烷環、環丁烷 環、環戊烷環、環己烷環、環庚烷環、原冰片烯環、金剛 烷環、苯環、萘環、四氫萘環、芴環、蒽環,更好爲單鍵 、碳數1至10之直鏈或分支伸烷基、碳數1至10之不飽和伸 院基、環己院環、原冰片嫌環、金剛院環、苯環、萘環、 荀環、恵環,又更好爲單鍵、碳數1至1〇之直鏈或分支伸 -17- 200948859 烷基、環己烷基、苯環、萘環,特好爲單鍵、碳數1至5之 直鏈或分支伸院基、苯環。最好爲單鍵、碳數1至3之直鏈 伸烷基或苯環。 式[1]中,χ3爲單鍵或選自由—NQ2—、-16- 200948859 wherein, the formula [la], the formula [lb], the formula [〗 〖], and the formula [Id] are preferred. Further, Q1 is the same as the definition of the formula [1]. In the formula [1], x2 is a single bond, an aliphatic hydrocarbon group having 1 to 20 carbon atoms, a non-aromatic aromatic hydrocarbon group, or an aromatic hydrocarbon group. The aliphatic hydrocarbon group having 1 to 20 carbon atoms may be linear or branched. Further, it may have an unsaturated bond. Specific examples of the aliphatic hydrocarbon group fluorene non-aromatic cyclic hydrocarbon group preferably having 1 to 10 carbon atoms are exemplified by a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, and a cyclooctane. Alkane ring, cyclodecane ring, cyclodecane ring, cycloundecyl ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, ring Heptadecane ring, cyclooctadecane ring, cyclodecadecane ring, cycloecosane ring, tricyclohexadecane ring, tricyclodecane ring, bicyclobutane ring, decahydronaphthalene ring, norbornene ring , adamantane ring, etc. Specific examples of the aromatic hydrocarbon group are a benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, an Austrian ring, a pitch ring, an anthracene ring, a ring, a phenanthrene ring, and a Phenalene ring. In the formula [1], preferred X2 is a single bond, a linear or branched alkyl group having 1 to 10 carbon atoms, an unsaturated alkyl group having 1 to 10 carbon atoms, a cyclopropane ring, a cyclobutane ring, and a cyclopentane. Alkane ring, cyclohexane ring, cycloheptane ring, norbornene ring, adamantane ring, benzene ring, naphthalene ring, tetrahydronaphthalene ring, anthracene ring, anthracene ring, more preferably a single bond, carbon number 1 to 10 Straight chain or branched alkyl, carbon number 1 to 10 unsaturated extension base, ring ring ring, original borneol ring, diamond ring, benzene ring, naphthalene ring, ring, ring, and better It is a single bond, a linear or branched carbon number of 1 to 1 -17. -17- 200948859 alkyl, cyclohexane, benzene, naphthalene ring, especially a single bond, straight chain or branch of carbon number 1 to 5. Extend the base and benzene ring. It is preferably a single bond, a linear alkyl group having a carbon number of 1 to 3 or a benzene ring. In the formula [1], χ3 is a single bond or is selected from -NQ2-,
—0(CH2)m- (m爲1至5之整數)所成群之至少一種二價有 機基’較佳爲單鍵、-〇-、一 C0NQ2-、—nQ2c〇-、 —COO _、— OCO-及—〇(CH2)m — (m爲 1 至 5之整數)。 最好爲單鍵、一 OCO-或—〇CH2—。且’ Q2係與式[1]之 定義相同。 式[1]中,x4爲含氮之芳香族雜環,且爲含有選自由 下述式[2 a]、式[2b]及式[2 c]組成之組群之至少一個結構之 含氮芳香族雜環。 [化3]—0(CH 2 ) m — (m is an integer of 1 to 5) at least one divalent organic group 'preferably a single bond, —〇—, a C0NQ 2−, —nQ 2 c〇—, —COO —, — OCO- and —〇(CH2)m — (m is an integer from 1 to 5). It is preferably a single bond, an OCO- or -〇CH2-. And the 'Q2 system is the same as the definition of the formula [1]. In the formula [1], x4 is a nitrogen-containing aromatic heterocyclic ring, and is a nitrogen-containing compound containing at least one structure selected from the group consisting of the following formula [2 a], the formula [2b], and the formula [2 c]. Aromatic heterocycle. [Chemical 3]
式[2 c]中’ Y!爲碳數1至5之直鏈或分支狀烷基。 式[1]中,較佳之X4爲1¾:略環、咪哗環、嚼哩環、噻 唑環、吡唑環、吡啶環、嘧啶環、喹琳環、吡唑啉環、異 喹啉環、咔唑環、嘌呤環、噻二唑環、塔拼環、啦唑琳環 、三畊環、吡唑啶環、三唑環、哌啶環、苯并咪唑環、苯 并咪唑環、噻諾啉環、菲啉環、吲哚環、喹諾啉環、苯并 -18- .200948859 噻唑環、菲噻D并環、噁二唑環、吖丁啶環,更好爲吡咯環 、咪唑環、吡唑環、吡啶環、嘧啶環、吡唑啉環、味唑環 、嗒畊環、吡唑啉環、三畊環、吡唑啶環、三唑環、哌啶 環、苯并咪唑環、苯并咪唑環,又更好爲吡咯環、咪唑環 、吡唑環、吡啶環、嘧啶環、嗒畊環、三畊環、三唑環、 哌啶環、苯并咪唑環、苯并咪唑環,最好爲吡咯環、咪唑 環、吡唑環、吡啶環、嘧啶環。又最好爲咪唑環、吡啶環 或嘧啶環。 又,X3較佳與未與X4中所含之式[2a]、式[2b]及式 [2c]相鄰之取代基鍵結。 式[1]中,η爲1至4之整數,且就與四羧酸二酐之反應 性之觀點而言較佳爲1至3之整數。最好,η爲1或2之整數 〇 式[1]中較佳之X,、Χ2、Χ3、Χ4及η之組合爲X,爲選自 由—— NQ1-、— CONQi-、— NQiCO-、 -CH20 —及- oco —所成群之至少一種,χ2爲選自由碳數 1至10之直鏈或分支狀伸烷基、碳數1至10之不飽和伸烷基 、環丙烷環、環丁烷環、環戊烷環、環己烷環、環庚烷環 、原冰片烯環、金剛烷環、苯環、萘環、四氫萘環、芴環 及蒽環等組成之組群之至少一種,χ3爲單鍵或選自由 -0_ 、 _ NQ2 —、- CONQ2 一、- NQ2CO -、— COO -、 一 OCO-及(111爲1至5之整數)所成群之至少 —種’ X4爲選自由吡咯環、咪唑環、噁唑環、噻唑環、吡 唑環、吡啶環、嘧啶環、喹啉環、吡唑啉環、異喹啉環、 -19- 200948859 味哗環、嘌呤環、噻二唑環、嗒畊環、吡唑啉環、三畊環 、啦哩陡環、三唑環、哌啶環、苯并咪唑環'苯并咪唑環 、噻諾啉環、菲啉環、吲哚環、喹諾啉環、笨并噻唑環、 菲噻淀環、噁二唑環及吖丁啶環所成群之至少一種,η爲1 或2之整數。 更好式[1]中之Xi、Χ2、Χ3、又4及η之組合爲Xl爲選自 由一〇—、一 NQi_、一 CONQ1-、一 NQkO—及 —CH2〇 —所成群之至少—種,x2爲選自由碳數1至10之直 鏈或分支狀伸烷基、碳數1至10之不飽和伸烷基、環己烷 環、原冰片烯環、金剛烷環、苯環、萘環、芴環及蒽環等 組成之組群之至少一種,χ3爲選自由單鍵、一 〇—、 -NQ2—、一 CONQ2—、— NQ2CO-、-COO-、 —OCO—及一 〇(CH2)m— (m爲1至5之整數)所成群之至少 一種,X4爲選自由吡咯環、咪唑環、吡唑環、吡啶環、嘧 啶環、吡唑啉環、咔唑環、嗒畊環、吡唑啉環、三畊環、 吡唑啶環、三唑環、哌啶環、苯并咪唑環及苯并咪唑環所 成群之至少一種,η爲1或2之整數。 又更好式[1]中之Xi、Χ2、Χ3、Χ4及η之組合爲X!爲選 自由-〇_、-NQi-、-CONQi-、-NQiCO-、 一 CH20 -及一 0C0 —所成群之至少一種,x2爲選自由碳數 1至10之直鏈或分支狀伸烷基、環己烷環、苯環及萘環組 成之組群之至少一種,X3爲選自由單鍵、一0—、 —C0NQ2-、— NQ2C0-、— C00-、—0C0-及 -0(CH2)m - (m爲1至5之整數)所成群之至少一種,X4 -20- 200948859 爲選自由吡咯環、咪唑環、吡唑環、吡啶環、嘧啶環、嗒 D并環、三畊環、三唑環、呱啶環、苯并咪唑環及苯并咪唑 環所成群之至少一種,η爲1或2之整數。 最好式[1]中之Χι、Χ2、Χ3、Χ4及η之組合爲Χι爲選自 由一 〇_、一 NQi—、一 C;〇NQi_、一 —及 —CH20-所成群之至少一種,χ2爲選自由單鍵、碳數1至 5之直鏈或分支狀伸烷基及苯環所成群之至少一種,X3爲 選自由單鍵、一0-、一C0NQ2-、一 NQ2CO—、 —C00—、— 0C0— 及—0(CH2)m— (m爲 1 至 5之整數)所 成群之至少一種,X4爲選自由吡咯環、咪唑環、吡唑環、 吡啶環及嘧啶環所成群之至少一種,η爲1或2之整數》 又最好式[1]中之Χι、Χ2、Χ3、Χ4及η之組合爲X,爲選 自由—0—、一 NQ1—、一 C0NQ1- 及—NQiCO -所成群之 至少一種,X2爲選自由單鍵、碳數1至3之直鏈伸烷基及苯 環所成群之至少一種,X3爲選自由單鍵、- 0C0 -及一 0CH2 —所成群之至少一種,X4爲選自由咪唑環、吡啶環 及嘧啶環所成群之至少一種,n爲1或2之整數。最好式 中之Χι、Χ2、Χ3、Χ4及η之組合爲下列表1至表3中所示。 且,Q1及Q2係與式[1]之定義相同。 -21 - 200948859 [表i]' Y! in the formula [2 c] is a linear or branched alkyl group having 1 to 5 carbon atoms. In the formula [1], preferred X4 is 13⁄4: a slightly ring, a oxime ring, a chewable ring, a thiazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a quinoline ring, a pyrazoline ring, an isoquinoline ring, Indazole ring, anthracene ring, thiadiazole ring, tower ring, oxazoline ring, three-till ring, pyrazolidine ring, triazole ring, piperidine ring, benzimidazole ring, benzimidazole ring, tino Phytoline ring, phenanthroline ring, anthracene ring, quinolino ring, benzo-18-.200948859 thiazole ring, phenothiazine D ring, oxadiazole ring, azetidine ring, more preferably pyrrole ring, imidazole ring, pyridyl Oxazole ring, pyridine ring, pyrimidine ring, pyrazoline ring, oxazole ring, sorghum ring, pyrazoline ring, three-till ring, pyrazolidine ring, triazole ring, piperidine ring, benzimidazole ring, benzene And an imidazole ring, more preferably a pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a sorghum ring, a three-till ring, a triazole ring, a piperidine ring, a benzimidazole ring, a benzimidazole ring, Preferably, it is a pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring or a pyrimidine ring. Further preferably, it is an imidazole ring, a pyridine ring or a pyrimidine ring. Further, X3 is preferably bonded to a substituent which is not adjacent to the formula [2a], the formula [2b] and the formula [2c] contained in X4. In the formula [1], η is an integer of 1 to 4, and is preferably an integer of 1 to 3 from the viewpoint of reactivity with tetracarboxylic dianhydride. Preferably, η is an integer of 1 or 2. The preferred combination of X, Χ2, Χ3, Χ4 and η in the formula [1] is X, which is selected from the group consisting of -NQ1-, -CONQi-, -NQiCO-, -CH20 - and - oco - at least one of the group, χ2 is selected from a linear or branched alkyl group having 1 to 10 carbon atoms, an unsaturated alkyl group having 1 to 10 carbon atoms, a cyclopropane ring, and a ring. a group consisting of a butane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a norbornene ring, an adamantane ring, a benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, an anthracene ring, and an anthracene ring. At least one type, χ3 is a single bond or at least selected from the group consisting of -0_, _NQ2-, -CONQ2, -NQ2CO-, -COO-, an OCO-, and (111 is an integer from 1 to 5) X4 is selected from the group consisting of pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, -19-200948859 miso ring, 嘌呤Ring, thiadiazole ring, sorghum ring, pyrazoline ring, three-till ring, scorpion steep ring, triazole ring, piperidine ring, benzimidazole ring 'benzimidazole ring, quinololine ring, phenanthroline Ring, anthracene ring, quinololine ring, stupid A thiazole ring, a phenanthrene ring lake thiazole, oxadiazole ring and azetidine ring at least one of the groups, [eta] is an integer of 1 or 2. Preferably, the combination of Xi, Χ2, Χ3, 4 and η in the formula [1] is Xl selected from at least one group consisting of one 〇—, one NQi_, one CONQ1-, one NQkO—and —CH2〇— And x2 is a linear or branched alkyl group having a carbon number of 1 to 10, an unsaturated alkyl group having 1 to 10 carbon atoms, a cyclohexane ring, a norbornene ring, an adamantane ring, a benzene ring, At least one of a group consisting of a naphthalene ring, an anthracene ring and an anthracene ring, the hydrazine 3 is selected from the group consisting of a single bond, a fluorene-, -NQ2-, a CONQ2-, -NQ2CO-, -COO-, -OCO- and a quinone (CH2)m—(m is an integer from 1 to 5) at least one of the group, and X4 is selected from the group consisting of a pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a pyrazoline ring, an indazole ring, At least one of a group consisting of a sorghum ring, a pyrazoline ring, a tri-negative ring, a pyrazolidine ring, a triazole ring, a piperidine ring, a benzimidazole ring, and a benzimidazole ring, and η is an integer of 1 or 2. Further, the combination of Xi, Χ2, Χ3, Χ4 and η in the formula [1] is X! is selected from the group consisting of -〇_, -NQi-, -CONQi-, -NQiCO-, a CH20-, and a 0C0- At least one of the groups, x2 is at least one selected from the group consisting of a linear or branched alkyl group having 1 to 10 carbon atoms, a cyclohexane ring, a benzene ring, and a naphthalene ring, and X3 is selected from a single bond, X0 -, -C0NQ2-, - NQ2C0-, - C00-, -0C0-, and -0(CH2)m - (m is an integer from 1 to 5) are at least one group, X4-20-200948859 is selected At least one of a group of a free pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a fluorene D ring, a three-till ring, a triazole ring, an acridine ring, a benzimidazole ring, and a benzimidazole ring. η is an integer of 1 or 2. Preferably, the combination of Χι, Χ2, Χ3, Χ4 and η in the formula [1] is at least one selected from the group consisting of one 〇, one NQi-, one C; 〇NQi_, one----CH20-. Χ2 is at least one selected from the group consisting of a single bond, a linear or branched alkyl group having a carbon number of 1 to 5, and a benzene ring selected from the group consisting of a single bond, a 0-, a C0NQ2-, and an NQ2CO- And -C00-, -0C0- and -0(CH2)m- (m is an integer from 1 to 5) in groups of at least one selected from the group consisting of a pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring, and a pyrimidine At least one of the groups of the rings, η is an integer of 1 or 2. Further, the combination of Χι, Χ2, Χ3, Χ4, and η in the formula [1] is X, which is selected from -0-, an NQ1-, At least one of a group of C0NQ1- and -NQiCO-, X2 is at least one selected from the group consisting of a single bond, a linear alkyl group having 1 to 3 carbon atoms, and a benzene ring, and X3 is selected from a single bond, - 0C0 - and -0CH2 - at least one of the group, X4 is at least one selected from the group consisting of an imidazole ring, a pyridine ring and a pyrimidine ring, and n is an integer of 1 or 2. The combination of Χι, Χ2, Χ3, Χ4 and η in the best formula is shown in Tables 1 to 3 below. Further, Q1 and Q2 are the same as defined in the formula [1]. -21 - 200948859 [Table i]
Xl X2 χ3 X4 A-l -0- 單鍵 單鍵 咪唑環 A-2 -0- 單鍵 單鍵 吡啶環 A-3 -0- 單鍵 單鍵 嘧啶環 A-4 —NQ1 — 單鍵 單鍵 咪唑環 A-5 -NQ1- 單鍵 單鍵 吡啶環 A-6 -NQ1- 單鍵 單鍵 嘧啶環 A—7 -CONQ1 — 單鍵 單鍵 咪唑環 A—8 -CONQ1- 單鍵 單鍵 口比陡環 A-9 -CONQ1- 單鍵 單鍵 嘧啶環 A-10 -NQ^O- 單鍵 單鍵 咪唑環 A-ll -nq'co- 單鍵 單鍵 吡啶環 A-12 _NQ】CO- 單鍵 單鍵 嘧啶環 A-13 -0- 碳數1至3之直鏈伸烷基 單鍵 咪唑環 A-14 —Q — 碳數1至3之直鏈伸烷基 單鍵 吡啶環 A—15 -o- 碳數1至3之直鏈伸烷基 單鍵 嘧啶環 A-16 -0- 碳數1至3之直鏈伸烷基 一 0C0- 咪唑環 A-17 -0- 碳數1至3之直鏈伸烷基 -0C0- 吡啶環 A-18 —0 — 碳數1至3之直鏈伸烷基 -0C0- 嘧啶環 A—19 -0- 碳數1至3之直鏈伸烷基 -och2- 咪唑環 A-20 -0— 碳數1至3之直鏈伸烷基 —och2— 咖定環 A-21 -0- 碳數1至3之直鏈伸烷基 -och2- 嘧啶環 A-22 -NQ1- 碳數1至3之直鏈伸烷基 單鍵 咪唑環 A-23 -NQ1- 碳數1至3之直鏈伸烷基 單鍵 耻陡環 A-24 -NQ1- 碳數1至3之直鏈伸烷基 單鍵 嘧啶環 A-25 -NQ1- 碳數1至3之直鏈伸烷基 -0C0- 咪唑環 A—26 -NQ1- 碳數1至3之直鏈伸烷基 -0C0- 口比π定環 A-27 -NQ1- 碳數1至3之直鏈伸烷基 -0C0- 嘧啶環 A_ 28 -NQ1- 碳數1至3之直鏈伸烷基 -och2— 咪唑環 A-29 -NQ1- 碳數1至3之直鏈伸烷基 -och2— 吡啶環 A—30 -NQ1- 碳數1至3之直鏈伸烷基 -och2- 嘧啶環 A-31 -CONQ1- 碳數1至3之直鏈伸烷基 單鍵 咪唑環 -22- 200948859 表2]Xl X2 χ3 X4 Al -0- single bond single bond imidazole ring A-2 -0- single bond single bond pyridine ring A-3 -0- single bond single bond pyrimidine ring A-4 —NQ1 — single bond single bond imidazole ring A-5 -NQ1- single bond single bond pyridine ring A-6 -NQ1- single bond single bond pyrimidine ring A-7-CONQ1 — single bond single bond imidazole ring A-8 -CONQ1- single bond single bond port ratio steep ring A-9 -CONQ1- single bond single bond pyrimidine ring A-10 -NQ^O- single bond single bond imidazole ring A-ll -nq'co- single bond single bond pyridine ring A-12 _NQ]CO- single button Aminopyrimidine ring A-13 -0- a linear alkyl group having a carbon number of 1 to 3, an imidazole ring A-14 —Q — a linear alkyl group having a carbon number of 1 to 3, a pyridine ring A-15-o - a straight-chain alkyl-monomethylpyrimidine ring having a carbon number of 1 to 3, A-16 -0- a linear alkyl group having a carbon number of 1 to 3, a 0C0-imidazole ring, A-17 -0-, and a carbon number of 1 to 3 Linear alkyl-0C0-pyridine ring A-18 — 0 — linear alkyl 1C to 10-C0-pyrimidine ring A-19-0- straight chain alkyl group having 1 to 3 carbon atoms Och2-imidazole ring A-20 -0 - linear alkyl 1 to 3 - och2 - ca ring A-21 -0 - linear alkyl 1 - 3 - och 2 - pyrimidine ring A -22 -NQ 1-Carbon number 1 to 3 linear alkyl group single bond imidazole ring A-23 -NQ1 carbon number 1 to 3 linear alkyl group single bond shaky steep ring A-24 -NQ1- carbon number 1 to 3 Linear one-chain alkyl single-bonded pyrimidine ring A-25 -NQ1- straight-chain alkyl-C0-C0-imidazole ring A-26 -NQ1- linear alkyl-alkyl group having 1 to 3 carbon atoms 0C0- mouth ratio π ring A-27 -NQ1 - 1 to 3 carbon chain alkyl-Oc0-pyrimidine ring A_ 28 -NQ1 - 1 to 3 straight chain alkyl-och2 - imidazole ring A-29 -NQ1 - straight chain alkyl-och2 of carbon number 1 to 3 - pyridine ring A-30 -NQ1 - linear alkyl group of 1 to 3 carbon atoms -och2-pyrimidine ring A-31 -CONQ1- Linear one-chain alkyl single bond imidazole ring of carbon number 1 to 3-22-200948859 Table 2]
Xl X2 χ3 X4 A-32 -CONQ1- 碳數1至3之直鏈伸烷基 單鍵 口比陡環 A—33 一CONQ1- 碳數1至3之直鏈伸烷基 單鍵 嘧啶環 A-34 -CONQ1- 碳數1至3之直鏈伸烷基 -OCO- 咪唑環 A—35 -CONQ1- 碳數1至3之直鏈伸烷基 -0C0- 吡陡環 A-36 -CONQ1- 碳數1至3之直鏈伸烷基 -0C0- 嘧啶環 A-37 -CONQ1- 碳數1至3之直鏈伸烷基 —och2- 咪唑環 A—38 -CONQ1- 碳數1至3之直鏈伸烷基 -och2— 口比陡環 A-39 -CONQ1- 碳數1至3之直鏈伸烷基 一 och2- 嘧啶環 A-40 -NQ^O- 碳數1至3之直鏈伸烷基 單鍵 咪唑環 A-41 -NQ^O- 碳數1至3之直鏈伸烷基 單鍵 啦淀環 A-42 -NQJCO- 碳數1至3之直鏈伸烷基 單鍵 嘧啶環 A-43 -nq'co- 碳數1至3之直鏈伸烷基 -0C0- 咪唑環 A—44 -NQ^O- 碳數1至3之直鏈伸烷基 -0C0- 吡淀環 A-45 -NQ^O- 碳數1至3之直鏈伸烷基 -0C0- 嘧啶環 A-46 -nq!co- 碳數1至3之直鏈伸烷基 —och2- 咪唑環 A-47 -NQ^O- 碳數1至3之直鏈伸烷基 —och2- 吡啶環 A—48 -NQ^O- 碳數1至3之直鏈伸烷基 -och2- 嘧啶環 A—49 —0- 苯環 單鍵 咪唑環 A-50 -0- 苯環 單鍵 吡啶環 A-51 -0- 苯環 單鍵 嘧啶環 A-52 -0- 苯環 -0C0- 咪唑環 A-53 -0 — 苯環 -0C0- 耻陡環 A-54 -0- 苯環 -0C0- 嘧啶環 A-55 -0- 苯環 -och2- 咪唑環 A—56 -0- 苯環 -och2- 啦陡環 A-57 -0- 苯環 -och2- 嘧啶環 A-58 -NQ1- 苯環 單鍵 咪唑環 A-59 -NQ1- 苯環 單鍵 吡啶環 A—60 -NQ1- 苯環 單鍵 嘧啶環 A—61 -NQ1- 苯環 -0C0- 咪唑環 A-62 -NQ1- 苯環 -0C0- 咖定環 -23- 200948859 表3]Xl X2 χ3 X4 A-32 -CONQ1- linear one-link alkyl single bond of carbon number 1 to 3 than steep ring A-33 A CONQ1- linear one-chain alkyl single bond pyrimidine ring A- 34 -CONQ1- Linear 1 -3 linear alkyl-OCO-imidazole ring A-35 -CONQ1- linear 1 to 3 linear alkyl-C0- pyridyl ring A-36 -CONQ1- carbon 1 to 3 linear alkyl-alkyl-C0-pyrimidine ring A-37-CONQ1- straight-chain alkyl group having 1 to 3 carbon atoms -och2-imidazole ring A-38 -CONQ1- carbon number 1 to 3 Chain alkyl-och2—mouth ratio steep ring A-39 -CONQ1- linear chain alkyl 1 to 3 och2-pyrimidine ring A-40 -NQ^O- linear extension of carbon number 1 to 3 Alkyl single bond imidazole ring A-41 -NQ^O- straight chain alkylene single bond ring of carbon number 1 to 3 A-42 -NQJCO- linear alkyl one-bonded pyrimidine of carbon number 1 to 3 Ring A-43 -nq'co- Linear alkyl 1C0-Imidazole ring A-44 -NQ^O- straight chain alkyl-C0-pyr ring of carbon number 1 to 3 A-45 -NQ^O- Linear alkyl 1C0-pyrimidine ring A-46 -nq!co- 1 to 3 linear alkyl-och2-imidazole ring A- 47 -NQ^O- Linear alkyl-och2-pyrene with 1 to 3 carbon atoms Ring A—48 -NQ^O- Linear alkyl-o-och2-pyrimidine ring A-49 —0- phenyl ring single bond imidazole ring A-50 -0- benzene ring single bond pyridine ring A -51 -0- phenyl ring single bond pyrimidine ring A-52 -0- benzene ring-0C0- imidazole ring A-53 -0 — benzene ring-0C0- shame steep ring A-54 -0- benzene ring-0C0-pyrimidine Ring A-55 -0- phenyl ring-och2-imidazole ring A-56 -0- benzene ring-och2- 陡 steep ring A-57 -0- phenyl ring-och2-pyrimidine ring A-58 -NQ1- benzene ring Key imidazole ring A-59 -NQ1- benzene ring single bond pyridine ring A-60 -NQ1- benzene ring single bond pyrimidine ring A-61 -NQ1-benzene ring-0C0-imidazole ring A-62 -NQ1-benzene ring-0C0 - 咖定环-23- 200948859 Table 3]
Xl X2 X3 X4 A—63 -NQ1- 苯環 -OCO- 嘧淀環 A—64 -NQ1- 苯環 -och2- 咪唑環 A-65 -NQ1- 苯環 _ OCH2 _ 口比陡環 A-66 -NQ1- 苯環 -OCH2- 喃陡環 A-67 一CONQ1- 苯環 單鍵 咪唑環 A-68 —CONQ1- 賴 單鍵 口比陡環 A-69 -CONQ1- 賴 單鍵 嘧啶環 A-70 -CONQ1- 苯環 -OCO— 咪唑環 A-71 -CONQ1- 苯環 -OCO- 吡啶環 A—72 -CONQ1- 苯環 -OCO- 嘧啶環 A—73 -CONQ1- 苯環 -och2- 咪唑環 A-74 -CONQ1- 苯環 -OCH2- 姐D定環 A-75 -CONQ1- 苯環 —och2- 嘧啶環 A—76 -NQ^O- 苯環 單鍵 咪唑環 A-77 -NQ*CO- 苯環 單鍵 啦陡環 A-78 -NQ^O- 苯環 單鍵 嘧啶環 A—79 -NQ^O- 苯環 -OCO- 咪唑環 A—80 -NQ^O- 苯環 -OCO- 吡啶環 A-81 -NQ^O- 苯環 -OCO- 嘧啶環 A-82 -NQ^O- 苯環 -och2- 咪唑環 A-83 -nq'co- 苯環 -OCH2- 口比淀環 A-84 -nq'co- 苯環 -OCH2- 嘧啶環 A-85 -CONQ1 — 苯環 單鍵 咪唑環 A-86 -CONQ1- 苯環 單鍵 D比陡環 A-87 -CONQ1- 苯環 單鍵 嘧啶環 A-88 -CONQ1- 苯環 -OCO- 咪唑環 A—89 -CONQ1- 苯環 -OCO- 吡啶環 A-90 -CONQ1- 苯環 -OCO- 嘧啶環 A-91 -CONQ1- 苯環 -och2- 咪唑環 A-92 -CONQ1- 苯環 —OCH2 _ 啦淀環 A-93 -CONQ1- 苯環 _ OCH2 _ 嘧啶環 -24- 200948859 [一胺化合物(A)之合成方法] 本發明之式[1]表示之二胺化合物之製造方法並無特別 限制’但較佳之方法列舉於下。 [化9]Xl X2 X3 X4 A-63 -NQ1-benzene ring-OCO- pyrimidine ring A-64 -NQ1-benzene ring-och2-imidazole ring A-65 -NQ1-benzene ring_ OCH2 _ mouth ratio steep ring A-66 - NQ1-benzene ring-OCH2- squirrel ring A-67-CONQ1- benzene ring single bond imidazole ring A-68 —CONQ1- lysing single bond port ratio steep ring A-69 -CONQ1- Lai single bond pyrimidine ring A-70 -CONQ1- benzene ring -OCO-Imidazole ring A-71 -CONQ1- Benzene ring-OCO-pyridine ring A-72 -CONQ1- benzene ring-OCO-pyrimidine ring A-73 -CONQ1-benzene ring-och2-imidazole ring A-74 -CONQ1- Benzene ring-OCH2- sister D-ring A-75-CONQ1-benzene ring-och2-pyrimidine ring A-76-NQ^O- benzene ring single bond imidazole ring A-77 -NQ*CO- benzene ring single bond Ring A-78 -NQ^O- phenyl ring single bond pyrimidine ring A-79 -NQ^O- benzene ring-OCO- imidazole ring A-80 -NQ^O- benzene ring-OCO- pyridine ring A-81 -NQ ^O- phenyl ring-OCO-pyrimidine ring A-82 -NQ^O- phenyl ring-och2-imidazole ring A-83 -nq'co- benzene ring-OCH2- port specific ring A-84 -nq'co- Benzene ring-OCH2-pyrimidine ring A-85-CONQ1 — phenyl ring single bond imidazole ring A-86 -CONQ1- benzene ring single bond D ratio steep ring A-87 -CONQ1- benzene ring single bond pyrimidine ring A-88 -CONQ1 - Benzene ring-OCO- Imidazole ring A-89 -CONQ1- benzene ring-OCO- pyridine ring A-90 -CONQ1- benzene ring-OCO-pyrimidine ring A-91 -CONQ1-benzene ring-och2-imidazole ring A-92 -CONQ1-benzene ring - OCH2 _ lyon ring A-93 -CONQ1 - benzene ring _ OCH2 _ pyrimidine ring-24- 200948859 [Synthesis method of monoamine compound (A)] The method for producing the diamine compound represented by the formula [1] of the present invention is not Particularly limited 'but the preferred method is listed below. [Chemistry 9]
本發明之特定二胺化合物係合成以式[4]表示之二硝基 體,接著使硝基還原轉化成胺基而所得。使二硝基化合物 還原之方法並無特別限制,通常藉由使用鈀一碳、氧化鈾 、阮尼鎳、鉑黑、釕-氧化鋁、硫化鉑碳等觸媒,於乙酸 乙酯、甲苯、四氫呋喃、二噁烷、醇系等溶劑中,以氫氣 、聯胺、氯化氫等進行之方法。式[4]中之X!、X2、X3、 X4及η與式[1]之定義相同。 式[4]之二硝基體可透過Χ3鍵結Χ2及Χ4,隨後,透過 Χι鍵結二硝基部之方法’透過連結部χι使二硝基部與Χ2鍵 結,隨後,透過Χ3與Χ4鍵結之方法等所得。 Χι爲選自由一 〇—(醚鍵)、—NQ1—(胺基鍵)、 —CONQ1—(醯胺鍵)、一 NQkO—(反醯胺鍵)、 —CH20—(亞甲基醚鍵)及—〇C〇—(反酯鍵)所成群之 至少一種鍵結基,該等之鍵結基可以通常之有機合成方法 形成。各鍵結基之Q1係與式Π]之定義相同。 例如,於Χι爲醚、亞甲基酿鍵之情況’舉例爲使對應 200948859 之含有二硝基之鹵素衍生物與含有Χ2、X3及X4之羥基衍生 物在鹼存在下反應之方法’或使含有二硝基之羥基衍生物 與含有Χ2、Χ3及Χ4之鹵素取代之衍生物在鹼存在下反應之 方法。 於胺基鍵之情況’舉例爲使對應之含有二硝基之鹵素 衍生物與含有Χ2、Χ3及Χ4之胺基衍生物在鹼存在下反應之 方法。 於反酯鍵之情況’舉例爲使對應之含有二硝基之經基 衍生物與含有Χ2、Χ3及又4之_氯體在鹼存在下反應之方法 Ο 於醯胺鍵之情況’舉例爲使對應之含有二硝基之醢氯 體與含有χ2、Χ3及X4之胺基取代體在鹼存在下反應之方法 〇 於反酿胺鍵之情況’舉例爲使對應之含有二硝基之胺 基取代體與含有Χ2、Χ3及·Χ4之醯氯體在鹼存在下反應之方 法。 含有二硝基之鹵素衍生物及含有二硝基之衍生物之具 體例舉例爲3,5 —二硝基氯苯、2,4 一二硝基氯苯、2,4 —二 硝基氟苯、3,5—二硝基苯甲醯氯、3,5 —二硝基苯甲酸、 2,4 一二硝基苯甲醯氯、2,4_二硝基苯甲酸、3,5_二硝基 苄基氯、2,4 一二硝基节基氯、3,5 —二硝基苄基醇、2,4_ 二硝基节基醇、2,4 —二硝基苯胺、3,5 —二硝基苯胺、2,6 —二硝基苯胺、2,4_二硝基酧、2,5 —二硝基酣、2,6_二 硝基酚、2,4 -二硝基苯基乙酸等。考量原料之取得性、 -26- 200948859 反應方面,可選擇一種或複數種。 [二胺化合物(B )] 本發明所使用之二胺化合物(B),分子内具有殘基 之二胺化合物。其具體之結構並未有特別限定,較佳爲式 [2]所表示之化合物。 [化 10]The specific diamine compound of the present invention is obtained by synthesizing a dinitro group represented by the formula [4], followed by reduction conversion of a nitro group to an amine group. The method for reducing the dinitro compound is not particularly limited, and is usually carried out by using a catalyst such as palladium-carbon, uranium oxide, ruthenium nickel, platinum black, ruthenium-alumina, or platinum sulfide carbon in ethyl acetate or toluene. Among the solvents such as tetrahydrofuran, dioxane, and alcohol, hydrogen, hydrazine, hydrogen chloride, and the like are used. X!, X2, X3, X4 and η in the formula [4] are the same as defined in the formula [1]. The dinitro group of the formula [4] can be bonded to the ruthenium 2 and the ruthenium 4 through the Χ3 bond, and then the dinitro moiety is bonded to the ruthenium 2 through the χι linkage through the Χι bond, and then bonded through the Χ3 and Χ4. The method and the like. Χι is selected from the group consisting of - (ether bond), -NQ1 - (amino bond), -CONQ1 - (melamine bond), -NQkO - (reverse amine bond), -CH20 - (methylene ether bond) And at least one bonding group in which 〇C〇-(anti-ester bond) is grouped, and the bonding group can be formed by a usual organic synthesis method. The Q1 system of each bonding group is the same as the definition of the formula Π]. For example, in the case where Χι is an ether or a methylene-branched bond, 'exemplification is a method of reacting a dinitro-containing halogen derivative corresponding to 200948859 with a hydroxy derivative containing ruthenium 2, X3 and X4 in the presence of a base' or A method of reacting a dinitro group-containing hydroxy derivative with a halogen-substituted derivative containing ruthenium 2, osmium 3 and ruthenium 4 in the presence of a base. The case of the amino group bond is exemplified by a method of reacting a corresponding halogen derivative containing a dinitro group with an amine derivative containing ruthenium, iridium 3 and ruthenium 4 in the presence of a base. In the case of the reverse ester bond, 'exemplified by the method of reacting the corresponding dinitro group-containing derivative with a ruthenium containing ruthenium 2, ruthenium 3 and 4 in the presence of a base, in the case of a guanamine bond' The method of reacting the corresponding dinitro-containing ruthenium chloride with the amine substituent containing ruthenium 2, ruthenium 3 and X4 in the presence of a base is exemplified by the case of a reversed urethane bond. A method in which a base substituent is reacted with a ruthenium chloride containing ruthenium 2, osmium 3, and ruthenium 4 in the presence of a base. Specific examples of the dinitro group-containing halogen derivative and the dinitro group-containing derivative are exemplified by 3,5-dinitrochlorobenzene, 2,4 dinitrochlorobenzene, and 2,4-dinitrofluorobenzene. , 3,5-dinitrobenzhydryl chloride, 3,5-dinitrobenzoic acid, 2,4-dinitrobenzylidene chloride, 2,4-dinitrobenzoic acid, 3,5_2 Nitrobenzyl chloride, 2,4 dinitrosyl chloride, 3,5-dinitrobenzyl alcohol, 2,4-dinitrobenzyl alcohol, 2,4-dinitroaniline, 3,5 -dinitroaniline, 2,6-dinitroaniline, 2,4-dinitroguanidine, 2,5-dinitroguanidine, 2,6-dinitrophenol, 2,4-dinitrobenzene Acetic acid and the like. Considering the availability of raw materials, -26-200948859, one or more of them can be selected. [Diamine compound (B)] The diamine compound (B) used in the present invention has a diamine compound having a residue in the molecule. The specific structure thereof is not particularly limited, and is preferably a compound represented by the formula [2]. [化10]
式[2]中,X5爲碳數6至30之具有芳香族環之有機基, η爲1至4之整數。 式[2]以具體例示表示時,可列舉如下述式[3]至[7]之 結構。 [化 11]In the formula [2], X5 is an organic group having an aromatic ring having 6 to 30 carbon atoms, and η is an integer of 1 to 4. When the formula [2] is represented by a specific example, the structures of the following formulas [3] to [7] can be cited. [化11]
I nh2I nh2
WCOOHWCOOH
(CH2)m5COOH(CH2)m5COOH
(CH2)meCOOH (CH2)meCOOH(CH2)meCOOH (CH2)meCOOH
H2 Η2ΝΌΧβί^Χ8〇·ΝΗ2H2 Η2ΝΌΧβί^Χ8〇·ΝΗ2
-27- 200948859 式[3]中,ml爲1至4之整數,式[4]中,X6爲單鍵、 —C Η 2 — ' — C 2 Η 4 —、一 C ( C Η 3 ) 2 —、~ c F 2 ~、 —C(CF3)2 —、一 Ο—、一 CO — 、一 NH _、一 N (C Η 3)—、 —CONH— ' — NHCO— ' — CH2〇— ' — OCH2— ' -coo—、- oco -、— con(ch3)— ’ 或-n(ch3)co- ,m2及m3分別爲o至4之整數,且m2+m3表示1至4之整數 ,式[5]中,m4及m5分別爲1至5之整數’式[6]中,X7爲碳 數1至5之直鏈或支鏈烷基’ m6爲1至5之整數’式[7]中’ X8 爲單鍵、—CH2—、— C2H4_、一 C(CH3)2_、_CF2 — 、一C(CF3)2— ' — Ο—、— CΟ —、— ΝΗ —、一 N(CH3) — 、一CONH-、一NHCO-、一CH2〇-、一OCH2-、 -COO -、- OCO -、- CON(CH3)-,或一 N(CH3)CO- ,m7爲1至4之整數。 式[3]至式[7]之結構中’較佳爲,式[3]中,ml爲1至2 之整數結構、式[4]中、X6爲單鍵、一 CH2—、-C2H4—、 -C(CH3)2— ' — ο- ' - CO— ' — NH— ' — N(CH3)— ' -CONH -、- NHCO -、- COO -,或一 〇CO— ’ m2 及 m3同時爲1之整數的結構,式[7]中,X8爲單鍵、一 CH2 — 、—〇—、_ c〇 -、- NH -、- CONH -、- NHCO -、 -CH20- ' - OCH2- ' — COO-,或一 0C0_,m7爲 1 至 2之整數的結構。 二胺化合物(B)之具體例’舉例如下述式至式 [18]之化合物。 200948859 〇 [化 12]-27- 200948859 In the formula [3], ml is an integer from 1 to 4, and in the formula [4], X6 is a single bond, —C Η 2 — ' — C 2 Η 4 —, a C (C Η 3 ) 2 —,~ c F 2 ~, —C(CF3)2 —, one Ο—, one CO—, one NH _, one N (C Η 3)—, —CONH— ' — NHCO— ' — CH2〇— ' — OCH2— ' -coo—, — oco —, — con(ch3)— ' or -n(ch3)co- , m2 and m3 are integers from 0 to 4, respectively, and m2+m3 represents an integer from 1 to 4. In the formula [5], m4 and m5 are each an integer of 1 to 5 in the formula [6], and X7 is a linear or branched alkyl group having a carbon number of 1 to 5 'm6 is an integer of 1 to 5' [7] ] 'X8 is a single bond, -CH2—, —C2H4_, one C(CH3)2_, _CF2 —, one C(CF3)2—′′—Ο—, —CΟ—, —ΝΗ—, one N(CH3) —, a CONH-, an NHCO-, a CH2〇-, an OCH2-, -COO-, - OCO-, -CON(CH3)-, or a N(CH3)CO-, m7 is an integer from 1 to 4. . In the structure of the formula [3] to the formula [7], 'preferably, in the formula [3], ml is an integer structure of 1 to 2, in the formula [4], X6 is a single bond, a CH2-, -C2H4- , -C(CH3)2— ' — ο- ' - CO— ' — NH— ' — N(CH3)— ' -CONH -, - NHCO -, - COO -, or a 〇CO— ' m2 and m3 simultaneously In the structure of an integer of 1, in the formula [7], X8 is a single bond, a CH2 —, —〇—, _ c〇-, —NH —, —CONH —, —NHCO —, —CH20— ' - OCH2- ' — COO-, or a 0C0_, m7 is a structure of integers from 1 to 2. Specific examples of the diamine compound (B) are, for example, compounds of the following formula to the formula [18]. 200948859 〇 [Chem. 12]
[化 13] η2νΗ2ν
參 式[17]中,Χ9 爲單鍵、一CH2—、一 0—、— CO—、 -NH—、一 CONH- 、一 NHCO -、一 CH20 -、一 OCH2-、—COO—,或一OCO—,式[18]中,Xi。爲單鍵、 _ CΗ2 一、一 〇 _ 、_ CΟ 一、_ ΝΗ 一、一 CONH — 、 -NHCO -、一 CH20 —、一 OCH2 -、一 COO —,或 -OCO —。 [其他二胺化合物] 29- 200948859 本發明中,於不損害本發明效果之範圍,可將二胺化 合物(A )、二胺化合物(B )以外之其他二胺化合物作爲 二胺成份合倂使用。其具體例如以下所示。 對一苯二胺、2,3,5,6—四甲基一對一苯二胺、2,5_ 二甲基一對一苯二胺、間一苯二胺、2,4 —二甲基一間一 苯二胺、2,5 -二胺基甲苯、2,6 -二胺基甲苯、2,5-二胺 基酚、2,4—二胺基酚、3,5-二胺基酚、3,5_二胺基苄基 醇、2,4 一二胺基苄基醇、4,6_二胺基間苯二甲酚、4,4’ 一二胺基聯苯、3,3’一二甲基_4,4’一二胺基聯苯、3,3’ — 二甲氧基— 4,4’一二胺基聯苯、3,3’一二羥基_4,4’ —二胺 基聯苯、3,3’一二氟一 4,4’一聯苯、3,3’一三氟甲基一 4,4’ _二胺基聯苯、3,4’ 一二胺基聯苯、3,3’ 一二胺基聯苯、 2,2’一二胺基聯苯、2,3’一二胺基聯苯、4,4’一二胺基二苯 基甲烷、3,3’ 一二胺基二苯基甲烷、3,4’ 一二胺基二苯基 甲烷、2,2’ 一二胺基二苯基甲烷、2,3’ 一二胺基二苯基甲 烷、4,4’ —二胺基二苯基醚、3,3’一二胺基二苯基醚、3,4’ 一二胺基二苯基醚、2,2’ —二胺基二苯基醚、2,3’_二胺 基二苯基醚、4,4’ _磺醯基二苯胺、3,3’ 一磺醯基二苯胺 、雙(4 —胺基苯基)矽烷、雙(3-胺基苯基)矽烷、二 甲基一雙(4一胺基苯基)矽烷、二甲基一雙(3 —胺基苯 基)矽烷、4,4’ 一硫二苯胺、3,3’一硫二苯胺、4,4’_二胺 基二苯基胺、3,3’ 一二胺基二苯基胺、3,4’ 一二胺基二苯 基胺、2,2’ 一二胺基二苯基胺、2,3’ _二胺基二苯基胺、N 一甲基(4,4’_二胺基二苯基)胺、N —甲基(3,3’_二胺 -30- 200948859 基二苯基)胺、N_甲基(3,4’ —二胺基二苯基)胺、N_ 甲基(2,2’_二胺基二苯基)胺、:^_甲基(2,3’一二胺基 二苯基)胺、4,4’ 一二胺基二苯甲酮、3,3’ —二胺基二苯 甲酮、3,4’一二胺基二苯甲酮、1,4 一二胺基萘、2,2’ _二 胺基二苯甲酮、2,3’ 一二胺基二苯甲酮、1,5 —二胺基萘、 1,6-二胺基萘、1,7_二胺基萘、1,8_二胺基萘、2,5 -二胺基萘、2,6_二胺基萘、2,7-二胺基萘、2,8 —二胺基 萘、1,2 —雙(4_胺基苯基)乙烷、1,2 _雙(3 —胺基苯 基)乙烷、1,3 —雙(4_胺基苯基)丙烷、1,3_雙(3 — 胺基苯基)丙烷、1,4 一雙(4一胺基苯基)丁烷、1,4_雙 (3_胺基苯基)丁烷、雙(3,5-二乙基_4_胺基苯基 )甲烷、1,4_雙(4_胺基苯氧基)苯、1,3_雙(4 —胺 基苯氧基)苯、1,4 一雙(4一胺基苯基)苯、1,3_雙(4 _胺基苯基)苯、1,4 —雙(4一胺基苄基)苯、1,3-雙( 4一胺基苯氧基)苯、4,4’_[1,4一伸苯基雙(亞甲基)] 二苯胺、4,4’_[1,3 —伸苯基雙(亞甲基)]二苯胺、3,4’ _[1,4 一伸苯基雙(亞甲基)]二苯胺、3,4’_[1,3 -伸苯 基雙(亞甲基)]二苯胺、3,3’_[1,4一伸苯基雙(亞甲基 )]二苯胺、3,3’一 [1,3 —伸苯基雙(亞甲基)]二苯胺、 1,4 一伸苯基雙[(4 一胺基苯基)甲烷]、1,4_伸苯基雙[ (3—胺基苯基)甲烷]、1,3 —伸苯基雙[(4 一胺基苯基) 甲烷]、1,3 -伸苯基雙[(3 —胺基苯基)甲烷]、1,4 一伸 苯基雙(4 一胺基苯甲酸酯)、1,4 一伸苯基雙(3 -胺基 苯甲酸酯)、1,3_伸苯基雙(4一胺基苯甲酸酯)、1,3_ -31 - 200948859 伸苯基雙(3—胺基苯甲酸酯)、雙(4 -胺基苯基)對苯 二甲酸酯、雙(3—胺基苯基)對苯二甲酸酯、雙(4一胺 基苯基)間苯二甲酸酯、雙(3 —胺基苯基)間苯二甲酸 酯、Ν,Ν’ 一( 1,4 -伸苯基)雙(4一胺基苄醯胺)、Ν,Ν’ 一(1,3 -伸苯基)雙(4 -胺基苄醯胺)、N,N’—(1,4-伸苯基)雙(3 -胺基苄醯胺)、Ν,Ν’- (1,3 —伸苯基) 雙(3 —胺基苄醯胺)、Ν,Ν’ 一(4 -胺基苯基)對苯二甲 醯胺、Ν,Ν’- (3 -胺基苯基)對苯二甲醯胺、Ν,Ν’- (4 -胺基苯基)間苯二甲醯胺、Ν,Ν’ - ( 3 —胺基苯基)間 苯二甲醯胺、9,10 -雙(4 —胺基苯基)蒽、4,4’ 一雙(4 一胺基苯氧基)二苯基颯、2,2’-雙[4 一(4 一胺基苯氧基 )苯基]丙烷、2,2’一雙[4 一(4 -胺基苯氧基)苯基]六氟 丙烷、2,2’ —雙(4一胺基苯基)六氟丙烷、2,2’ 一雙(3 一胺基苯基)六氟丙烷、2,2’ 一雙(3 —胺基一 4 一甲基苯 基)六氟丙烷、2,2’ 一雙(4 一胺基苯基)丙烷、2,2’一雙 (3_胺基苯基)丙烷、2,2’_雙(3—胺基_4_甲基苯基 )丙烷、1,3_雙(4_胺基苯氧基)丙烷、1,3_雙(3 — 胺基苯氧基)丙烷、1,4 一雙(4 一胺基苯氧基)丁烷、1,4 _雙(3 —胺基苯氧基)丁烷、1,5 —雙(4 一胺基苯氧基 )戊烷、1,5 —雙(3_胺基苯氧基)戊烷、1,6—雙(4_ 胺基苯氧基)己烷、1,6_雙(3 —胺基苯氧基)己烷、1,7 —雙(4 一胺基苯氧基)庚烷、1,7-雙(3 —胺基苯氧基 )庚烷、1,8-雙(4_胺基苯氧基)辛烷、1,8 —雙(3_ 胺基苯氧基)辛烷、1,9 -雙(4 -胺基苯氧基)壬烷、1,9 -32- 200948859 —雙(3 -胺基苯氧基)壬烷、l,l〇 -雙(4 —胺基苯氧基 )癸烷、1,1〇—雙(3 —胺基苯氧基)癸烷、1,11—雙(4 —胺基苯氧基)十一烷、1,11—雙(3_胺基苯氧基)十 一烷、1,12 —雙(4 一胺基苯氧基)十二烷、1,12-雙(3 一胺基苯氧基)十二烷、雙(4 一胺基環己基)甲烷、雙 (4 —胺基_3 —甲基環己基)甲烷、1,3 —二胺基丙烷、 1,4一二胺基丁烷、1,5_二胺基戊烷、1,6 -二胺基己烷、 1,7 —二胺基庚烷、1,8_二胺基辛烷、1,9一二胺基壬烷、 1,10 —二胺基癸烷、1,11 一二胺基十一烷、1,12 —二胺基 十二烷等。 另外,可舉例爲二胺側鏈上具有院基、含氟院基、芳 香環、脂肪族環、雜環’以及由該等所組成之大環狀取代 基之二胺,具體而言可例示爲以下述式[DA1]至式[DA26] 表示之二胺化合物。In the formula [17], Χ9 is a single bond, a CH2-, a 0-, -CO-, -NH-, a CONH-, an NHCO-, a CH20-, an OCH2-, a -COO-, or a OCO—, in the formula [18], Xi. It is a single bond, _ CΗ2 one, one 〇 _, _ CΟ one, _ ΝΗ one, one CONH — , —NHCO −, one CH20 —, one OCH 2 —, one COO —, or —OCO —. [Other diamine compound] 29-200948859 In the present invention, a diamine compound other than the diamine compound (A) or the diamine compound (B) can be used as a diamine component without impairing the effects of the present invention. . Specifically, it is shown below. p-Toluenediamine, 2,3,5,6-tetramethyl-p-phenylenediamine, 2,5-dimethyl-p-phenylenediamine, m-phenylenediamine, 2,4-dimethyl a monophenylene diamine, 2,5-diaminotoluene, 2,6-diaminotoluene, 2,5-diaminophenol, 2,4-diaminophenol, 3,5-diamino Phenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminoresorcinol, 4,4'-diaminobiphenyl, 3, 3'-Dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 3,3'-dihydroxy- 4,4 '-Diaminobiphenyl, 3,3'-difluoro-4,4'-biphenyl, 3,3'-trifluoromethyl-4,4'-diaminobiphenyl, 3,4' Diaminobiphenyl, 3,3'-diaminobiphenyl, 2,2'-diaminobiphenyl, 2,3'-diaminobiphenyl, 4,4'-diaminodiphenyl Methane, 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 2,2'-diaminodiphenylmethane, 2,3'-diaminodiyl Phenylmethane, 4,4'-diaminodiphenyl ether, 3,3'-diaminodiphenyl ether, 3,4'-diamino 2 Ether, 2,2'-diaminodiphenyl ether, 2,3'-diaminodiphenyl ether, 4,4'-sulfonyldiphenylamine, 3,3'-sulfonyldiphenylamine , bis(4-aminophenyl)decane, bis(3-aminophenyl)decane, dimethyl-bis(4-aminophenyl)decane, dimethyl-bis(3-aminophenyl) ) decane, 4,4' monothiodiphenylamine, 3,3'-monodiphenylamine, 4,4'-diaminodiphenylamine, 3,3'-diaminodiphenylamine, 3,4 'monodiaminodiphenylamine, 2,2'-diaminodiphenylamine, 2,3'-diaminodiphenylamine, N-methyl (4,4'-diamino) Phenyl)amine, N-methyl (3,3'-diamine-30-200948859-diphenyl)amine, N-methyl(3,4'-diaminodiphenyl)amine, N-methyl (2,2'-diaminodiphenyl)amine, :^-methyl (2,3'-diaminodiphenyl)amine, 4,4'-diaminobenzophenone, 3, 3'-Diaminobenzophenone, 3,4'-diaminobenzophenone, 1,4-diaminonaphthalene, 2,2'-diaminobenzophenone, 2,3' Monoaminobenzophenone, 1,5-diaminonaphthalene, 1,6- Amino naphthalene, 1,7-diaminonaphthalene, 1,8-diaminonaphthalene, 2,5-diaminonaphthalene, 2,6-diaminonaphthalene, 2,7-diaminonaphthalene, 2 ,8-diaminonaphthalene, 1,2-bis(4-aminophenyl)ethane, 1,2-bis(3-aminophenyl)ethane, 1,3-bis(4-amino Phenyl)propane, 1,3_bis(3-aminophenyl)propane, 1,4-bis(4-aminophenyl)butane, 1,4-bis(3-aminophenyl) Alkane, bis(3,5-diethyl_4-aminophenyl)methane, 1,4-bis(4-aminophenoxy)benzene, 1,3_bis(4-aminophenoxy) Benzene, 1,4-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1,4-bis(4-aminobenzyl)benzene, 1, 3-bis(4-aminophenoxy)benzene, 4,4'-[1,4-phenylphenylbis(methylene)]diphenylamine, 4,4'-[1,3-phenylene (methylene)]diphenylamine, 3,4' _[1,4 phenylphenylbis(methylene)]diphenylamine, 3,4'-[1,3-phenylenebis(methylene) Diphenylamine, 3,3'-[1,4-phenylphenylbis(methylene)]diphenylamine, 3,3'-[1,3-phenylphenylbis(methylene)]diphenylamine, 1 , 4 Phenyl bis[(4-aminophenyl)methane], 1,4_phenylene bis[(3-aminophenyl)methane], 1,3-phenylene bis[(4-amino group) Phenyl)methane], 1,3-phenylenebis[(3-aminophenyl)methane], 1,4-phenylphenylbis(4-aminobenzoate), 1,4 phenylene Bis(3-aminobenzoic acid ester), 1,3_phenylene bis(4-aminobenzoate), 1,3_-31 - 200948859 phenylene bis(3-aminobenzoic acid) Ester), bis(4-aminophenyl)terephthalate, bis(3-aminophenyl)terephthalate, bis(4-aminophenyl)isophthalate , bis(3-aminophenyl)isophthalate, hydrazine, Ν'-(1,4-phenylene)bis(4-aminobenzylbenzylamine), hydrazine, Ν'- (1, 3-(phenylene) bis(4-aminobenzamide), N,N'-(1,4-phenylene)bis(3-aminobenzylamine), hydrazine, Ν'- (1, 3 —Extended phenyl) bis(3-aminobenzamide), hydrazine, Ν'-(4-aminophenyl)terephthalamide, hydrazine, Ν'-(3-aminophenyl) Para-xylyleneamine, hydrazine, Ν'-(4-aminophenyl)-isophenyl Formamide, hydrazine, Ν'-(3-aminophenyl)m-xylyleneamine, 9,10-bis(4-aminophenyl)anthracene, 4,4'-double (4-amino group) Phenoxy)diphenylphosphonium, 2,2'-bis[4 mono(4-monoaminophenoxy)phenyl]propane, 2,2'-double [4-(4-aminophenoxy) Phenyl]hexafluoropropane, 2,2'-bis(4-aminophenyl)hexafluoropropane, 2,2'-bis(3-aminophenyl)hexafluoropropane, 2,2'-double ( 3 —Amino-4-methylphenyl)hexafluoropropane, 2,2′-bis(4-aminophenyl)propane, 2,2′-bis(3-aminophenyl)propane, 2, 2'_bis(3-amino-4-methylphenyl)propane, 1,3-bis(4-aminophenoxy)propane, 1,3_bis(3-aminophenoxy)propane 1,4-bis(4-monophenoxy)butane, 1,4-bis(3-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane Alkane, 1,5-bis(3-aminophenoxy)pentane, 1,6-bis(4-aminophenoxy)hexane, 1,6-bis(3-aminophenoxy)hexene Alkane, 1,7-bis(4-monoaminophenoxy)heptane, 1,7-bis (3) Aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane, 1,8-bis(3-aminophenoxy)octane, 1,9-bis(4- Aminophenoxy)decane, 1,9-32-200948859-bis(3-aminophenoxy)decane, l,l-bis(4-aminophenoxy)decane, 1, 1〇-bis(3-aminophenoxy)decane, 1,11-bis(4-aminophenoxy)undecane, 1,11-bis(3-aminophenoxy) eleven Alkane, 1,12-bis(4-monophenoxy)dodecane, 1,12-bis(3-aminophenoxy)dodecane, bis(4-aminocyclohexyl)methane, double (4 -Amino-3-methylcyclohexyl)methane, 1,3 -diaminopropane, 1,4 diaminobutane, 1,5-diaminopentane, 1,6-diamine Hexyl, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminodecane, 1,10-diaminodecane, 1,11-diamine Adecane, 1,12-diaminododecane, and the like. In addition, a diamine having a pendant group, a fluorine-containing substituent, an aromatic ring, an aliphatic ring, a heterocyclic ring, and a macrocyclic substituent composed of the above may be exemplified as a diamine side chain, and specifically, may be exemplified. It is a diamine compound represented by the following formula [DA1] to formula [DA26].
[化 14][Chem. 14]
(式[DA1]至式[DA5]中,R!爲碳數1以上22以了之院 基或含氟烷基)。 -33- 200948859 [化 15](In the formula [DA1] to the formula [DA5], R! is a group having a carbon number of 1 or more and 22 or a fluorine-containing alkyl group). -33- 200948859 [Chem. 15]
(式[DA6]至式[DA9]中,R2 表示一COO—、— OCO— © 、-CONH -、- NHCO -、-CH2—、- Ο -、—CO-或 一 NH—,R3表示碳數1以上22以下之烷基或含氟烷基)。 [化 16](In the formula [DA6] to the formula [DA9], R2 represents a COO-, - OCO-©, -CONH-, -NHCO-, -CH2-, - Ο-, -CO- or an NH-, and R3 represents carbon An alkyl group having 1 or more and 22 or less or a fluorine-containing alkyl group). [Chemistry 16]
(式[DA10]至式[DA11]中,R4 表示一0—、一OCH2 — 、-CH20—、一 COOCH2 —或—CH2OCO -,R5 表示碳數 1 以上22以下之烷基、烷氧基、含氟烷基或含氟烷氧基)。 -34- 200948859 [化 17](In the formula [DA10] to the formula [DA11], R4 represents a 0-, an OCH2-, -CH20-, a COOCH2- or -CH2OCO-, and R5 represents an alkyl group having 1 to 22 or less carbon atoms, an alkoxy group, Fluorinated alkyl or fluoroalkoxy). -34- 200948859 [Chem. 17]
(式[DA12]至式[DA14]中,R6 表示一COO-、(In the formula [DA12] to the formula [DA14], R6 represents a COO-,
-OCO-、一 CONH -、一 NHCO -、一 COOCH2 -、 -ch2oco -、— CH20—、-〇CH2-或—CH2-,R7 表示 碳數1以上22以下之烷基、烷氧基、含氟烷基或含氟烷氧 基)。 .-OCO-, a CONH-, an NHCO-, a COOCH2-, -ch2oco-, -CH20-, -〇CH2- or -CH2-, and R7 represents an alkyl group, an alkoxy group having a carbon number of 1 or more and 22 or less Fluoroalkyl or fluoroalkoxy). .
[化 18][Chem. 18]
(式[DA15]至式[DA16]中,R8 表示一 COO-、 -0C0-、一CONH-、一NHCO-、一COOCH2—、 ~ C Η 2 〇 C 0 — 、一 C Η 2 〇 — 、_ 0 C Η 2 _ 、_ C Η 2 一 、_ 0 — 或-ΝΗ—,R9表示氟、氰基、三氟甲基、硝基、偶氮基 、甲醯基、乙醯基、乙醯氧基或羥基)。 -35- 200948859 [化 19](In the formula [DA15] to the formula [DA16], R8 represents a COO-, -0C0-, a CONH-, an NHCO-, a COOCH2-, a C Η 2 〇C 0 — , a C Η 2 〇 — _ 0 C Η 2 _ , _ C Η 2 I, _ 0 — or —ΝΗ—, R9 represents fluorine, cyano, trifluoromethyl, nitro, azo, indolyl, ethyl hydrazine, acetamidine Oxy or hydroxy). -35- 200948859 [Chem. 19]
[化 20][Chem. 20]
-36- 200948859 [化 21]-36- 200948859 [Chem. 21]
除此之外,亦可舉例爲以下述式[DA27]表示之二胺基 矽氧烷等 [化 22] h2n—(ch2)3In addition, a diamine oxirane represented by the following formula [DA27], etc., may also be exemplified. [Chem. 22] h2n-(ch2)3
ch3 ίπ· -(CH2)3-NH2 [DA2 7] (式[DA27]中,m爲1至10之整數)。 ® 其他二胺化合物可依據作爲液晶配向膜時之液晶配向 性、電壓維持特性、累積電荷等特性,以一種或混合兩種 以上使用。 <四羧酸二酐> 本發明所使用之四羧酸二酐並未有特別限定,其具體 例如以下所列舉者。 均苯四酸二酐、2,3,6,7 —萘四羧酸二酐、ι,2,5,6_萘 四羧酸二酐、1,4,5,8—萘四羧酸二酐、2,3,6,7—蒽四羧酸 -37- 200948859 二酐、1,2,5,6—蒽四羧酸二酐、3,3’,4,4’ _聯苯四羧酸二 酐、2,3,3’,4 一聯苯四羧酸二酐、雙(3,4_二羧基苯基) 醚、3,3’,4,4’ —二苯甲酮四羧酸二酐、雙(3,4 —二羧基苯 基)颯、雙(3,4一二羧基苯基)甲烷、2,2_雙(3,4—二 羧基苯基)丙烷、1,1,1,3,3,3 —六氟_2,2 —雙(3,4_二 羧基苯基)丙烷、雙(3,4 一二羧基苯基)二甲基矽烷、 雙(3,4_二羧基苯基)二苯基矽烷、2,3,4,5-吡啶四羧 酸二酐、2,6-雙(3,4_二羧基苯基)吡啶、3,3’,4,4’_ 二苯基颯四羧酸二酐、3,4,9,10 -芘四羧酸二酐、1,3 -二 苯基一 1,2,3,4-環丁烷四羧酸二酐、氧基二苯四羧酸二酐 、1,2,3,4-環丁烷四羧酸二酐、1,2,3,4—環戊烷四羧酸二 酐、1,2,4,5 _環己烷四羧酸二酐、1,2,3,4 —四甲基— 1,2,3,4_環丁烷四羧酸二酐、1,2_二甲基一1,2,3,4_環 丁烷四羧酸二酐、1,3 —二甲基_1,2,3,4 一環丁烷四羧酸 二酐、1,2,3,4_環庚烷四羧酸二酐、2,3,4,5_四氫呋喃四 羧酸二酐、3,4 —二羧基—1—環己基琥珀酸二酐、2,3,5_ 三羧基環戊基乙酸二酐、3,4 —二羧基一 1,2,3,4_四氫—1 一萘琥珀酸二酐、雙環[3.3.0]辛烷_2,4,6,8—四羧酸二酐 、雙環[4,3,0]壬烷一 2,4,7,9-四羧酸二酐、雙環[4,4,0]癸 烷一2,4,7,9-四羧酸二酐、雙環[4,4,0]癸烷—2,4,8,10_ 四羧酸二酐、三環[6·3·0.0<2,6>]十一烷-3,5,9,11 —四羧 酸二酐、1,2,3,4 一丁烷四羧酸二酐、4一(2,5_二氧代四 氫呋喃_3—基)_1,2,3,4 -四氫萘—1,2_二羧酸二酐、 雙環[2,2,2]辛—7_ 烯—2,3,5,6 - 四羧酸二酐、5— (2,5 — -38- 200948859 二氧代四氫呋喃基)一 3 —甲基—3 —環己烷—1,2 —二羧 酸二酐、四環[6,2,1,1,0,2,7]癸—4,5,9,10 —四羧酸二酐、 3,5,6 _三羧基原冰片烷一 2: 3,5: 6 —二羧酸二酐、 1,2,4,5_環己烷四羧酸二酐等。 四羧酸二酐可依據成爲液晶配向膜時之液晶配向性、 電壓保持性、累積電荷等特定,以一種使用或兩種以上倂 用。 <共聚物> 本發明之共聚物,爲將包含二胺化合物(A)及二胺 化合物(B)之二胺成份’與四羧酸二酐反應所得之聚醯 胺酸,及該聚醯胺酸經脫水閉環所得之聚醯亞胺。該些聚 醯胺酸及聚醯亞胺中任一者,皆適合作爲製得液晶配向膜 所使用之共聚物。 使用本發明之共聚物所得之液晶配向膜,上述二胺成 φ 份中之特定二胺化合物之含有比例越多時,具有高電壓保 持率,且即使於長時間暴露於高溫下時,可及早緩和直流 電壓所蓄積之殘留電荷。 因此,二胺成份中,二胺化合物(B)之含量,相對 於二胺化合物(A)之1莫耳,以0.01至99莫耳爲佳。更佳 爲0.1至50莫耳,最佳爲0.5至20莫耳,特佳爲0.5至1〇莫耳 〇 藉由二胺成份與四羧酸二酐之反應’以所得本發明之 聚醯胺酸之方法,可使用習知之合成方法。通常爲使四羧 -39- 200948859 酸=酐與二胺在有機溶劑中反應之方法。四羧酸二酐與二 胺之s應在有機溶劑中比較容易進行,且不產生副產物而 言較有利。 四殘酸二酐與二胺之反應中使用之有機溶劑只要可使 產生之聚醯胺酸溶解則無特別限制。其具體例列舉於下。 舉例爲N,N -二甲基甲醯胺、Ν,Ν -二甲基乙醯胺、N —甲基一2 —吡咯啶酮、Ν —甲基己內醯胺、二甲基亞颯、 四甲基尿素、吡啶、二甲基颯、六甲基亞颯、7_ 丁內酯 '異丙醇、甲氧基甲基戊醇、二戊烯、乙基戊基酮、甲基 壬基酮、甲基乙基酮、甲基異戊基酮、甲基異丙基酮、甲 基溶纖素、乙基溶纖素、甲基溶纖素乙酸酯、乙基溶纖素 乙酸酯、丁基卡必醇、乙基卡必醇、乙二醇、乙二醇單乙 酸酯、乙二醇單異丙基醚、乙二醇單丁基醚、丙二醇、丙 二醇單乙酸酯、丙二醇單甲基醚、丙二醇第三丁基醚 '二 丙二醇單甲基醚、二乙二醇、二乙二醇單乙酸酯、二乙二 醇二甲基醚、二丙二醇單乙酸酯單甲基醚、二丙二醇單甲 基醚、二丙二醇單乙基醚、二丙二醇單乙酸酯單乙基醚、 二丙二醇單丙基醚、二丙二醇單乙酸酯單丙基醚、3 —甲 基一 3 —甲氧基丁基乙酸酯、三丙二醇甲基醚、3—甲基一 3-甲氧基丁醇、二異丙基醚、乙基異丁基醚、二異丁烯 、乙酸戊酯、丁酸丁酯、丁基醚、二異丁基酮、甲基環己 烯、丙基醚、二己基醚、二噁烷、正己烷、正戊烷'正辛 烷、二乙基醚、環己酮、碳酸乙烯酯、碳酸丙烯酯、乳酸 甲酯、乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸正丁酯、乙 -40- 200948859 酸丙二醇單乙基醚、丙酮酸甲酯、丙酮酸乙酯、3—甲氧 基丙酸甲酯、3—乙氧基丙酸甲基乙酯、3 —甲氧基丙酸乙 酯、3_乙氧基丙酸、3 —甲氧基丙酸、3 -甲氧基丙酸丙 酯、3 —甲氧基丙酸丁酯、二甘醇二甲醚、4 —羥基一 4 — 甲基- 2 -戊酮等。該等可單獨使用,亦可混合使用。而 且,即使無法使聚醯胺酸溶解之溶劑,在不使產生之聚醯 胺酸析出之範圍內,亦可混合於上述溶劑中使用。 另外,有機溶劑中之水分會妨礙聚合反應,進而成爲 使所生成之聚醯胺酸水解之原因,因此有機溶劑以使用儘 可能經脫水乾燥者爲佳。 使四羧酸二酐與二胺成份在有機溶劑中反應時,舉例 爲攪拌使二胺成份分散或溶解於有機溶劑中而成之溶液, 且直接添加四羧酸二酐之方法,或使之分散或溶解於有機 溶劑中而添加之方法;相反地使二胺成份添加於將四羧酸 二酐分散或溶解於有機溶劑中而成之溶液中之方法;交互 添加四羧酸二酐及二胺成份之方法等,亦可使用該等之任 一種方法。另外,四羧酸二酐或二胺成份爲由複數種化合 物構成之情況下,亦可在事先混合之狀態下反應,亦可個 別依序反應,進而亦可使個別反應成之低分子量體混合反 應成高分子量體。 此時之聚合溫度可選擇自- 20 °C至150 °C之任意溫度 ’但較佳爲- 5 °C至1 〇〇 °C之範圍。另外,反應可在任意之 濃度下進行,但由於濃度太低時難以所得高分子量之共聚 物,濃度太高時反應液體之黏性過高使得均勻攪拌變得困 -41 - 200948859 難,因此四羧酸二酐與二胺成份之反應溶液中之合計濃度 較佳爲1至50質量%,更好爲5至30質量%。反應初期可在 高濃度下進行,隨後,再追加有機溶劑。 聚醯胺酸之聚合反應中,四羧酸二酐之合計莫耳數, 與二胺成份之合計莫耳數之比,較佳爲0.8至1.2。如一般 之聚縮合反應般,該莫耳比趨近於1.0所生成之聚醯胺酸 之分子量最大。 本發明之聚醯亞胺爲使上述之聚醯胺酸經脫水閉環所 得之聚醯亞胺,可使用作爲用以所得液晶配向膜之聚合物 〇 本發明之聚醯亞胺中,醯胺酸基之脫水閉環率(醯亞 胺化率)未必須爲1 00%,可依據用途或目的做任意調整。 使聚醯亞胺酸醯亞胺化之方法舉例爲將聚醯胺酸之溶 液直接加熱之熱醯亞胺化,將觸媒添加於聚醯胺酸之溶液 中之觸媒醯亞胺化。 使聚醯胺酸溶液中熱醯亞胺化時之溫度爲100 °C至400 °C,較佳爲120°c至2 5 0,且較佳同時將醯亞胺化反應產生 之水排除於系統外。 聚醯胺酸之觸媒醯亞胺化可在聚醯胺酸之溶液中添加 鹼性觸媒及酸酐,且在-20至250 °C,較佳在0至180°C下 攪拌而進行。鹼性觸媒之量爲醯胺酸基之0.5至30莫耳倍 ’較佳爲2至20莫耳倍,酸酐之量爲醯胺酸基之1至5〇莫耳 倍’較佳爲3至30莫耳倍。至於鹸性觸媒可列舉爲吡啶、 三乙胺、三甲基胺、三丁基胺、三辛基胺等,其中吡啶由 -42- 200948859 於可維持適度的鹼性以使反應進行而較佳。至於酸酐可舉 例爲乙酸酐、偏苯三酸酐、苯均四甲酸酐等,其中若使用 酸酐則反應結束後之純化變得容易而較佳。由觸媒醯亞胺 化之醯亞胺化率可藉由調節觸媒量及反應溫度、反應時間 予以控制。 由聚醯胺酸或聚醯亞胺之反應溶液回收所產生之聚醯 胺酸或聚醯亞胺之情況,可將反應溶液倒入弱溶劑中形成 沉澱。沉澱所使用之弱溶劑可舉例爲甲醇、丙酮、己烷、 丁基溶纖素、庚烷、甲基乙基酮、甲基異丁基酮、乙醇、 甲苯、苯、水等。倒入弱溶劑中而沉殿之聚合物經過濾回 收後,可在常壓或減壓下,於常溫或加熱乾燥。另外,使 沉澱回收之聚合物再溶解於有機溶劑中,重複再沉澱回收 操作2至10次,可減少聚合物中之雜質。此時之弱溶劑舉 例爲例如醇類、酮類、烴等,若使用選自該等之內之三種 以上弱溶劑,由於可更進一步的提高純化效率而較佳。 本發明之液晶配向處理劑中所含聚醯胺酸及聚醯亞胺 之分子量,於考量自其所得之塗膜強度及塗膜形成時之作 業性、塗膜之均勻性之情況下,以GPC (凝膠滲透層析) 法測定之重量平均分子量以5,000至1,000,000較佳,更好 爲10,000至 150,000 。 <液晶配向處理劑> 本發明之液晶配向處理劑爲用以形成液晶配向膜之塗 佈液,爲將用以形成樹脂被膜之樹脂成份溶解於有機溶劑 -43- 200948859 中而成之溶液。其中,上述之樹脂成份爲含有選自上述本 發明之聚合物之至少一種聚合物之樹脂成份。此時,樹脂 成份之含量以1質量%至20質量%較佳,更好爲3質量%至15 質量%,最好爲3至1 0質量%。 本發明中,上述之樹脂成份可全部爲本發明中使用之 共聚物,亦可混合本發明之聚合物以外之其他聚合物。此 時,樹脂成份中之本發明聚合物以外之其他聚合物之含量 爲〇.5質量%至15質量%,較佳爲1質量%至10質量%。 該其他之聚合物,例如,可與四羧酸二酐反應之二胺 成份,可使用二胺化合物(A)及二胺化合物(B)以外之 二胺化合物所得之聚醯胺酸或聚醯亞胺等。 本發明之液晶配向處理劑中所使用之有機溶劑只要是 可溶解上述樹脂成份之有機溶劑則無特別限制。其具體例 列舉於下。 舉例爲Ν,Ν —二甲基甲醯胺、N,N-二甲基乙醯胺、N 一甲基一 2 —吡咯啶酮、N—甲基己內醯胺、2_吡咯啶酮 、N —乙基吡咯啶酮、N—乙烯基吡咯啶酮、二甲基亞颯 、四甲基尿素、吡啶、二甲基碾、六甲基亞楓、γ —丁內 酯、1,3—二甲基_咪唑啶酮、乙基戊基酮、甲基壬基酮 、甲基乙基酮、甲基異戊基酮、甲基異丙基酮、環己酮、 碳酸乙烯酯、碳酸丙烯酯、二甘醇二甲醚、4 -羥基—4 — 甲基一2 -戊酮等。該等可單獨使用,亦可混合使用。 〇 面 份表 成或 之性 外勻 以均 述厚 上膜 有善 含改 可可 亦時 劑劑 m-1 m-1 理 理 處處 向 向 配 配 晶晶 液液 之佈 明塗 發在 本爲 例 其 -44 - 200948859 平滑性之溶劑或化合物,提高液晶配向膜與基板之密著性 之化合物等。 提高膜厚均勻性或表面平滑性之溶劑(弱溶劑)之具 體例舉例爲下列者。 舉例爲例如異丙醇、甲氧基甲基戊醇、甲基溶纖素、 乙基溶纖素、丁基溶纖素、甲基溶纖素乙酸酯、乙基溶纖 素乙酸醋、丁基卡必醇、乙基卡必醇、乙基卡必醇乙酸酯 、乙二醇、乙二醇單乙酸酯、乙二醇單異丙基醚、乙二醇 單丁基醚、丙二醇、丙二醇單乙酸酯、丙二醇單甲基醚、 丙二醇第三丁基醚、二丙二醇單甲基醚、二乙二醇、二乙 二醇單乙酸酯、二乙二醇二甲基醚、二丙二醇單乙酸酯單 甲基醚、二丙二醇單甲基醚、二丙二醇單乙基醚、二丙二 醇單乙酸酯單乙基醚、二丙二醇單丙基醚、二丙二醇單乙 酸酯單丙基醚、3 —甲基一 3 —甲氧基丁基乙酸酯、三丙二 醇甲基醚、3 —甲基一 3—甲氧基丁醇、二異丙基醚、乙基 異丁基醚、二異丁烯、乙酸戊酯、丁酸丁酯、丁基醚、二 異丁基酮、甲基環己烯、丙基醚 '二己基醚、1一己醇、 正己烷、正戊烷、正辛烷、二乙基醚、乳酸甲酯、乳酸乙 酯、乙酸甲酯、乙酸乙酯、乙酸正丁酯、乙酸丙二醇單乙 基醚、丙酮酸甲酯、丙酮酸乙酯、3—甲氧基丙酸甲酯、3 一乙氧基丙酸甲基乙酯、3_甲氧基丙酸乙酯、3 —乙氧基 丙酸、3 —甲氧基丙酸、3_甲氧基丙酸丙酯、3 —甲氧基 丙酸丁酯、1一甲氧基_2_丙醇、1 一乙氧基—2 —丙醇、 1 一丁氧基一 2 —丙醇、1_苯氧基一 2—丙醇、丙二醇單乙 -45- 200948859 酸酯、丙二醇二乙酸酯、丙二醇—1_單甲基醚—2 一乙酸 醋、丙二醇_1 一單乙基酸—2 -乙酸醋、二丙二醇、2 — (2—乙氧基丙氧基)丙醇、乳酸甲酯、乳酸乙酯、乳酸 正丙酯、乳酸正丁酯、乳酸異戊酯等具有低表面張力之溶 劑等。 該等弱溶劑可單一種使用,亦可混合複數種使用。使 用如上述之溶劑時,較佳爲液晶配向處理劑中所含之全部 溶劑之5至80質量%,更好爲20至60質量%。 至於提高膜後均勻性或表面平滑性之化合物舉例爲氟 系界面活性劑、矽氧系界面活性劑、非離子系界面活性劑 等。 更具體而言舉例爲例如F TOP EF301、EF3 03、EF352 (TOKEMU PRODUCT公司製造)、MEGAFAX F171 、 F173、R— 30(大日本油墨公司製造)、FLU0RAD FC430 、FC431 (住友 3M公司製造)、ASAHIGUARD AG710、 SURFLON S- 382 、 SC101 、 SC102 、 SC103 、 SC104 、 SCI 05、SCI 06 (旭硝子公司製造)等。該等界面活性劑 之使用比例相對於液晶配向劑中所含樹脂成份100質量份 較佳爲0.01至2質量份,更好爲0.01至1質量份。 提高液晶配向膜與基板之密著性之化合物之具體例舉 例爲以下所示之含有官能性矽烷之化合物或含有環氧基之 化合物等。 舉例爲例如3 -胺基丙基三甲氧基矽烷、3-胺基丙基 三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基 -46- 200948859 三乙氧基矽烷、N— (2 —胺基乙基)-3—胺基丙基三甲 氧基矽烷、N— (2—胺基乙基)—3 —胺基丙基甲基二甲 氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙 氧基矽烷、N-乙氧基羰基- 3—胺基丙基三甲氧基矽烷、 N —乙氧基羰基—3 —胺基丙基三乙氧基矽烷、N—三乙氧 基矽烷基丙基三伸乙基三胺、N-三甲氧基矽烷基丙基三 伸乙基三胺、1〇_三甲氧基矽烷基一1,4,7 -三氮雜癸烷、 10 —三乙氧基矽烷基—1,4,7 —三氮雜癸烷、9 —三甲氧基 矽烷基一 3,6 —二氮雜壬基乙酸酯、9 —三乙氧基矽烷基— 3,6_二氮雜壬基乙酸酯、N—苄基_3_胺基丙基三甲氧 基矽烷、N-苄基—3 -胺基丙基三乙氧基矽烷、N-苯基 _3_胺基丙基三甲氧基矽烷、N_苯基一 3—胺基丙基三 乙氧基矽烷、N—雙(氧伸乙基)—3—胺基丙基三甲氧基 矽烷、N —雙(氧伸乙基)一 3_胺基丙基三乙氧基矽烷、 乙二醇二縮水甘油醚、聚乙二醇二縮水甘油醚、丙二醇二 縮水甘油醚、三丙二醇二縮水甘油醚、聚丙二醇二縮水甘 油醚、新戊二醇二縮水甘油醚、1,6 _己二醇二縮水甘油 醚、丙三醇二縮水甘油醚、2,2-二溴新戊二醇二縮水甘 油醚、1,3,5,6 —四縮水甘油基—2,4-己二醇、N,N,N’,N’ -四縮水甘油基一間-二甲苯二胺、1,3-雙(N,N —二縮 水甘油基胺碁甲基)環己烷、Ν,Ν,Ν’,Ν’ 一四縮水甘油基 —4,4’_二胺基二苯基甲烷等。 使用提高與基板之密著性之化合物時,其使用量相對 於液晶配向處理劑中所含樹脂成份100質量份,較佳爲〇.1 -47- 200948859 至30質量份’更好爲1至20質量份。使用量若低於^丨質量 份’則無法期待密著性提高之效果,若多於3 0質量份,則 有液晶配向性變差之情況。 本發明之液晶配向處理劑中,除上述以外,在不損及 本發明效果之範圍內’於使液晶配向膜之介電率或導電性 等之電性特性改變之目的下,亦可添加介電體或導電物質 ’進而’亦可添加成爲液晶配向膜之際提高膜之硬度或緻 密度之目的之交聯性化合物。 <液晶配向膜、液晶顯示元件> 本發明之液晶配向處理劑塗佈於基板上並燒成之後, 以摩擦處理或光照射等予以配向處理,或於垂直配向用途 等未經配向處理,可作爲液晶配向膜使用。此時,作爲所 用之基板只要是透明性高的基板則無特別限制,而可使用 玻璃基板或丙烯酸基板或聚碳酸酯基板等之塑膠基板等。 又,由製程簡單化之觀點觀之,使用形成有用以驅動液晶 之ITO電極等之基板較佳。又,即使於反射型液晶顯示元 件之僅成爲單面基板之矽晶圓等之不透明物亦可使用,此 時之電極亦可使用鋁等之可反射光之材料。 液晶配向處理劑之塗佈方法並無特別限制,工業上, 一般爲以網版印刷、平版印刷、軟版印刷、噴墨印刷等進 行之方法。至於其他塗佈方法,有浸漬塗佈、輥塗佈、狹 縫塗佈、旋轉塗佈等,亦可依據目的使用該等。 將液晶配向處理劑塗佈於基板上後之燒成’可藉由加 -48- 200948859 熱板等之加熱機構,於50至300°C,較佳於80至25(TC進行 ,使溶劑蒸發並形成塗膜。燒成後所形成之塗膜厚度,若 過厚則對液晶顯示元件之消耗電力方面不利,若過薄則有 液晶顯示元件之信賴性降低之情況,因此較佳爲5至300nm ,更好爲10至l〇〇nm。液晶於水平配向或傾斜配向時,燒 成後之塗膜以摩擦或偏光紫外線照射等予以處理。 本發明之液晶顯示元件爲藉由上述方法自本發明之液 晶配向處理劑所得貼附有液晶配向膜之基板後,以習知方 法製作液晶單元,並作爲液晶顯示元件者。 若舉出液晶晶胞製作之一例,可舉例有準備形成有液 晶配向膜之一對基板,於其中一基板之液晶配向膜上散佈 隔離材,使液晶配向膜面成爲內側之方式,貼合另一片基 板,減壓注入液晶並封裝之方法,或於散佈隔離材之液晶 配向膜面上滴下液晶後貼合基板並進行封裝之方法等。此 時之隔離材厚度較佳爲1至30μπι,更好爲2至ΙΟμιη。 如以上,使用本發明之液晶配向處理劑製作之液晶顯 示元件成爲信賴性優異者,可適當利用於大畫面且高精細 之液晶電視等。 【實施方式】 [實施例] 以下列舉實施例以更詳細說明本發明,但本發明之解 釋並不受該等實施例之限制。 -49- 200948859 [二胺化合物之合成] 〈合成例1> 二胺化合物(4)之合成Ch3 ίπ· -(CH2)3-NH2 [DA2 7] (in the formula [DA27], m is an integer of 1 to 10). ® Other diamine compounds may be used singly or in combination of two or more kinds depending on the characteristics of liquid crystal alignment, voltage maintenance characteristics, and accumulated electric charge when used as a liquid crystal alignment film. <tetracarboxylic dianhydride> The tetracarboxylic dianhydride used in the present invention is not particularly limited, and specific examples thereof are as follows. Pyromellitic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, iota, 2,5,6-naphthalenetetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic acid Anhydride, 2,3,6,7-tetracarboxylic acid-37- 200948859 dianhydride, 1,2,5,6-nonanedicarboxylic dianhydride, 3,3',4,4'-biphenyltetracarboxylate Acid dianhydride, 2,3,3',4-biphenyltetracarboxylic dianhydride, bis(3,4-dicarboxyphenyl) ether, 3,3',4,4'-benzophenone tetracarboxylate Acid dianhydride, bis(3,4-dicarboxyphenyl)anthracene, bis(3,4-dicarboxyphenyl)methane, 2,2-bis(3,4-dicarboxyphenyl)propane, 1,1 ,1,3,3,3—hexafluoro-2,2-bis(3,4-dicarboxyphenyl)propane, bis(3,4-dicarboxyphenyl)dimethyl decane, double (3,4 _Dicarboxyphenyl)diphenyl decane, 2,3,4,5-pyridinetetracarboxylic dianhydride, 2,6-bis(3,4-dicarboxyphenyl)pyridine, 3,3', 4, 4'_ Diphenylphosphonium tetracarboxylic dianhydride, 3,4,9,10-decanetetracarboxylic dianhydride, 1,3 -diphenyl-1,2,3,4-cyclobutanetetracarboxylic acid Dihydride, oxydiphenyltetracarboxylic dianhydride, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentane tetracarboxylic dianhydride, 1,2 , 4,5 _cyclohexane tetracarboxylic dianhydride 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2-dimethyl- 1,2,3,4-cyclobutane Carboxylic dianhydride, 1,3 - dimethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-cyclohexanetetracarboxylic dianhydride, 2,3, 4,5_tetrahydrofuran tetracarboxylic dianhydride, 3,4-dicarboxy-1-cyclohexyl succinic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, 3,4-dicarboxy-1, 2,3,4_tetrahydro-1 mononaphthalene succinic dianhydride, bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylic dianhydride, bicyclo[4,3,0]decane a 2,4,7,9-tetracarboxylic dianhydride, bicyclo[4,4,0]decane-2,4,7,9-tetracarboxylic dianhydride, bicyclo[4,4,0]decane —2,4,8,10_ Tetracarboxylic dianhydride, tricyclo[6·3·0.0<2,6>]undecane-3,5,9,11-tetracarboxylic dianhydride, 1,2 , 3,4-butane tetracarboxylic dianhydride, 4-(2,5-dioxotetrahydrofuran-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic dianhydride Bicyclo[2,2,2]oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 5-(2,5--38-200948859 dioxotetrahydrofuranyl)-3-methyl —3 —cyclohexane-1,2-dicarboxylic dianhydride, tetracyclo[6,2,1,1 ,0,2,7]癸—4,5,9,10—tetracarboxylic dianhydride, 3,5,6-tricarboxycarboxyr-norbornane-2:3,5:6-dicarboxylic dianhydride, 1 , 2, 4, 5 - cyclohexane tetracarboxylic dianhydride, and the like. The tetracarboxylic dianhydride may be used alone or in combination of two or more depending on the liquid crystal alignment property, voltage retention property, and accumulated electric charge when the liquid crystal alignment film is used. <Copolymer> The copolymer of the present invention is a polylysine obtained by reacting a diamine component of the diamine compound (A) and the diamine compound (B) with a tetracarboxylic dianhydride, and the poly Polyimine obtained by dehydration ring closure of proline. Any of these polyamic acids and polyimines is suitable as a copolymer for producing a liquid crystal alignment film. The liquid crystal alignment film obtained by using the copolymer of the present invention has a high voltage holding ratio when the content ratio of the specific diamine compound in the above diamine is φ, and can be early even when exposed to a high temperature for a long period of time. Relieves the residual charge accumulated by the DC voltage. Therefore, the content of the diamine compound (B) in the diamine component is preferably from 0.01 to 99 mol based on 1 mol of the diamine compound (A). More preferably from 0.1 to 50 moles, most preferably from 0.5 to 20 moles, particularly preferably from 0.5 to 1 moles of the reaction of the diamine component with the tetracarboxylic dianhydride to obtain the polyamine of the present invention. For the acid method, a conventional synthesis method can be used. It is usually a method of reacting tetracarboxylic acid-39-200948859 acid=anhydride with a diamine in an organic solvent. It is advantageous that the tetracarboxylic dianhydride and the diamine s should be relatively easy to carry out in an organic solvent without producing by-products. The organic solvent used in the reaction of the tetrabasic acid dianhydride and the diamine is not particularly limited as long as it can dissolve the produced polyamic acid. Specific examples thereof are listed below. Examples are N,N-dimethylformamide, hydrazine, hydrazine-dimethylacetamide, N-methyl-2-pyrrolidone, hydrazine-methyl caprolactam, dimethyl hydrazine, Tetramethyl urea, pyridine, dimethyl hydrazine, hexamethylarylene, 7-butyrolactone 'isopropanol, methoxymethylpentanol, dipentene, ethyl amyl ketone, methyl decyl ketone , methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, methyl cellosolve, ethyl cellulolytic, methyl cellosolve acetate, ethyl cellosolve acetate , butyl carbitol, ethyl carbitol, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetate, Propylene glycol monomethyl ether, propylene glycol tert-butyl ether 'dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol monoacetate single Methyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3-methyl A 3-methoxy butyl Acetate, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, amyl acetate, butyl butyrate, butyl Ether, diisobutyl ketone, methylcyclohexene, propyl ether, dihexyl ether, dioxane, n-hexane, n-pentane 'n-octane, diethyl ether, cyclohexanone, ethylene carbonate, Propylene carbonate, methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate, ethyl-40-200948859 acid propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, 3-A Methyl oxypropionate, methyl ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, 3-methoxy Propyl propionate, butyl 3-methoxypropionate, diglyme, 4-hydroxy-4-methyl-2-pentanone, and the like. These may be used singly or in combination. Further, even a solvent in which polylysine cannot be dissolved may be used in the above solvent in a range in which the produced polyamine acid is not precipitated. Further, since the water in the organic solvent hinders the polymerization reaction and further causes hydrolysis of the produced polyaminic acid, it is preferred that the organic solvent be dried by dehydration as much as possible. When the tetracarboxylic dianhydride and the diamine component are reacted in an organic solvent, for example, a solution obtained by stirring or dissolving a diamine component in an organic solvent, and directly adding a tetracarboxylic dianhydride, or making it a method of dispersing or dissolving in an organic solvent; and conversely adding a diamine component to a solution obtained by dispersing or dissolving a tetracarboxylic dianhydride in an organic solvent; and simultaneously adding tetracarboxylic dianhydride and two Any of these methods may be used as the method of the amine component. Further, when the tetracarboxylic dianhydride or the diamine component is composed of a plurality of kinds of compounds, it may be reacted in a state of being mixed beforehand, or may be individually reacted in order, or may be a mixture of low molecular weight bodies which are individually reacted. The reaction is carried out into a high molecular weight body. The polymerization temperature at this time may be selected from any temperature of from - 20 ° C to 150 ° C, but preferably from - 5 ° C to 1 ° C. In addition, the reaction can be carried out at any concentration, but it is difficult to obtain a copolymer of high molecular weight because the concentration is too low, and the viscosity of the reaction liquid is too high when the concentration is too high, so that uniform stirring becomes difficult -41 - 200948859 The total concentration in the reaction solution of the carboxylic acid dianhydride and the diamine component is preferably from 1 to 50% by mass, more preferably from 5 to 30% by mass. The initial stage of the reaction can be carried out at a high concentration, and then an organic solvent is added. In the polymerization of polyamic acid, the ratio of the total number of moles of tetracarboxylic dianhydride to the total number of moles of the diamine component is preferably from 0.8 to 1.2. As with the general polycondensation reaction, the molecular weight of the polyamic acid formed by the molar ratio approaching 1.0 is the largest. The polyimine of the present invention is a polyimine obtained by subjecting the above polyamic acid to dehydration ring closure, and can be used as a polymer for obtaining the liquid crystal alignment film. The polyamidene of the present invention, proline is used. The dehydration ring closure ratio (醯 imidization ratio) of the base is not necessarily 100%, and can be arbitrarily adjusted depending on the purpose or purpose. The method of imidating polyruthenium imidate is exemplified by hot amination of a solution of polylysine directly by heating, and the catalyst is added to a solution of polylysine to imidize. The temperature at which the hydrazide imidization reaction is carried out is carried out at a temperature of from 100 ° C to 400 ° C, preferably from 120 ° C to 250 °, and preferably at the same time Outside the system. The ruthenium imidization of polylysine may be carried out by adding a basic catalyst and an acid anhydride to a solution of polyamic acid, and stirring at -20 to 250 ° C, preferably 0 to 180 ° C. The amount of the basic catalyst is 0.5 to 30 moles of the guanyl group, preferably 2 to 20 moles, and the amount of the anhydride is 1 to 5 moles of the amidate group, preferably 3 Up to 30 moles. As the inert catalyst, pyridine, triethylamine, trimethylamine, tributylamine, trioctylamine and the like can be exemplified, wherein pyridine is maintained from -42 to 200948859 to maintain moderate alkalinity for the reaction to proceed. good. The acid anhydride may, for example, be acetic anhydride, trimellitic anhydride or benzene tetracarboxylic anhydride. In the case where an acid anhydride is used, purification after completion of the reaction becomes easy and preferable. The imidization ratio of the ruthenium imidized by the catalyst can be controlled by adjusting the amount of the catalyst, the reaction temperature, and the reaction time. In the case where the resulting polyamic acid or polyimine is recovered from a reaction solution of polyglycolic acid or polyimine, the reaction solution can be poured into a weak solvent to form a precipitate. The weak solvent used for the precipitation may, for example, be methanol, acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, water or the like. Pour into the weak solvent and the polymer of the sinking chamber is filtered and returned to dryness at normal temperature or under normal pressure or reduced pressure. Further, the precipitate-recovered polymer is redissolved in an organic solvent, and the reprecipitation recovery operation is repeated 2 to 10 times to reduce impurities in the polymer. The weak solvent at this time is, for example, an alcohol, a ketone, a hydrocarbon or the like. When three or more kinds of weak solvents selected from the above are used, it is preferable to further improve the purification efficiency. The molecular weight of the poly-proline and the polyimine contained in the liquid crystal alignment treatment agent of the present invention is determined by considering the strength of the coating film obtained therefrom and the workability at the time of formation of the coating film, and the uniformity of the coating film. The weight average molecular weight measured by the GPC (gel permeation chromatography) method is preferably 5,000 to 1,000,000, more preferably 10,000 to 150,000. <Liquid Crystal Alignment Treatment Agent> The liquid crystal alignment treatment agent of the present invention is a coating liquid for forming a liquid crystal alignment film, and is a solution obtained by dissolving a resin component for forming a resin film in an organic solvent -43-200948859 . Here, the above resin component is a resin component containing at least one polymer selected from the above polymers of the present invention. In this case, the content of the resin component is preferably from 1% by mass to 20% by mass, more preferably from 3% by mass to 15% by mass, most preferably from 3 to 10% by mass. In the present invention, the above-mentioned resin components may all be the copolymer used in the present invention, and other polymers other than the polymer of the present invention may be mixed. At this time, the content of the polymer other than the polymer of the present invention in the resin component is from 5% by mass to 15% by mass, preferably from 1% by mass to 10% by mass. The other polymer, for example, a diamine component which can be reacted with a tetracarboxylic dianhydride, can be obtained by using a diamine compound (A) and a diamine compound other than the diamine compound (B). Imine and the like. The organic solvent used in the liquid crystal alignment agent of the present invention is not particularly limited as long as it is an organic solvent which can dissolve the above resin component. Specific examples thereof are listed below. Examples are hydrazine, hydrazine-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methyl caprolactam, 2-pyrrolidone, N-ethylpyrrolidone, N-vinylpyrrolidone, dimethyl hydrazine, tetramethyl urea, pyridine, dimethyl milling, hexamethyl sulfoxide, γ-butyrolactone, 1,3 Dimethyl-imidazolidinone, ethyl amyl ketone, methyl decyl ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, cyclohexanone, ethylene carbonate, propylene carbonate Ester, diglyme, 4-hydroxy-4-methyl-2-pentanone, and the like. These may be used singly or in combination. 〇 份 表 成 成 成 均 均 均 均 均 均 均 均 均 均 均 均 均 均 均 均 均 均 m m m m m m m m m m m m m m m m m m m m m m m m m m m Examples thereof -44 - 200948859 A solvent or a compound which is smooth, a compound which improves the adhesion between a liquid crystal alignment film and a substrate, and the like. Examples of the solvent (weak solvent) for improving film thickness uniformity or surface smoothness are as follows. Examples are, for example, isopropanol, methoxymethylpentanol, methyl cellosolve, ethyl cellosolve, butyl cellosolve, methyl cellosolve acetate, ethyl cellosolve acetate, butyl Carbitol, ethyl carbitol, ethyl carbitol acetate, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, Propylene glycol monoacetate, propylene glycol monomethyl ether, propylene glycol tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, two Propylene glycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl Ether, 3-methyl-3-methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether , diisobutylene, amyl acetate, butyl butyrate, butyl ether, diisobutyl ketone, methyl cyclohexene, propyl ether 'dihexyl ether, 1-hexanol, n-hexane, n-pentyl Alkane, n-octane, diethyl ether, methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, 3 - methyl methoxypropionate, methyl ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, 3-A Propyl oxypropionate, butyl 3-methoxypropionate, 1-methoxy-2-propanol, 1-ethoxy-2-propanol, 1-butoxy-2-propanol, 1_phenoxy-2-propanol, propylene glycol monoethyl-45- 200948859 acid ester, propylene glycol diacetate, propylene glycol-1_monomethyl ether-2 acetic acid vinegar, propylene glycol_1 monoethyl acid 2--acetic acid vinegar, dipropylene glycol, 2-(2-ethoxypropoxy)propanol, methyl lactate, ethyl lactate, n-propyl lactate, n-butyl lactate, isoamyl lactate, etc. with low surface tension Solvents, etc. These weak solvents may be used singly or in combination of plural kinds. When the solvent is as described above, it is preferably from 5 to 80% by mass, more preferably from 20 to 60% by mass based on the total of the solvent contained in the liquid crystal alignment agent. Examples of the compound which improves post-film uniformity or surface smoothness are fluorine-based surfactants, rhodium-based surfactants, nonionic surfactants, and the like. More specifically, for example, F TOP EF301, EF3 03, EF352 (manufactured by TOKEMU PRODUCT), MEGAFAX F171, F173, R-30 (manufactured by Dainippon Ink Co., Ltd.), FLU0RAD FC430, FC431 (manufactured by Sumitomo 3M), ASAHIGUARD AG710, SURFLON S-382, SC101, SC102, SC103, SC104, SCI 05, SCI 06 (made by Asahi Glass Co., Ltd.). The use ratio of the surfactants is preferably 0.01 to 2 parts by mass, more preferably 0.01 to 1 part by mass, per 100 parts by mass of the resin component contained in the liquid crystal alignment agent. Specific examples of the compound which improves the adhesion between the liquid crystal alignment film and the substrate are the functional decane-containing compound or the epoxy group-containing compound shown below. For example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2-aminopropyl-46-200948859 triethoxy Basear, N-(2-aminoethyl)-3-aminopropyltrimethoxydecane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxydecane, 3-ureidopropyltrimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-alkylaminotrimethoxydecane, N-ethoxycarbonyl-3 Aminopropyltriethoxydecane, N-triethoxydecylpropyltriethylamine, N-trimethoxydecylpropyltriethylamine, 1〇-trimethoxydecane 1,1,7-triazadecane, 10-triethoxydecyl-1,4,7-triazadecane, 9-trimethoxydecyl-3,6-diaza Mercaptoacetate, 9-triethoxydecyl- 3,6-diazepine acetate, N-benzyl-3-aminopropyltrimethoxydecane, N-benzyl-3 -Aminopropyltriethoxydecane, N-phenyl-3-ylaminopropyltrimethoxydecane, N_phenyl-3 Aminopropyltriethoxydecane, N-bis(oxyethyl)-3-aminopropyltrimethoxydecane, N-bis(oxyethyl)-3-aminopropyltriethoxy Base decane, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1 , 6 _ hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromo neopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2,4 - hexanediol, N,N,N',N'-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diglycidylamine oxime methyl)cyclohexane, Ν, Ν, Ν ', Ν 'four-glycidyl- 4,4'-diaminodiphenylmethane and the like. When the compound which improves the adhesion to the substrate is used, the amount thereof is preferably from 10,000 parts by mass to about 30 parts by mass of the resin component contained in the liquid crystal alignment agent, preferably from 1 to 1. 20 parts by mass. When the amount of use is less than the mass part, the effect of improving the adhesion cannot be expected, and if it is more than 30 parts by mass, the liquid crystal alignment property may be deteriorated. In addition to the above, the liquid crystal alignment treatment agent of the present invention may be added to the purpose of changing the electrical properties such as the dielectric constant or the conductivity of the liquid crystal alignment film, without impairing the effects of the present invention. The electric or conductive material 'and further' may be added as a crosslinkable compound for the purpose of increasing the hardness or density of the film when it is a liquid crystal alignment film. <Liquid Crystal Alignment Film, Liquid Crystal Display Element> The liquid crystal alignment treatment agent of the present invention is applied onto a substrate and fired, and then subjected to alignment treatment by rubbing treatment or light irradiation, or unaligned treatment such as vertical alignment use. Can be used as a liquid crystal alignment film. In this case, the substrate to be used is not particularly limited as long as it is a substrate having high transparency, and a glass substrate, a plastic substrate such as an acrylic substrate or a polycarbonate substrate, or the like can be used. Further, from the viewpoint of simplification of the process, it is preferable to use a substrate which forms an ITO electrode or the like which is useful for driving a liquid crystal. Further, it is also possible to use an opaque material such as a tantalum wafer which is a single-sided substrate of the reflective liquid crystal display element, and a material such as aluminum which can reflect light can be used as the electrode. The coating method of the liquid crystal alignment agent is not particularly limited, and industrially, it is generally a method of screen printing, lithography, flexographic printing, ink jet printing or the like. As for other coating methods, there are dip coating, roll coating, slit coating, spin coating, etc., and these may be used depending on the purpose. After the liquid crystal alignment treatment agent is applied onto the substrate, the firing can be carried out by heating a heating mechanism such as a -48-200948859 hot plate at 50 to 300 ° C, preferably 80 to 25 (TC) to evaporate the solvent. The coating film is formed. The thickness of the coating film formed after firing is too low for the power consumption of the liquid crystal display element, and if it is too thin, the reliability of the liquid crystal display element is lowered. Therefore, it is preferably 5 to 300 nm, more preferably 10 to 10 nm. When the liquid crystal is aligned horizontally or obliquely, the film after firing is treated by rubbing or polarized ultraviolet light irradiation, etc. The liquid crystal display element of the present invention is self-assisted by the above method. In the liquid crystal alignment film obtained by the invention, a liquid crystal cell is produced by a conventional method, and a liquid crystal cell is produced as a liquid crystal display element. As an example of the liquid crystal cell production, a liquid crystal alignment is prepared. One of the films is a pair of substrates, and the spacer is dispersed on the liquid crystal alignment film of one of the substrates, so that the liquid crystal alignment film surface becomes the inner side, the other substrate is bonded, the liquid crystal is decompressed and packaged, or The method of laminating the liquid crystal on the liquid crystal alignment film surface of the cloth spacer, laminating the substrate, and encapsulating the film, etc. The thickness of the spacer at this time is preferably from 1 to 30 μm, more preferably from 2 to ΙΟμιη. As above, the liquid crystal of the present invention is used. The liquid crystal display element produced by the alignment treatment agent is excellent in reliability, and can be suitably used for a large-screen, high-definition liquid crystal television, etc. [Embodiment] [Embodiment] Hereinafter, the present invention will be described in more detail, but the present invention The explanation is not limited by the examples. -49- 200948859 [Synthesis of diamine compound] <Synthesis Example 1> Synthesis of diamine compound (4)
將含化合物(2) (29.92克’ 277毫莫耳)及三乙胺 (28_03克,277毫莫耳)之四氫呋喃(300克)溶液冷卻 至10。(:以下,且在一面注意發熱一面滴加含化合物(1) (60·76克,263毫莫耳)之四氫呋喃(150克)溶液。滴 加結束後,使反應溫度上升至23 °C,繼續進行反應。以 HPLC (高速液體層析)確認反應結束後’將反應液體倒 入蒸餾水(2升)中,過濾析出之固體’水洗後’以乙醇 (450克)分散洗淨,製得化合物(3)(產量:72.91克 ,產率:9 2 % )。 1H-NMR ( 400MHz > DMSO-d6 » δ ppm) : 9.79 ( 1Η ,t) ,9· 10-9.09 ( 2Η,m ) > 9.00-8.96 ( 1 Η > m ) ' 8.61 (1Η,broad) ,8.50-8.48 ( 1H’ m) ’ 7.79-7.76 ( 1H’ m -50- 200948859 )’ 7.40-7.36 (lH,m) ,4.57(2H,s)。 接著’在氫氣存在下,於60 r下攪拌化合物(3)( 72.00克’ 238毫莫耳)、5%鈀/碳(含水型,7.2克, 10 wt°/〇 )及1,4 -二噁烷(720克)之混合物。反應結束後 ,以矽藻土過濾觸媒後,以旋轉蒸發器餾除溶劑所得粗製 產物。以乙醇(360克)使所得粗製產物分散洗淨,製得 二胺化合物(4)(產量:43.62克,產率:76%)。A solution of the compound (2) (29.92 g '277 mmol) and triethylamine (28_03 g, 277 mmol) in tetrahydrofuran (300 g) was cooled to 10. (: In the following, a solution of the compound (1) (60·76 g, 263 mmol) in tetrahydrofuran (150 g) was added dropwise while paying attention to the heat. After the completion of the dropwise addition, the reaction temperature was raised to 23 ° C. The reaction was continued. After confirming the completion of the reaction by HPLC (high-speed liquid chromatography), the reaction liquid was poured into distilled water (2 liters), and the precipitated solid was filtered and washed with ethanol (450 g) to obtain a compound. (3) (yield: 72.91 g, yield: 92%). 1H-NMR (400 MHz > DMSO-d6 » δ ppm) : 9.79 (1Η, t) , 9· 10-9.09 ( 2Η,m ) > ; 9.00-8.96 ( 1 Η > m ) ' 8.61 (1Η, broad) , 8.50-8.48 ( 1H' m) ' 7.79-7.76 ( 1H' m -50- 200948859 )' 7.40-7.36 (lH,m) , 4.57 (2H, s). Then 'in the presence of hydrogen, compound (3) (72.00 g '238 mmol), 5% palladium/carbon (aqueous form, 7.2 g, 10 wt ° / 搅拌) at 60 r And a mixture of 1,4 -dioxane (720 g). After the reaction was completed, the catalyst was filtered with celite, and the solvent was evaporated to give a crude product. Wash the product dispersion, to obtain the diamine compound (4) (yield: 43.62 g, yield: 76%).
1H-NMR ( 400MHz,DMSO-d6,<5 ppm ) : 8.64 ( 1H ,t) > 8.50 ( 1H > d ) ,8.44(lH,d) * 7.67 ( 1H > d ) ,7.34(lH,q) ,6.23(2H,d) ,5.94(lH,s) > 4.87 (4H > s ) ,4.3 9 ( 2H,d )。 <合成例2> 二胺化合物(7 )之合成1H-NMR (400MHz, DMSO-d6, <5 ppm): 8.64 (1H, t) > 8.50 ( 1H > d ) , 8.44 (lH, d) * 7.67 ( 1H > d ) , 7.34 (lH) , q) , 6.23 (2H, d), 5.94 (lH, s) > 4.87 (4H > s ) , 4.3 9 ( 2H, d ). <Synthesis Example 2> Synthesis of diamine compound (7)
將含化合物(5) (40.00克,328毫莫耳)及三乙胺 (33.18克,328毫莫耳)之四氫呋喃(400克)溶液冷卻 -51 - 200948859 至10 °C以下,且一面注意發熱一面滴加含化合物(1)( 72.00克,312毫莫耳)之四氫呋喃(176克)溶液。滴加 結束後,使反應溫度上升至23 °C ,繼續進行反應。以 HPLC確認反應結束後,將反應液體倒入蒸餾水(3.5升) 中,過濾析出之固體,水洗後,以甲醇(200克)分散洗 淨,製得化合物(6)(產量:81.4克,產率:82%)。 1H-NMR ( 400MHz > DMSO-d6 > δ ppm) : 8.83-8.34 (5H,m) > 7.83 -7.66 ( 1 H > m ) ,7 · 3 9 - 7 · 3 3 ( 1 H,m ) > 4.69-4.49 ( 2H - m ) ,2 · 9 1 - 2.8 5 ( 3 H,m )。 接著,在氫氣存在下,於23 °C下攪拌化合物(6)( 80.00克,253毫莫耳)、氫氧化鈀/碳(含水型,8.0克, 10 wt% )及1,4 —二噁烷(1200克)之混合物。反應結束後 ’以矽藻土過濾觸媒後,以旋轉蒸發器餾除溶劑所得粗製 產物。以四氫呋喃(150克)使所得粗製產物均勻溶解, 且在-20 °C下將溶液滴加於己烷(660克)中,析出固體 。隨後’過濾、以冷己烷洗淨,製得二胺化合物(7 )( 產量:7 4 · 9 8克,產率:9 8 % )。 1H-NMR ( 400MHz > DMSO-d6 > δ ppm) : 8.46-8.34 (2H ’ m) 5 7.63-7.54 ( 1 H > broad ) ,7.3 6 - 7 · 3 3 ( 1 H,m ),5.86-5.76 ( 3H,m ) ,4.86 ( 4H,s) ,4.5 7-4.5 3 ( 2H,broad) ’ 2.8〇 ( 3H,broad)。 <合成例3> 二胺化合物(10)之合成 -52- 200948859 [化 16]A solution containing compound (5) (40.00 g, 328 mmol) and triethylamine (33.18 g, 328 mmol) in tetrahydrofuran (400 g) was cooled -51 - 200948859 to below 10 °C, with a fever A solution of the compound (1) (72.00 g, 312 mmol) in tetrahydrofuran (176 g) was added dropwise. After the completion of the dropwise addition, the reaction temperature was raised to 23 ° C, and the reaction was continued. After confirming the completion of the reaction by HPLC, the reaction liquid was poured into distilled water (3.5 liters), and the precipitated solid was filtered, washed with water, and then washed with methanol (200 g) to obtain compound (6) (yield: 81.4 g, yield) Rate: 82%). 1H-NMR (400MHz > DMSO-d6 > δ ppm) : 8.83-8.34 (5H, m) > 7.83 -7.66 ( 1 H > m ) , 7 · 3 9 - 7 · 3 3 ( 1 H, m ) > 4.69-4.49 ( 2H - m ) , 2 · 9 1 - 2.8 5 ( 3 H,m ). Next, compound (6) (80.00 g, 253 mmol), palladium hydroxide/carbon (aqueous form, 8.0 g, 10 wt%) and 1,4-dioxin were stirred at 23 ° C in the presence of hydrogen. A mixture of alkanes (1200 g). After the completion of the reaction, the catalyst was filtered through celite, and the solvent was distilled off on a rotary evaporator to give a crude product. The obtained crude product was uniformly dissolved in tetrahydrofuran (150 g), and the solution was added dropwise to hexane (660 g) at -20 ° C to precipitate a solid. Subsequently, it was filtered and washed with cold hexane to obtain a diamine compound (7) (yield: 7 4 · 9 8 g, yield: 98%). 1H-NMR (400MHz > DMSO-d6 > δ ppm) : 8.46-8.34 (2H ' m) 5 7.63-7.54 ( 1 H > broad ) , 7.3 6 - 7 · 3 3 ( 1 H, m ), 5.86-5.76 ( 3H,m ) , 4.86 ( 4H,s) , 4.5 7-4.5 3 ( 2H,broad) ' 2.8〇 ( 3H, broad). <Synthesis Example 3> Synthesis of diamine compound (10) -52- 200948859 [Chem. 16]
(8) ❹ 將含化合物(8) (16.69克’137毫莫耳)及三乙胺 (13.82克,137毫莫耳)之四氫呋喃(200克)溶液冷卻 至10 °C以下,且一面注意發熱一面滴加含化合物(1)( 30.00克,130毫莫耳)之四氫呋喃(150克)溶液。滴加 結束後,使反應溫度上升至2 3 °C ’繼續進行反應。以 HPLC確認反應結束後,將反應液體倒入蒸餾水(2.8升) 中,過濾析出之固體’水洗後,以乙醇(200克)分散洗 〇 淨,製得化合物(9)(產量:34.53克,產率:84%)。 1H-NMR ( 400MHz > DMSO-d6 » δ ppm) : 9.30 ( 1H ,t) ,9.01-9.00 ( 2H,m ) > 8.95 -8.93 ( 1 H * m ) > 8.47(8) 冷却 Cool a solution containing compound (8) (16.69 g '137 mmol) and triethylamine (13.82 g, 137 mmol) in tetrahydrofuran (200 g) to below 10 °C, and pay attention to heat A solution of the compound (1) (30.00 g, 130 mmol) in tetrahydrofuran (150 g) was added dropwise. After the completion of the dropwise addition, the reaction temperature was raised to 23 ° C to continue the reaction. After confirming the completion of the reaction by HPLC, the reaction liquid was poured into distilled water (2.8 liters), and the precipitated solid was filtered, washed with ethanol (200 g), and the compound (9) was obtained (yield: 34.53 g, Yield: 84%). 1H-NMR (400MHz > DMSO-d6 » δ ppm) : 9.30 ( 1H , t ) , 9.01-9.00 ( 2H,m ) > 8.95 -8.93 ( 1 H * m ) > 8.47
(lH,d) ,8.42(lH,dd) ,7.69(2H,d) * 7.32 ( 1H ,q ) ,3.64-3.58 ( 2H,m ) ,2.92 ( 2H,t )。 接著,在氫氣存在下,於60 °C下攪拌化合物(9)( 32.00克,101毫莫耳)、5%鈀/碳(含水型,3.2克, 1(^1%)及1,4一二噁烷(32〇克)之混合物。反應結束後 ’以砂藻土過濃觸媒後,以旋轉蒸發器餾除溶劑所得粗製 -53- 200948859 產物。以四氫呋喃(1 5 0克)分散洗淨所得粗製產物’製 得二胺化合物(10)(產量:19.21克,產率:74%) ° 1H-NMR ( 400MHz,DMS0-d6,δ ppm ) : 8.43-8.39(lH, d) , 8.42 (lH, dd), 7.69 (2H, d) * 7.32 ( 1H , q ) , 3.64 - 3.58 ( 2H, m ) , 2.92 ( 2H, t ). Next, the compound (9) (32.00 g, 101 mmol), 5% palladium/carbon (aqueous form, 3.2 g, 1 (^1%) and 1, 4 in the presence of hydrogen were stirred at 60 °C. a mixture of dioxane (32 g). After the end of the reaction, the product was obtained by distilling off the solvent with a rotary evaporator, and then the solvent was evaporated to give a crude product of -53-200948859. Disperse and wash with tetrahydrofuran (150 g) The net crude product was obtained to give the diamine compound (10) (yield: 19.21 g, yield: 74%) ° 1H-NMR (400 MHz, DMS0-d6, δ ppm): 8.43-8.39
(2H,m),8.09 ( 1H ’ t) ’ 7.63 ( 1H,d),7.30 ( 1H ,dd) ,6.16 ( 2H,d) ,5.92 ( 1H ’ d) ,4.84 ( 4H ’ s ),3.44-3.28 ( 3H,m ) ,2.82 ( 3H,t)。 <合成例4> 二胺化合物(14)之合成 [化 17](2H,m), 8.09 ( 1H ' t) ' 7.63 ( 1H,d), 7.30 ( 1H ,dd ) , 6.16 ( 2H,d) , 5.92 ( 1H ' d ) ,4.84 ( 4H ' s ),3.44- 3.28 ( 3H,m ) , 2.82 ( 3H,t). <Synthesis Example 4> Synthesis of diamine compound (14) [Chem. 17]
(12) ❹ 於含化合物( 12) (35.00克,321毫莫耳)及三乙胺 (97.39克,962毫莫耳)之四氫呋喃(24〇克)溶液中滴 加含化合物( 11) (29.84克,160毫莫耳)之四氫呋喃( 60克)溶液。滴加結束後,以HPLC追蹤反應,確認反應 結束後,添加二氯甲烷(1升)後,以蒸餾水(600毫升) 進行洗淨三次。以無水硫酸鎂使有機層乾燥後,過濾、去 除溶劑,製得化合物(13)之粗製產物。以乙酸乙酯( -54- 200948859 5 00克)/己烷(1升)使所得粗製產物再結晶,製得化合 物(13)(產量:38.74克,產率:88%)。 1H-NMR ( 400MHz > CDC13 > δ ppm) : 8.79 ( 1H,d ),8.71 ( 1H,d) ,8.66 ( 1H,dd ) ,8.46 ( 1H « dd ) > 7.8 8-7.85 ( 1 H > m ) ,7.40 ( 1H,q) ,7.30 ( 1H,d) ,5.38 ( 2H,s )。 接著,在氫氣存在下,於40 °C下攪拌化合物(13 )( 20.00克,72.7毫莫耳)、氧化鉑(IV)(含水型,2.0克 ,10wt% )及乙酸乙酯 / 乙醇(200克,1 00/50 ( v/v% )) 之混合物。反應結束後,以矽藻土過濾觸媒後,以旋轉蒸 發器餾除溶劑製得化合物(14)之粗製產物。所得粗製產 物經矽膠管柱層析(溶離溶劑爲己烷/乙酸乙酯( 1 0 0/5 0v/v% ))純化,製得二胺化合物(14 )(產量: 15.27克,產率:98%)。 1H-NMR ( 400MHz,CDC13,5 ppm ) : 8.66 ( 1H,d )> 8.57 ( 1H > dd ) ,7.7 7 - 7.7 3 ( 1 H,m ) ,7.3 3-7.29 ( lH,m) ,6.67(lH,d) ,5.00(2H,s) ,3.37(4H,s <合成例5 > 二胺化合物(16)之合成 -55- 200948859 [化 18](12) 滴 In a solution containing compound (12) (35.00 g, 321 mmol) and triethylamine (97.39 g, 962 mmol) in tetrahydrofuran (24 g), compound (11) (29.84) A solution of 160 mils of tetrahydrofuran (60 g). After completion of the dropwise addition, the reaction was followed by HPLC, and after confirming completion of the reaction, dichloromethane (1 liter) was added, and then washed with distilled water (600 ml) three times. After the organic layer was dried over anhydrous magnesium sulfate, the solvent was filtered and evaporated to give the crude product of compound (13). The obtained crude product was recrystallized from ethyl acetate (-54-200948859 550 g) /hexane (1 liter) to give compound (13) (yield: 38.74 g, yield: 88%). 1H-NMR (400MHz > CDC13 > δ ppm) : 8.79 ( 1H,d ), 8.71 ( 1H,d) , 8.66 ( 1H,dd ) ,8.46 ( 1H « dd ) > 7.8 8-7.85 ( 1 H > m ) , 7.40 ( 1H, q) , 7.30 ( 1H, d) , 5.38 ( 2H, s ). Next, compound (13) (20.00 g, 72.7 mmol), platinum (IV) oxide (aqueous form, 2.0 g, 10 wt%) and ethyl acetate/ethanol (200) were stirred at 40 ° C in the presence of hydrogen. a mixture of grams, 1 00/50 (v/v%)). After completion of the reaction, the catalyst was filtered through diatomaceous earth, and then the solvent was distilled off by a rotary evaporator to obtain a crude product of compound (14). The obtained crude product was purified by silica gel column chromatography (solvent solvent hexane/ethyl acetate (1 0 0/5 0 v/v%)) to give the diamine compound (14) (yield: 15.27 g, yield: 98%). 1H-NMR (400MHz, CDC13, 5 ppm): 8.66 ( 1H,d )> 8.57 ( 1H > dd ) , 7.7 7 - 7.7 3 ( 1 H,m ) , 7.3 3-7.29 ( lH,m) , 6.67 (lH, d), 5.00 (2H, s), 3.37 (4H, s < Synthesis Example 5 > Synthesis of diamine compound (16) -55- 200948859 [Chem. 18]
(2)(2)
(16) 在23 °C下於含化合物(2) (29.98克,277毫莫耳) ❿ 、碳酸氫鈉(29.12克,347毫莫耳)及蒸餾水(630克) 之混合溶液中滴加含化合物(11) (43.0克,231毫莫耳 )之乙醇(830克)溶液。滴加結束後,以HPLC確認反應 結束後,添加二氯甲烷(2升)去除水層。隨後,有機層 以飽和食鹽水( 500毫升)洗淨三次,以無水硫酸鎂使有 機層乾燥後,進行溶劑之餾除。以乙酸乙酯(500克)/己 烷(1升)使所得粗製產物再結晶,製得化合物(1 5 )( 產量:55.28克,產率:87%)。 ❹ 1H-NMR ( 400MHz > CDC13 > δ ppm) : 9.18 ( 1H,d )> 9.17 ( 1H > broad) » 8.66-8.62 ( 2H > m) > 8.29-8.25 (1H,m) ,7.69-7.66 ( 1 H,m ) ,7.3 7 - 7 · 3 3 ( 1 H,m ) > 6.90 ( 1H > d ) ,4.68(2H,m)。 接著’在氫氣存在下,於23 °C下攪拌化合物(15)( 3.0克’10.9毫莫耳)、氧化鉛(IV)(含水型,0.3克, 10wt%)及1,4 —二噁烷(30克)之混合物。反應結束後, 以矽藻土過濾觸媒後,以旋轉蒸發器餾除溶劑製得二胺化 -56- 200948859 合物(16)(產量:2.30克,產率:98%)。 1H-NMR ( 400MHz,CDC13,δ ppm ) : 8.63 ( 1H > d ),8.52 ( 1H,dd) ,7 · 7 1 - 7.6 6 ( 1 H,m ) ,7.28-7.24 ( lH,m) ,6.53(lH,d) ,6.18-6.11 (2H,m) ,4.22( 2H,s) ,3.70 ( 1H,s) ,3.5 6 - 3 · 3 4 ( 4 H,br o ad )。 <合成例6> 二胺化合物(19)之合成 [化 19](16) Add in a mixture of compound (2) (29.98 g, 277 mmol) ❿, sodium bicarbonate (29.12 g, 347 mmol) and distilled water (630 g) at 23 °C. A solution of compound (11) (43.0 g, 231 mmol) in ethanol (830 g). After completion of the dropwise addition, after confirming completion of the reaction by HPLC, dichloromethane (2 L) was added to remove the aqueous layer. Subsequently, the organic layer was washed three times with saturated brine (500 ml), and the organic layer was dried over anhydrous magnesium sulfate. The obtained crude product was recrystallized from ethyl acetate (500 g) / hexane (1 liter) to yield Compound (15) (yield: 55.28 g, yield: 87%). ❹ 1H-NMR (400MHz > CDC13 > δ ppm) : 9.18 ( 1H,d )> 9.17 ( 1H > broad) » 8.66-8.62 ( 2H > m) > 8.29-8.25 (1H,m) , 7.69-7.66 ( 1 H,m ) , 7.3 7 - 7 · 3 3 ( 1 H,m ) > 6.90 ( 1H > d ) , 4.68 (2H, m). Then, the compound (15) (3.0 g '10.9 mmol), lead (IV) (aqueous form, 0.3 g, 10 wt%) and 1,4-dioxane were stirred at 23 ° C in the presence of hydrogen. a mixture of (30 grams). After the completion of the reaction, the catalyst was filtered through celite, and then the solvent was distilled off on a rotary evaporator to obtain a diamined- 56- 200948859 compound (16) (yield: 2.30 g, yield: 98%). 1H-NMR (400MHz, CDC13, δ ppm) : 8.63 ( 1H > d ), 8.52 ( 1H, dd ) , 7 · 7 1 - 7.6 6 ( 1 H, m ) , 7.28-7.24 ( lH,m) , 6.53 (lH, d), 6.18-6.11 (2H, m), 4.22 (2H, s), 3.70 (1H, s), 3.5 6 - 3 · 3 4 ( 4 H, br o ad ). <Synthesis Example 6> Synthesis of diamine compound (19) [Chem. 19]
(2)(2)
在40 °C下於含化合物( 17) (50.00克,170毫莫耳) 、碳酸鉀(47.01克,340毫莫耳)、碘化銅(I) (6.48克 ’ 34.0毫莫耳)、N—甲基甘胺酸(6.06克,68.0毫莫耳) 及DMSO (二甲基亞颯)(1升)之混合溶液中滴加化合物 (2) (36.78克,340毫莫耳)。滴加結束後,以HP LC確 認反應結束後,添加乙酸乙酯(4升)/蒸餾水(5升), 過濾去除不溶物。隨後’以乙酸乙酯(500克)萃取自分 液回收去除之水層兩次’且合倂有機層,並以無水硫酸鎂 -57- 200948859 進行乾燥。以旋轉蒸發器餾除溶劑後,以乙酸乙酯(700 毫升)/己烷(2升)進行再結晶,製得化合物(18 )(產 量:23.04克,產率:49%)。 1H-NMR ( 400MHz,CDC13,<5 ppm ) : 8.63 ( 1 Η > broad ) ,8.5 0- 8.49 ( 1 H > broad ) ,7.95 ( 1H,t), 7.80-7.76 ( 3H,m) ,7.67 ( 1H,t) ,7.39 ( 1H,q), 4.52 ( 2H,d )。 接著,在氫氣存在下,於23 °C下攪拌化合物(18)( 1.0克,3.65毫莫耳)、氧化鉛(IV)(含水型,0.1克, 10 wt% )及甲醇(10克)之混合物。反應結束後,以矽藻 土過濾觸媒後,以旋轉蒸發器餾除溶劑製得二胺化合物( 19)(產量:0.97克,產率:97%)。Containing compound (17) (50.00 g, 170 mmol), potassium carbonate (47.01 g, 340 mmol), copper iodide (I) (6.48 g '34.0 mmol), N at 40 °C Compound (2) (36.78 g, 340 mmol) was added dropwise to a mixed solution of methylglycine (6.06 g, 68.0 mmol) and DMSO (dimethyl sulfonium) (1 L). After completion of the dropwise addition, after confirming the completion of the reaction by HP LC, ethyl acetate (4 L) / distilled water (5 L) was added, and insoluble materials were removed by filtration. Subsequently, the aqueous layer was removed twice by extraction from ethyl acetate (500 g) and the organic layer was combined and dried over anhydrous magnesium sulfate - 57 - 200948859. After distilling off the solvent by a rotary evaporator, ethyl acetate (700 ml) / hexane (2 liter) was recrystallized to give compound (18) (yield: 23.04 g, yield: 49%). 1H-NMR (400MHz, CDC13, <5 ppm): 8.63 ( 1 Η > broad ) , 8.5 0- 8.49 ( 1 H > broad ) , 7.95 ( 1H, t), 7.80-7.76 ( 3H, m) , 7.67 ( 1H, t) , 7.39 ( 1H, q), 4.52 ( 2H, d ). Next, compound (18) (1.0 g, 3.65 mmol), lead (IV) oxide (aqueous form, 0.1 g, 10 wt%) and methanol (10 g) were stirred at 23 ° C in the presence of hydrogen. mixture. After the completion of the reaction, the catalyst was filtered through celite, and then the solvent was distilled off on a rotary evaporator to obtain a diamine compound (19) (yield: 0.97 g, yield: 97%).
1H-NMR ( 400MHz,DMSO-d6,δ ppm ) : 8.52 ( 1H ,d) ,8.41(lH,dd) ,7.69(lH,d) ,7.32(lH,q ),5.60 ( 1H,t) ,5.17 ( 2H,s ) ,4.37-4.14 ( 4H > m <合成例7> 二胺化合物(23)之合成 -58- 200948859 [化 20]1H-NMR (400MHz, DMSO-d6, δ ppm) : 8.52 ( 1H , d ) , 8.41 (lH, dd) , 7.69 (lH, d) , 7.32 (lH, q ), 5.60 ( 1H, t) , 5.17 (2H, s), 4.37-4.14 (4H > m < Synthesis Example 7 > Synthesis of diamine compound (23) -58- 200948859 [Chem. 20]
(21) Ο 在氮氣氛圍下,使含化合物(21) (51.43克’ 281毫 莫耳)之四氫呋喃(3 00克)溶液維持於1 〇 t:以下,且一 面注意發熱一面滴加含化合物(20) (50.00克,281毫莫 耳)、三乙胺(170.5克,1.69毫莫耳)及DMAP ( 4—二甲 胺基吡啶)(6.87克,56.2毫莫耳)之四氫呋喃(500克) 溶液。滴加結束後,使反應溫度上升至23 °C,攪拌1小時 後,再進行加熱回流。以HPLC確認反應結束後,將反應 Ο 液體倒入蒸餾水(6.4升)中,進行過濾、水洗,製得粗 製產物。以四氫呋喃(243克)/己烷(1458克)使粗製產 物再結晶,製得化合物(22 )(產量:72.58克,產率: 8 9%)。 1H-NMR ( 400MHz > DMSO-d6 > <5 ppm) : 11.25 ( 1H ,s) ,9.18(lH,d) ,9.09(2H,dd) ,8.82(lH,dd ),8.57(lH,t) > 8.3 8-8.3 5 ( 1 H » m ) > 7.64 ( 1H > q )0 接著’在氫氣存在下,於90°C下攪拌化合物(22 )( -59- 200948859 20.00克,69.4毫莫耳)、5%鈀一碳( 10wt%)及1,4-二噁烷( 400克)之混 ,以矽藻土過濾觸媒後,以旋轉蒸發器 產物。以乙醇(75克)分散洗淨所得粗 化合物(23 )(產量:10.14克’產率: 1H-NMR ( 400MHz,DMSO-d6,<5 ,s ) > 9.03-9.01 ( 1H > m ) ,8.72-5 8.23-8.19 ( 1H,m) ,7.54-7.5 0 ( 1 H, 2H,m) ,5·63-5·61 ( 1H,m ) > 4.75-^ <合成例8> 二胺化合物(26)之合成 [化 21] 含水型,2.0克, 合物。反應結束後 餾除溶劑製得粗製 製產物,製得二胺 6 4%)。 ppm ) : 9.87 ( 1H ? .70 ( 1Η > m ), m) > 6.27-6.26 ( ^.73 ( 2H > m )。(21) 维持 Maintain a solution of compound (21) (51.43 g '281 mmol) of tetrahydrofuran (300 g) under 1 〇t: under nitrogen atmosphere, and add the compound while paying attention to heat ( 20) (50.00 g, 281 mmol), triethylamine (170.5 g, 1.69 mmol) and DMAP (4-dimethylaminopyridine) (6.87 g, 56.2 mmol) of tetrahydrofuran (500 g) Solution. After completion of the dropwise addition, the reaction temperature was raised to 23 ° C, and the mixture was stirred for 1 hour, and then heated to reflux. After confirming the completion of the reaction by HPLC, the reaction hydrazine liquid was poured into distilled water (6.4 liter), filtered, and washed with water to obtain a crude product. The crude product was recrystallized from tetrahydrofuran (243 g) / hexane (1458 g) to yield Compound (22) (yield: 72.58 g, yield: 8 9%). 1H-NMR (400 MHz > DMSO-d6 < 5 ppm): 11.25 (1H, s), 9.18 (1H, d), 9.09 (2H, dd), 8.82 (lH, dd), 8.57 (lH, t) > 8.3 8-8.3 5 ( 1 H » m ) > 7.64 ( 1H > q )0 Then 'in the presence of hydrogen, the compound (22 ) is stirred at 90 ° C ( -59- 200948859 20.00 g, A mixture of 69.4 mmol, 5% palladium-carbon (10 wt%) and 1,4-dioxane (400 g) was filtered with diatomaceous earth to rotate the evaporator product. The obtained crude compound (23) was washed with ethanol (75 g) (yield: 10.14 g) yield: 1H-NMR (400 MHz, DMSO-d6, <5, s) > 9.03-9.01 (1H > m ), 8.72-5 8.23-8.19 (1H, m), 7.54-7.50 (1H, 2H, m), 5·63-5·61 (1H, m) > 4.75-^ <Synthesis Example 8> Synthesis of diamine compound (26) Aqueous form, 2.0 g of a compound. After completion of the reaction, the solvent was distilled off to give a crude product to give a diamine (4%). Ppm ) : 9.87 ( 1H ? .70 ( 1Η > m ), m) > 6.27-6.26 ( ^.73 ( 2H > m ).
(26) 在氮氣氛圍下,使含化合物(21) 莫耳)之四氫呋喃(120克)之溶液冷 一面注意發熱一面滴加含化合物(24) 莫耳)、三乙胺(68.18克’ 674毫莫耳 -60- (20.00克,112毫 卻至1 〇 °c以下,且 (20.57克,112毫 )&DMAP(2.74* 200948859 ,22.5毫莫耳)之四氫呋喃(200克)溶液。滴 ,使反應溫度上升至23 °C,攪拌1小時後’再進 流17小時。以HPLC確認反應結束後,將反應液 餾水(2.6升)中,進行過濾、水洗,所得粗製 乙醇(40克)將所得粗製產物分散洗淨後,進行 燥,製得化合物(25)(產量:16·45克,產率: 1H-NMR ( 400MHz,DMSO-d6,<5 ppm ): ,s) - 9.15-9.14 ( 1Η > m ) > 8.86 ( 1Η > d ), ,d) - 8.64-8.60 ( 1 H · m ) > 8.33 ( 1H > d ), ,d) ,7.66(lH,q) ,2.92 ( 2H,t )。 接著,在氫氣存在下,於60°C下攪拌化合物 15.00克,52.0毫莫耳)、5%鈀/碳(含水型, 10wt%)及1,4 —二噁烷(150克)之混合物。反 ,以矽藻土過濾觸媒後,以旋轉蒸發器餾除溶劑 物(26)之粗製產物。製得粗製產物經矽膠管柱 離溶劑爲己烷/乙酸乙酯(l〇〇/5〇v/v% ))純化, 氫呋喃(400克)/己烷(600克)再結晶純化, 化合物(26)(產量:6.11克,產率:51%)。 1H-NMR ( 400MHz,DMSO-d6,<5 ppm ): ,s ) ,9.10 ( 1H,d) ,8.72 ( 1H,dd ) ,8.30- ,m) ,7.90 ( 1H,s) > 7.52 ( 1H > q ) > 6.75 ( ,6.61 ( 1H,d) ,5.99 ( 1H,m) ,4.65-4.59 ( 加結束後 行加熱回 體倒入蒸 產物。以 過爐、乾 5 1%)。 11-4 ( 1 Η 8.77 ( 1Η 8.06 ( 1Η (25 )( 1.5 克, 應結束後 製得化合 層析(溶 接著自四 製得二胺 9-54 ( in 8.27 ( in 1Η,d) 4H > m ) -61 - 200948859 <合成例9> 二胺化合物(29)之合成 [化 22](26) A solution containing the compound (21) Mohr in tetrahydrofuran (120 g) was cooled while under nitrogen atmosphere. The compound (24) molar and triethylamine (68.18 g '674 m) were added dropwise while heating. Mohr-60- (20.00 g, 112 mM but below 1 〇 °c, and (20.57 g, 112 mM) & DMAP (2.74 * 200948859, 22.5 mmol) tetrahydrofuran (200 g) solution. The reaction temperature was raised to 23 ° C, and after stirring for 1 hour, the mixture was further refluxed for 17 hours. After confirming the completion of the reaction by HPLC, the reaction liquid was distilled (2.6 liter), filtered, and washed with water to obtain crude ethanol (40 g). The obtained crude product was dispersed and washed, and then dried to obtain Compound (25) (yield: 16.45 g, yield: 1H-NMR (400 MHz, DMSO-d6, <5 ppm): , s) - 9.15 -9.14 ( 1Η > m ) > 8.86 ( 1Η > d ), ,d) - 8.64-8.60 ( 1 H · m ) > 8.33 ( 1H > d ), ,d) , 7.66(lH,q ), 2.92 ( 2H, t ). Next, a mixture of 15.00 g of the compound, 52.0 mmol, 5% palladium on carbon (aqueous form, 10 wt%) and 1,4-dioxane (150 g) was stirred at 60 ° C in the presence of hydrogen. Instead, after filtering the catalyst with diatomaceous earth, the crude product of the solvent (26) was distilled off by a rotary evaporator. The crude product was purified by purifying the hexane/ethyl acetate (1 〇〇/5 〇v/v%) from a solvent column, and then recrystallized from hydrogenfuran (400 g) / hexane (600 g). (26) (yield: 6.11 g, yield: 51%). 1H-NMR (400MHz, DMSO-d6, <5 ppm): , s), 9.10 (1H, d), 8.72 (1H, dd), 8.30-, m), 7.90 (1H, s) > 7.52 ( 1H > q ) > 6.75 ( , 6.61 ( 1H, d) , 5.99 ( 1H, m) , 4.65 - 4.59 (after the end of the addition, heat the body and pour the steamed product into a furnace, dry 5 1%). 11-4 ( 1 Η 8.77 ( 1 Η 8.06 ( 1 Η (25 ) ( 1.5 g, should be prepared after the completion of the chromatography (dissolved from the four-made diamine 9-54 (in 8.27 (in 1 Η, d) 4H > ; m ) -61 - 200948859 <Synthesis Example 9> Synthesis of diamine compound (29) [Chem. 22]
(29) 在氮氣氛圍下,於含化合物(27) ( 10.00克’49.0毫 莫耳)及三乙胺(59.50克,588毫莫耳)之四氫呋喃( 1〇〇克)溶液中緩慢滴加化合物(12) (21.39克’ 196毫 莫耳)。反應結束後,將反應液體倒入蒸餾水(1升)中 ,進行過濾、洗淨,製得化合物(28 )之粗製產物。以乙 腈(200克)/乙酸乙酯(3 00克)使製得粗製產物再結晶 ,製得化合物(2 8 )(產量:1 1 · 3 5克,產率:6 1 % )。 1H-NMR ( 400MHz,DMSO-d6, δ ppm ) : 8.74-8.73(29) Slowly add the compound to a solution of compound (27) (10.00 g '49.0 mmol) and triethylamine (59.50 g, 588 mmol) in tetrahydrofuran (1 g) under nitrogen atmosphere. (12) (21.39 g '196 mmol). After completion of the reaction, the reaction liquid was poured into distilled water (1 liter), filtered, and washed to obtain a crude product of the compound (28). The crude product obtained was recrystallized from acetonitrile (200 g) / ethyl acetate (30 g) to yield compound (2 8 ) (yield: 1 1 · 3 5 g, yield: 61%). 1H-NMR (400MHz, DMSO-d6, δ ppm ) : 8.74-8.73
(3H,m) ’ 8.61 ( 2H,dd) ,7.93 ( 2H,d) ,7.50 ( 2H ,q ) ,7_44 ( 1H,s ) ,5.56 ( 4H,s )。 接著’在氫氣存在下,於60°C下攪拌化合物(28 )( -62- 200948859 8.00克,20.1毫莫耳)、氧化鉑(IV)(含水型,0.8克, 10wt% )及1,4 -二噁烷(80克)之混合物。反應結束後, 以矽藻土過濾觸媒後,以旋轉蒸發器餾除溶劑所得粗製產 物以四氫呋喃(200克)/己烷(600克)使所得粗製產物 再結晶,製得二胺化合物(29 )(產量:4.66克,產率: 7 2%)。(3H,m) ' 8.61 ( 2H,dd) , 7.93 ( 2H,d) , 7.50 ( 2H ,q ) , 7_44 ( 1H,s ) , 5.56 ( 4H,s ). Then, the compound (28) (-62-200948859 8.00 g, 20.1 mmol), platinum (IV) (aqueous form, 0.8 g, 10 wt%) and 1,4 were stirred at 60 ° C in the presence of hydrogen. a mixture of dioxane (80 g). After the completion of the reaction, the catalyst was filtered through celite, and the obtained crude product was evaporated to dryness eluted with EtOAc (EtOAc) (Yield: 4.66 g, yield: 7 2%).
1H-NMR ( 400MHz,DMSO-d6, δ ppm ) : 8.65 ( 2H ,d ) ,8.52 ( 2H > dd ) ,7 · 8 8 - 7 · 8 5 ( 2 H,m ) ,7.40 ( 2H,q) ,6.68(lH,s) ,6.07(lH,s) ,4.96(4H,s )> 4.25 ( 4H > s ) ° <合成例1 〇> 二胺化合物(34)之合成 [化 23]1H-NMR (400MHz, DMSO-d6, δ ppm) : 8.65 ( 2H ,d ) , 8.52 ( 2H > dd ) , 7 · 8 8 - 7 · 8 5 ( 2 H,m ) , 7.40 ( 2H,q ), 6.68 (lH, s), 6.07 (lH, s), 4.96 (4H, s) > 4.25 ( 4H > s ) ° <Synthesis Example 1 〇> Synthesis of diamine compound (34) twenty three]
-63- 200948859 在氮氣氛圍下,將含化合物(31 ) ( 81.60克,74.1毫 莫耳)、氫氧化鉀(18.29克’24.7毫莫耳)及〇1^180(375 克)之混合物加熱至50 °C後,滴加含化合物(30)( 50.00克,24.7毫莫耳)之DMSO( 125克)溶液。滴加結束 後,以HPLC確認反應結束後,將反應液體注入5質量%之 鹽酸冰水(4升)中,過濾固體,經水洗,製得化合物( 32)之濕潤產物。隨後,以2 —丙醇(205克)/己烷(335 克)進行再結晶,製得化合物(32)(產量:49·0克,產 率 7 2 % )。-63- 200948859 A mixture of compound (31) (81.60 g, 74.1 mmol), potassium hydroxide (18.29 g '24.7 mmol) and 〇1^180 (375 g) was heated to a nitrogen atmosphere. After 50 ° C, a solution of compound (30) (50.00 g, 24.7 mmol) in DMSO (125 g) was added dropwise. After completion of the dropwise addition, the reaction liquid was poured into 5 mass% hydrochloric acid ice water (4 liters), and the solid was filtered and washed with water to obtain a wet product of the compound (32). Subsequently, recrystallization was carried out with 2-propanol (205 g) / hexane (335 g) to give Compound (32) (yield: 49·0 g, yield: 72%).
1H-NMR ( 400MHz,DMSO-d6,δ ppm ) : 9.73 ( 1H1H-NMR (400MHz, DMSO-d6, δ ppm) : 9.73 ( 1H
,s) ,8_86(lH,d) ,8_42(lH,dd) > 7.1 1 -7.05 ( 3H ,m ) ,6.90-6.87 ( 2H,m )。 接著,在氮氣氛圍下,使含化合物(21) (19.34克 ,109毫莫耳)之四氫呋喃(180克)溶液冷卻至10°C以下 ,且一面注意發熱一面滴加含化合物(31) (30.0克, 109毫莫耳)' 三乙胺(33.0克,324毫莫耳)及DMAP( 2.65克,21.7毫莫耳)之DM SO (300克)溶液。滴加結束 後,使反應溫度上升至23 °C,攪拌1小時後,再進行加熱 回流19小時。以HPLC確認反應結束後,將反應液體倒入 蒸餾水(3·9升)中,經過濾、水洗、且進行甲醇水洗, 製得粗製產物。使所得粗製產物溶解於氯仿中之後,過濾 不溶物。隨後,濃縮濾液,且以矽膠管柱層析(溶離溶劑 爲1,2—二氯乙烷/乙酸乙酯(100/4〇ν/ν% ))純化,製得 化合物(33)(產量:35.8克,產率:86%)。 200948859 1H-NMR ( 400MHz > DMSO-d6 > <5 ppm) ,dd ) ,8.92-8.91 ( 2H,m ) ,8.52-8.48 ( 7.69-7.66 ( 1 H,m) ,7.53-7.51 ( 2H,m), 2H,m ) ,7.24 ( 1 H,d )。 接著,在氮氣氛圍下,使含化合物(33 ,78.7毫莫耳)及鐵粉( 26.36克,472毫莫耳 170克)溶液加熱至70 °C後,滴加含10質量 12.63克’ 236毫莫耳)之水溶液。反應結束後 過濾固體。隨後,自濾液去除水層後,以旋轉 有機層’製得粗製產物。接著,使所得粗製產 酸乙酯(1升)中,以蒸餾水(500毫升)洗淨 機層以無水硫酸鎂乾燥,餾除溶劑,以甲醇 —丙醇(100克)使所得化合物(34 )之粗製 ,製得二胺化合物(34)(產量:15.4克,產 〇 1H-NMR ( 400MHz,DMSO-d6,δ ppm ) ’ dd ) ’ 8.85 ( 1H,dd ) ,8.43 -8.40 ( 1 H - 7.59 ( 1H > m ) ,7.19-7.16 (2H,m) ^ 6.88- m) ,6.53(lH,d) ,6.02(lH,d) . 5.8 1 ’ 4.69 ( 2H,s ) > 4.57 ( 2H > s )。 <合成例1 1> 二胺化合物(37)之合成 :9.29 ( 1H 2H,m ) > 7.44-7.40 ( )(30.00克 )之甲苯( %氯化銨( ,以矽藻土 蒸發器濃縮 物溶解於乙 三次後,有 (100克)/2 產物再結晶 i 率:6 1 % ) :9.20 ( 1H m) 5 7.62- .6.84 ( 2H, (1 Η,dd ) -65- 200948859 [化 24], s) , 8_86 (lH, d) , 8_42 (lH, dd) > 7.1 1 -7.05 ( 3H , m ) , 6.90-6.87 ( 2H, m ). Next, a solution of the compound (21) (19.34 g, 109 mmol) in tetrahydrofuran (180 g) was cooled to below 10 ° C under a nitrogen atmosphere, and the compound (31) was added dropwise while paying attention to heat generation (30.0). Gram, 109 mM) Triethylamine (33.0 g, 324 mmol) and DMAP ( 2.65 g, 21.7 mmol) in DM SO (300 g). After completion of the dropwise addition, the reaction temperature was raised to 23 ° C, and the mixture was stirred for 1 hour, and then heated and refluxed for further 19 hours. After confirming the completion of the reaction by HPLC, the reaction liquid was poured into distilled water (3.9 liter), filtered, washed with water, and washed with methanol to give a crude product. After the obtained crude product was dissolved in chloroform, the insoluble matter was filtered. Subsequently, the filtrate was concentrated, and purified by a silica gel column chromatography (solvent solvent: 1,2-dichloroethane / ethyl acetate (100 / 4 〇 ν / ν%)) to obtain compound (33) (yield: 35.8 g, yield: 86%). 200948859 1H-NMR (400MHz > DMSO-d6 ><5 ppm) , dd ) , 8.92 - 8.91 ( 2H, m ) , 8.52 - 8.48 ( 7.69 - 7.66 ( 1 H, m ) , 7.53 - 7.51 ( 2H ) , m), 2H, m ) , 7.24 ( 1 H, d ). Then, under a nitrogen atmosphere, a solution containing the compound (33, 78.7 mmol) and iron powder (26.36 g, 472 mmol: 170 g) was heated to 70 ° C, and then 10 masses of 12.63 g '236 m were added dropwise. An aqueous solution of Moh. After the reaction was over, the solid was filtered. Subsequently, after the aqueous layer was removed from the filtrate, a crude product was obtained by rotating the organic layer. Next, the obtained crude acid-producing ethyl ester (1 liter) was washed with distilled water (500 ml), dried over anhydrous magnesium sulfate, and the solvent was evaporated to give the compound (34) as methanol-propanol (100 g). The crude product was prepared to give the diamine compound (34) (yield: 15.4 g, 〇1H-NMR (400 MHz, DMSO-d6, δ ppm) ' dd ) ' 8.85 ( 1H, dd ) , 8.43 - 8.40 ( 1 H - 7.59 ( 1H > m ) , 7.19-7.16 (2H, m) ^ 6.88- m) , 6.53 (lH, d) , 6.02 (lH, d) . 5.8 1 ' 4.69 ( 2H, s ) > 4.57 ( 2H > s ). <Synthesis Example 1 1> Synthesis of diamine compound (37): 9.29 (1H 2H, m ) > 7.44 - 7.40 ( ) (30.00 g) of toluene (% ammonium chloride (concentrated by diatomaceous earth evaporator) After dissolved in B three times, there is (100 g)/2 product recrystallization i rate: 6 1 %): 9.20 (1H m) 5 7.62- .6.84 ( 2H, (1 Η, dd ) -65- 200948859 twenty four]
在氮氣氛圍下,以冰浴使含化合物(32) ( 17.00克 ,61.6毫莫耳)、化合物(35) (6.57毫升,67.7毫莫耳 )及三苯基膦(20.99克,80.0毫莫耳)之四氫呋喃(340 克)溶液冷卻,且緩慢滴加含DEAD (偶氮二羧酸二乙酯 )(40質量%甲苯溶液,34.84毫升,80.0毫莫耳)溶液。 滴加結束後,使反應溫度緩慢上升至2 3 °C進行反應。以 HPLC確認反應結束後,以蒸發器餾除溶劑,所得粗製產 物。隨後,以2—丙醇(45 0克)進行再結晶兩次,製得化 合物(36)(產量:17.77克,產率:79%)。 1H-NMR ( 400MHz,CDC13,<5 ppm ) : 8.84 ( 1H,d ),8.71 ( 1Η > broad ) ,8.63 ( 1Η,dd ) ,8 3〇 ( ih, dd) ,7.80(lH,d) ,7.36(lH,q) ,7.12_7〇8(4H, m ) ,7.01 ( 1H,d ) ,5.04 ( 2H,s )。 接著,在氮氣氛圍中,於氫氣存在下,於23 ^下擾泮 化合物(36)(15.00克,40_8毫莫耳)、氧化銷(11^)( -66 - 200948859 含水型,1.5克,10wt%)及1,4—二噁烷( 230克)之混合 物。反應結束後,以矽藻土過濾觸媒後,以旋轉蒸發器餾 除溶劑製得粗製產物。所得粗製產物以2 -丙醇(6 0克) 再結晶,所得二胺化合物(37)(產量:9.66克,產率: 7 7%)。 1H-NMR ( 400MHz,CDC13,5 ppm ) : 8.66 ( 1H > d ),8.57(lH,dd) ,7.77(lH,m) ,7.3 4(lH,q), 6.87 ( 4H > s ) > 6.69 ( 1H > d ) > 6.16 ( 1H > d ) ,6.07( 1H ’ dd) ’ 5.02 ( 2H,s) ,3.65-3.48 ( 4H,broad)。 <合成例12> 二胺化合物(4〇)之合成The compound (32) (1,700 g, 61.6 mmol), the compound (35) (6.57 ml, 67.7 mmol) and triphenylphosphine (20.99 g, 80.0 mmol) were placed in an ice bath under a nitrogen atmosphere. The tetrahydrofuran (340 g) solution was cooled, and a solution containing DEAD (diethyl azodicarboxylate) (40% by mass in toluene, 34.84 ml, 80.0 mmol) was slowly added dropwise. After the completion of the dropwise addition, the reaction was slowly raised to 23 ° C to carry out a reaction. After confirming the completion of the reaction by HPLC, the solvent was distilled off with an evaporator to obtain a crude product. Subsequently, recrystallization was carried out twice with 2-propanol (45 g) to give Compound (36) (yield: 17.77 g, yield: 79%). 1H-NMR (400MHz, CDC13, <5 ppm): 8.84 (1H,d), 8.71 (1Η > broad ) , 8.63 ( 1Η,dd ) , 8 3〇( ih, dd ) , 7.80 (lH,d ), 7.36(lH,q) , 7.12_7〇8(4H, m ) , 7.01 ( 1H,d ) , 5.04 ( 2H,s ). Next, the compound (36) (15.00 g, 40-8 mmol) and the oxidation pin (11^) (-66 - 200948859 water-containing form, 1.5 g, 10 wt%) were scrambled under a nitrogen atmosphere in the presence of hydrogen at 23 °. %) and a mixture of 1,4-dioxane (230 g). After completion of the reaction, the catalyst was filtered through diatomaceous earth, and then the solvent was distilled off on a rotary evaporator to obtain a crude product. The obtained crude product was recrystallized from 2-propanol (60 g) to give diamine compound (37) (yield: 9.66 g, yield: 7 7%). 1H-NMR (400MHz, CDC13, 5 ppm): 8.66 (1H > d ), 8.57 (lH, dd), 7.77 (lH, m), 7.3 4 (lH,q), 6.87 ( 4H > s ) > 6.69 ( 1H > d ) > 6.16 ( 1H > d ) , 6.07( 1H ' dd) ' 5.02 ( 2H, s) , 3.65-3.48 ( 4H, broad). <Synthesis Example 12> Synthesis of diamine compound (4〇)
使含化合物(3 8 ) ( 23.45克,190毫莫耳)及三乙胺 (19.23克’ 277毫莫耳)之四氫呋喃(23〇克)溶液冷卻 至10 °C以下’且一面注意發熱—面滴加含化合物(1)( 41.68克,180鼋莫耳)之四氫呋喃(11〇克)溶液。滴加 -67- 200948859 結束後’使反應溫度上升至23°C ’再進行反應。以HPLC (高速液體層析)確認反應結束後’將反應液體倒入蒸餾 水(1 .5升)中,過濾析出之固體’並經水洗。隨後,以 乙醇(380克)分散洗淨固體,製得化合物(39)(產量 :50.82克,產率:89%)。Cool the solution containing the compound (3 8 ) ( 23.45 g, 190 mmol) and triethylamine (19.23 g '277 mmol) in tetrahydrofuran (23 g) to below 10 °C. A solution of the compound (1) (41.68 g, 180 Torr) in tetrahydrofuran (11 g) was added dropwise. After the dropwise addition -67- 200948859, the reaction temperature was raised to 23 ° C and the reaction was carried out. After confirming the completion of the reaction by HPLC (high-speed liquid chromatography), the reaction liquid was poured into distilled water (1.5 liter), and the precipitated solid was filtered and washed with water. Subsequently, the solid was washed with ethanol (380 g) to obtain Compound (39) (yield: 50.82 g, yield: 89%).
1H-NMR ( 400MHz,DMS〇-d6,6 ppm ) : 9.76 ( 1H ,t) ,9.09-9.02 ( 2H,m ) ,8 · 9 9 - 8.9 3 ( 1 H ’ m ) ' 8.50 (1H,mbroad) > 7.64-7.60 ( 1H 1 m ) > 7.3 6-7.3 2 ( 1 H > m ) ,7.20-7.14 (lH,m) ,4.57(2H,s) ,3.35(2H, s ) ° 接著,在氫氣存在下,於60°c下攪拌化合物(39 )( 48.00克,151毫莫耳)、5%鈀/碳(含水型,4.8克, 10wt%)及1,4 —二噁烷( 490克)之混合物。反應結束後 ,以矽藻土過濾觸媒後,以旋轉蒸發器餾除溶劑所得粗製 產物。以乙醇(3 00克)分散洗淨所得粗製產物,製得二 胺化合物(40)(產量:27.20克,產率:70%)。1H-NMR (400MHz, DMS〇-d6, 6 ppm): 9.76 ( 1H , t) , 9.09-9.02 ( 2H, m ) , 8 · 9 9 - 8.9 3 ( 1 H ' m ) ' 8.50 (1H, mbroad > 7.64-7.60 ( 1H 1 m ) > 7.3 6-7.3 2 ( 1 H > m ) , 7.20-7.14 (lH,m) , 4.57(2H,s) , 3.35(2H, s ) ° The compound (39) (48.00 g, 151 mmol), 5% palladium/carbon (aqueous form, 4.8 g, 10 wt%) and 1,4-dioxane were stirred at 60 ° C in the presence of hydrogen. a mixture of 490 g). After completion of the reaction, the catalyst was filtered with diatomaceous earth, and the solvent was distilled off on a rotary evaporator to give a crude product. The obtained crude product was washed with ethanol (300 g) to give a diamine compound (40) (yield: 27.20 g, yield: 70%).
1H-NMR ( 400MHz,DMSO-d6,δ ppm ) : 8.64 ( 1H ,t) ,8.50(lH,d) ,8.44(lH,d) ,7.67(lH,d) ,7.34 ( 1H,q) ,6.23 ( 2H,d) ,5.94 ( 1H,s) 4.87 ( 4H,s ) ,4.39 ( 2H,d )。 <合成例13> 二胺化合物(43)之合成 -68 .200948859 [化 26]1H-NMR (400MHz, DMSO-d6, δ ppm): 8.64 (1H, t), 8.50 (lH, d), 8.44 (lH, d), 7.67 (lH, d), 7.34 (1H, q), 6.23 ( 2H,d) , 5.94 ( 1H,s) 4.87 ( 4H,s ) , 4.39 ( 2H,d ). <Synthesis Example 13> Synthesis of diamine compound (43) -68 .200948859 [Chem. 26]
(41)(41)
(43) ❹ 使含化合物(41) (15.22克,142毫莫耳)及三乙胺 ❹ (15.09克,149毫莫耳)之四氫呋喃(150克)溶液冷卻 至10 °C以下’且一面注意發熱一面滴加含化合物(1)( 31.1克,135毫莫耳)之四氫呋喃(50克)溶液。滴加結 束後,使反應溫度上升至23°C,再進行反應。以HPLC確 認反應結束後’將反應液體倒入蒸餾水(1升)中,過濾 析出之固體’並經水洗。隨後,以乙醇(3 00克)分散洗 淨固體,製得化合物(42 )(產量:36.92克,產率:90% )° 1H-NMR ( 400MHz > DMSO-d6 > δ ppm) : 9.75 ( 1Η ,broad ) ,9.10 ( 2H,s) ,8.97-8.92 ( 1 H > m ) - 7.40- 7·22 ( 5H,m) ,4.5 9 - 4.5 2 ( 2 H,m )。 接著,在氫氣存在下,於60°C下攪拌化合物(42 )( 36.00克,119毫莫耳)、5%鈀/碳(含水型,3.6克, 10wt% )及1,4 -二噁烷(300克)之混合物。反應結束後 ,以矽藻土過濾觸媒後,以旋轉蒸發器餾除溶劑所得粗製 -69- 200948859 產物。以甲醇(200克)使所得粗製產物再結晶,製得二 胺化合物(4 3 )(產量:2 1 . 5克,產率:7 2 % )。(43) 冷却 Cool the solution containing the compound (41) (15.22 g, 142 mmol) and triethylamine hydrazine (15.09 g, 149 mmol) in tetrahydrofuran (150 g) to below 10 °C. A solution of the compound (1) (31.1 g, 135 mmol) in tetrahydrofuran (50 g) was added dropwise while heating. After the dropwise addition, the reaction temperature was raised to 23 ° C, and the reaction was further carried out. After confirming the completion of the reaction by HPLC, the reaction liquid was poured into distilled water (1 liter), and the precipitated solid was filtered and washed with water. Subsequently, the solid was washed with ethanol (300 g) to obtain a compound (42) (yield: 36.92 g, yield: 90%). 1H-NMR (400 MHz > DMSO-d6 > δ ppm) : 9.75 (1Η, broad), 9.10 ( 2H, s) , 8.97-8.92 ( 1 H > m ) - 7.40- 7·22 ( 5H, m) , 4.5 9 - 4.5 2 ( 2 H, m ). Next, compound (42) (36.00 g, 119 mmol), 5% palladium/carbon (aqueous form, 3.6 g, 10 wt%) and 1,4-dioxane were stirred at 60 ° C in the presence of hydrogen. a mixture of (300 g). After completion of the reaction, the catalyst was filtered with diatomaceous earth, and then the solvent was distilled off on a rotary evaporator to yield crude product -69-200948859. The obtained crude product was recrystallized from methanol (200 g) to give the diamine compound (4 3 ) (yield: 21.5 g, yield: 72%).
1H-NMR ( 400MHz,DMSO-d6,δ ppm ) : 8.55 ( 1H ,broad ) ,7.34-7.17 ( 5H > m ) > 6.28 ( 2H > s) > 6.98- 6.94 ( 1H,m) 1 4.85-4.74 ( 4H 1 broad) » 4.42-4.35 ( 2H,m )。 表4] 二胺化雜 Χι x2 x3 X4 η 合成例1 4 -CONH- 亞甲基 單鍵 吡陡環 1 合成例2 7 —con(ch3)— 亞甲基 單鍵 吡陡環 1 合成例3 10 -CONH- 伸乙基 單鍵 吡陡環 1 合成例4 14 -0- 亞甲基 單鍵 吡啶環 1 合成例5 16 -NH- 亞甲基 單鍵 吡陡環 1 合成例6 19 -NH- 亞甲基 單鍵 吡啶環 1 合成例7 23 -NHCO- 單鍵 單鍵 吡啶環 1 合成例8 26 -NHCO- 單鍵 單鍵 吡啶環 1 合成例9 29 —0 — 亞甲基 單鍵 吡啶環 2 合成例10 24 —0 — 苯基 -OCO- 吡啶環1 1 合成例Π 37 —0— 苯基 -och2- 口比陡環 •-------- 1 合成例1 40 -coo- 伸乙基 單鍵 吡陡環 1 合成例2 43 -CONH- 亞甲基 單鍵 赖 1 [聚醯亞胺之合成] 以下顯示所使用之四羧酸二酐等化合物之簡稱。 (四羧酸二酐) CBDA: 1,2,3,4—環丁烷四羧酸二酐 -70- 200948859 BODA :雙環[3,3,0]辛烷—2,4,6,8_四羧酸二酐 [化 36] (二胺) DBA : 3,5—二胺基苯甲酸 p— PDA :對—苯二胺 PCH7DAB : 1,3 - 二胺基 _ 4一 [4_ (反式—4_ 正庚 基環己基)苯氧基]苯 [化 35] ❹1H-NMR (400MHz, DMSO-d6, δ ppm): 8.55 ( 1H , broad ) , 7.34 - 7.17 ( 5H > m ) > 6.28 ( 2H > s) > 6.98- 6.94 ( 1H,m) 1 4.85-4.74 ( 4H 1 broad) » 4.42-4.35 ( 2H,m ). Table 4] Diamine hydrazide i x x x X X η Synthesis Example 1 4 -CONH-methylene single bond pyridyl ring 1 Synthesis Example 2 7 —con(ch3)—methylene single bond pyridyl ring 1 Synthesis Example 3 10 -CONH-extended ethyl single bond pyridyl ring 1 Synthesis Example 4 14 -0-methylene single bond pyridine ring 1 Synthesis Example 5 16 -NH-methylene single bond pyridyl ring 1 Synthesis Example 6 19 -NH - Methylene single bond pyridine ring 1 Synthesis Example 7 23 -NHCO- Single bond single bond pyridine ring 1 Synthesis Example 8 26 -NHCO- Single bond single bond pyridine ring 1 Synthesis Example 9 29 - 0 - Methylene single bond pyridine Ring 2 Synthesis Example 10 24 —0 — Phenyl-OCO-pyridine ring 1 1 Synthesis Example Π 37 —0—Phenyl-och2-mouth ratio steep ring•-------- 1 Synthesis Example 1 40 -coo - Ethylethyl single-chain pyrrole ring 1 Synthesis Example 2 43 -CONH-methylene single bond lysine 1 [Synthesis of polyimine] The following is abbreviated as a compound such as tetracarboxylic dianhydride used. (tetracarboxylic dianhydride) CBDA: 1,2,3,4-cyclobutanetetracarboxylic dianhydride-70- 200948859 BODA :bicyclo[3,3,0]octane-2,4,6,8_ Tetracarboxylic dianhydride [Chem. 36] (Diamine) DBA: 3,5-Diaminobenzoic acid p-PDA: p-phenylenediamine PCH7DAB : 1,3 -diamino _ 4 -[4_ (trans —4 — n-heptylcyclohexyl)phenoxy]benzene [化35] ❹
Η2ΝχχΗ2 -p-PDAΗ2ΝχχΗ2 -p-PDA
PCH7DAB (有機溶劑) NMP : N —甲基一2 —吡咯啶酮 BCS : 丁基溶纖素 <聚醯亞胺之分子量測定> 合成例中之聚醯亞胺之分子量係使用昭和電工公司製 -71 - 200948859 造之常溫凝膠滲透層析(GPC )裝置(GPC _ 1〇1 ), Shodex公司製造之管柱(KD- 803,KD- 805),如下列 般測定。PCH7DAB (organic solvent) NMP : N -methyl-2-pyrrolidone BCS : butyl cellulolytic < molecular weight measurement of polyimine] The molecular weight of the polyimine in the synthesis example is made by Showa Denko Co., Ltd. - 71 - 200948859 A room temperature gel permeation chromatography (GPC) device (GPC _ 1〇1), a column made by Shodex (KD-803, KD-805), was measured as follows.
管柱溫度:50°C 溶離液.N,N’- 一甲基甲酿胺(作爲添加劑,溴化鋰 —水合物(LiBr· HW)爲30毫莫耳/升,磷酸•無水結晶 (〇_磷酸)爲30毫莫耳/升,四氫呋喃(THF)爲1〇毫升/ 升) 流速:1.0毫升/分鐘 校正線製作用標準樣品:東曹公司製造之TSK,標準 聚環氧乙院(分子量 900,000, 150,000, 100,000, 30,〇〇〇 )及聚合物實驗室公司製造之聚乙二醇(分子量約12,000 > 4,000 > 1,000 ) ° <醯亞胺化率之測定> 合成例中之聚醯亞胺之醯亞胺化率係如下列般測定。 將20毫克之聚醯亞胺粉末加入NMR樣品管(草野科學公司 製造之NMR樣品管標準,φ 5 )中,添加0.53毫升之氘化 二甲基亞颯(〇1^150—(16,0.05%丁1^8混合物),且以超音 波使之完全溶解。使用日本電子DATUM公司製造之NMR 測定器(JNW-ECA500 ),測定該溶液之500MHz之質子 NMR。醯亞胺化率係使用源自醯亞胺化前後未變化之結構 之質子作爲基準質子予以決定之該質子之峰估算値’及自 9.5至lO.Oppm附近出現之來自醯胺酸之NH基之質子峰之估 200948859 算値,以下列之式求得。Column temperature: 50 ° C Dissolved solution. N, N'- methyl methamine (as an additive, lithium bromide-hydrate (LiBr · HW) is 30 mmol / liter, phosphoric acid • anhydrous crystals (〇_phosphoric acid) ) 30 mmol / liter, tetrahydrofuran (THF) 1 〇 ml / liter) Flow rate: 1.0 ml / min Calibration line production standard sample: TSK manufactured by Tosoh Corporation, standard poly epoxy plant (molecular weight 900,000, 150,000, 100,000, 30, 〇〇〇) and polyethylene glycol manufactured by Polymer Laboratories, Inc. (molecular weight: about 12,000 > 4,000 > 1,000 ) ° <Measurement of oxime imidization rate > The imidization ratio of quinone imine is determined as follows. 20 mg of the polyimine powder was added to the NMR sample tube (NMR sample tube standard manufactured by Kusano Scientific Co., Ltd., φ 5 ), and 0.53 ml of dimethylated dimethyl hydrazine was added (〇1^150—(16, 0.05) %丁1^8 mixture), and completely dissolved by ultrasonic waves. The proton NMR of the solution was measured using a NMR measuring instrument (JNW-ECA500) manufactured by JEOL DATUM Co., Ltd. The source of yttrium imidization was used. Estimation of the peak of the proton determined by the protons of the unaltered structure before and after imidization as the reference proton and the estimation of the proton peak of the NH group derived from proline from 9.5 to 10 ppm. It is obtained by the following formula.
醯亞胺化率(%) = (1-α · x/y)xlOO 上述式中,x爲源自醯胺酸之NH基之質子峰估算値, y爲基準質子峰估算値,α爲聚醯胺酸(醯亞胺化率爲0% )時相對於醯胺酸之ΝΗ基一個質子之基準質子之個數比 <合成例14> BODA ( 3.83g > 15.3 mmol ) 、D B A ( 1.0 9 g,7 1 7 mmol) 、PCH7DAB ( 3.88g,10.2 mmol),及二胺化合物 (4) (0.74g,3.06 mmol)於 NMP( 17.5g)中混合,於 8〇°C下反應5小時後,加入CBDA( l.OOg,5.10 mmol )與 NMP ( 14.Og ) ’於40 °C下進行6小時反應,而製得聚醯胺 酸溶液。 於此聚酿胺酸溶液(10.0g)中加入NMP,稀釋至6質 量%後,添加作爲醯亞胺化觸媒之乙酸酐(1.67g),及吡 啶(〇.90g),使其於90°C下反應3.5小時》將該反應溶液 投入甲醇(13 0ml)中,將所得沉澱物濾除。該沉澱物使 用甲醇洗淨,於100 °C下減壓乾燥得聚醯亞胺粉末(A)。 該聚醯亞胺之醯亞胺化率爲55%,數平均分子量爲18,500 、重量平均分子量爲48,200。 -73- 200948859 <合成例1 5> 於合成例14所得聚醯胺酸溶液(i〇.0g)中,加入nmP 稀釋至6質量%後,加入醯亞胺觸媒之乙酸酐(2 17g), 及吡啶(1.68g) ’使其於9(TC下反應3.5小時。將該反應 溶液投入甲醇(140ml )中,將所得沉澱物濾除。該沉澱 物使用甲醇洗淨,於l〇(TC下減壓乾燥得聚醯亞胺粉末(B )。該聚醯亞胺之醯亞胺化率爲80 %,數平均分子量爲 17,100、重量平均分子量爲46,900。 <合成例1 6 > 將 BODA ( 2.41g,9.64 mmol ) 、D B A ( 1. 3 7 g,9.0 1 mmol) ' PBCH7DAB ( 0.48g » 1.27 mmol),及二胺化合 物(7) ( 〇.66g,2.72 mmol )於 NMP ( 9.00g )中混合, 於80°C下反應5小時後,加入CBDA(0.63g,3.21 mmol) 與NMP ( 7.80g ),於40°C下進行6小時反應,而製得聚醯 胺酸溶液。 所得聚醯胺酸溶液(10.0g)中加入NMP,稀釋至6質 量%後,加入醯亞胺觸媒之乙酸酐(1 · 60g )、及吡啶( 〇.90g ),使其於90°C下反應3.5小時。將該反應溶液投入 甲醇(140ml )中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於l〇〇°C下減壓乾燥得聚醢亞胺粉末(C)。該聚 醯亞胺之醯亞胺化率爲56 %,數平均分子量爲17,300、重 量平均分子量爲46,000。 -74- 200948859 <合成例17> 將 BODA ( 4.59g,18.4 mmol ) 、D B A ( 1 · 3 0 g,8.5 5 mmol) 、PCH7DAB ( 4.66g,1 2_2 mmol ),及二胺化合物 (10) (0.94g,3.88mmol)於 NMP (21.5g)中混合,於 8〇°C下反應5小時後,加入CBDA( 1.20g,6.12 mmol)與 NMP ( 17.Og),於40 °C下進行6小時反應,而製得聚醯胺 酸溶液。 於所得聚醯胺酸溶液(10.0g)中加入NMP,稀釋至6 質量%後,加入醢亞胺觸媒之乙酸酐(1.68g )、及吡啶( 〇.92g ),使其於90°C下反應3.5小時。將該反應溶液投入 甲醇(13 0ml)中,將所得沉澱物瀘除。該沉澱物使用甲 醇洗淨,於100 °C下減壓乾燥得聚醯亞胺粉末(D)。該聚 醯亞胺之醯亞胺化率爲60%,數平均分子量爲18,100、重 量平均分子量爲47,800。 <合成例1 8 > 於合成例17所所得聚醯胺酸溶液(10.0g )中加入NMP ,稀釋至6質量%後,加入醯亞胺觸媒之乙酸酐(2.16g ) ,及吡啶(1.75g),使其於90t下反應3.5小時。將該反 應溶液投入甲醇(13 0ml)中,將所得沉澱物濾除。該沉 澱物使用甲醇洗淨,於1〇〇 °C下減壓乾燥得聚醯亞胺粉末 (E )。該聚醯亞胺之醯亞胺化率爲83%,數平均分子量 爲1 7,3 00、重量平均分子量爲45,900。 -75- 200948859 <合成例19> 將 BODA ( 2.56g,10.3 mmol ) 、DB A ( 0.94g,6.1 8 mmol ) 、PCH7DAB ( 1.56g,4.10 mmol),及二胺化合物 (14) (0.74g,3·04 mmol)於 NMP(10.50g)中混合, 於80°C下反應5小時後,加入CBDA(0.67g,3.42 mmol) 與NMP(9.00g),於40 °C下進行6小時反應,而製得聚醯 胺酸溶液。 於所得聚醯胺酸溶液(l〇.〇g )中加入NMP,稀釋至6 質量%後,加入醯亞胺觸媒之乙酸酐(1 · 1 6g ),及吡啶( 〇.88g ),使其於90°C下反應3.5小時。將該反應溶液投入 甲醇(140ml )中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於1〇〇 °C下減壓乾燥得聚醯亞胺粉末(F)。該聚 醯亞胺之醯亞胺化率爲55 %,數平均分子量爲19,100、重 量平均分子量爲49,1 00。 <合成例20> 將 BODA ( 2.49g,9.94 mmol ) 、DBA ( l.llg,7.30 mmol ) ' PCH7DAB ( 0.75g > 1.97 mmol),及二胺化合物 (16) (0.85g,3.52 mmol)於 NMP(9.50g)中混合,於 80°C下反應5小時後,加入CBDA(0.65g,3.31 mmol)與 NMP ( 8.10g ),於40 °C下進行6小時反應,而製得聚醯胺 酸溶液。 所得聚醯胺酸溶液(10.0g)中加入NMP,稀釋至6質 量%後’加入醯亞胺觸媒之乙酸酐(1 . 1 2 g ),及吡啶( -76- 200948859 0.9 0g ) ,80°C下反應2小時。將該反應溶液投入甲醇( 1 20ml )中,將所得沉澱物濾除。該沉澱物使用甲醇洗淨 ,於100°C下減壓乾燥得聚醯亞胺粉末(G)。該聚醯亞胺 之醯亞胺化率爲53 %,數平均分子量爲18,800、重量平均 分子量爲47,900。 <合成例21> 將 BODA ( 2.53g,10.1 mmol ) 、DBA ( 0.72g,4.74 mmol ) ' PCH7DAB ( 2.56g 1 6.73 mmol),及二胺化合物 (19) (0.43g,1·79 mmol)於 NMP(12.1g)中混合,於 8〇°C下反應5小時後,加入CBDA(0.66g,3.37 mmol)與 NMP ( 9.20g ),於40°C下進行6小時反應,而製得聚醯胺 酸溶液。 於所得聚醯胺酸溶液(lO.Og )中加入NMP,稀釋至6 質量%後,加入醯亞胺觸媒之乙酸酐(1 . 1 6g ),及吡啶( l.OOg),使其於90°c下反應3.5小時。將該反應溶液投入 甲醇(140ml )中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於l〇〇°C下減壓乾燥得聚醯亞胺粉末(H)。該聚 醯亞胺之醯亞胺化率爲55%,數平均分子量爲16,900、重 量平均分子量爲46,500。 <合成例22> 將 BODA ( 2_60g,10.4 mmol ) 、DBA ( 0.74g,4.87 mmol ) ' PCH7DAB ( 2.64g » 6.93 mmol),及二胺化合物 -77- 200948859 ( 23) ( 0.47g,1.96 mmol)於 NMP(ll.lg)中混合,於 8〇°C下反應5小時後,加入CBDA(0.68g,3.47 mmol)與 NMP ( 9.50g),於40°C下進行6小時反應,而製得聚醯胺 酸溶液。 於所得聚醯胺酸溶液(lO.lg)中加入NMP,稀釋至6 質量%後,加入醯亞胺觸媒之乙酸酐(i . i 5g ),及吡啶( l.〇lg ),使其於90°C下反應3.5小時。將該反應溶液投入 甲醇(1 20ml )中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨’於100 °C下減壓乾燥得聚醯亞胺粉末(I)。該聚 醯亞胺之醯亞胺化率爲54%,數平均分子量爲18,100、重 量平均分子量爲48,100。 <合成例23> 將 BODA ( 2.49g,9.94 mmol ) 、DBA ( l.llg,7.30 mmol) ' PCH7DAB ( 0.50g > 1.31 mmol),及二胺化合物 (26) (l_06g,4·37 mmol)於 NMP(9.50g)中混合,於 80°C下反應5小時後,加入CBDA(0_65g,3·31 mmol)與 NMP ( 8.10g),於40 °C下進行6小時反應,而製得聚醢胺 酸溶液。 於所得聚醯胺酸溶液(1 〇.2g )中加入NMP,稀釋至6 質量%後,加入醯亞胺觸媒之乙酸酐(1 . 1 7g ),及吡啶( 〇.99g ),使其於90°C下反應3.5小時。將該反應溶液投入 甲醇(130ml )中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於1〇〇 °C下減壓乾燥得聚醯亞胺粉末(J)。該聚 200948859 醯亞胺之醯亞胺化率爲57%,數平均分子量爲18,100、重 量平均分子量爲47,000。 <合成例24> 將 BODA ( 2.45g,9.79 mmol ) 、DBA ( 1.59g,10.5 mmol ) 、PCH7DAB ( 0.49g,1 .29 mmol ),及二胺化合物 ( 29) ( 0.42g,1.74 mmol)於 NMP(8.50g)中混合,於 8〇°C下反應5小時後,加入CBDA(0.64g,3.26 mmol)與 NMP ( 7.50g ),於40 °C下進行6小時反應,而製得聚醯胺 酸溶液。 於所得聚醯胺酸溶液(l〇.〇g )中加入NMP,稀釋至6 質量%後,加入醯亞胺觸媒之乙酸酐(1 · 1 6g ),及吡啶( l.OOg ),使其於90 °C下反應3.5小時。將該反應溶液投入 甲醇(130ml )中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於1〇〇 °C下減壓乾燥得聚醯亞胺粉末(K)。該聚 醯亞胺之醯亞胺化率爲5 5%,數平均分子量爲1 8,400、重 量平均分子量爲47,900。 <合成例25> 將 BODA ( 2.49g,9.94 mmol ) 、DBA ( 0.61g > 4.0 1 mmol) 、PCH7DAB ( 2.52g,6.63 mmol),及二胺化合物 (34) ( 0.8 5g > 3_52 mmol)於 NMP(12.5g)中混合,於 8〇°C下反應5小時後,加入CBDA ( 0.65g,3.31 mmol )與 NMP ( 10.5 g ),於40 °C下進行6小時反應,而製得聚醯胺 -79- 200948859 酸溶液。 於所得聚醯胺酸溶液(10.0g)中加入NMP,稀釋至6 質量%後,加入醯亞胺觸媒之乙酸酐(1.1 6g),及吡啶( l.Olg ),使其於90°C下反應3.5小時。將該反應溶液投入 甲醇(150ml )中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於l〇〇°C下減壓乾燥得聚醯亞胺粉末(L)。該聚 醯亞胺之醯亞胺化率爲55 %,數平均分子量爲18,400、重 量平均分子量爲47,400。 <合成例26> 將 B OD A ( 4.4 0 g,1 7.6 m m ο 1 ) 、DBA ( 1.25g,8.22 mmol ) ' PCH7DAB ( 4.46g 5 11.7 mmol),及二胺化合物 (3 7 ) ( 1.08g > 4.46 mmol)於 NMP(21.0g)中混合,於 8〇°C下反應5小時後,加入CBDA ( 1.15g,5_86 mmol )與 NMP ( 16.5g ),於40 °C下進行6小時反應,而製得聚醯胺 酸溶液。 於所得聚醯胺酸溶液(l〇.〇g )中加入NMP,稀釋至6 質量%後,加入醯亞胺觸媒之乙酸酐(1 .1 5g ),及吡啶( 1.〇〇8),使其於90°(:下反應3.5小時。將該反應溶液投入 甲醇(150ml )中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於1〇〇 °C下減壓乾燥得聚醯亞胺粉末(M)。該聚 醯亞胺之醯亞胺化率爲55 %,數平均分子量爲19,800、重 量平均分子量爲48,800。 -80- 200948859 <合成例27> 於合成例26所得之聚醯胺酸溶液中加入NMP,稀釋至 6質量%後,加入醯亞胺觸媒之乙酸酐(2.17g ),及吡啶 (l-66g),使其於9(TC下反應3.5小時。將該反應溶液投 入甲醇(31 Oral)中,將所得沉澱物濾除。該沉澱物使用 甲醇洗淨,於l〇〇°C下減壓乾燥得聚醯亞胺粉末(N)。該 聚醯亞胺之醯亞胺化率爲82%,數平均分子量爲16,800、 重量平均分子量爲46,300。 <合成例28> 將 BODA ( 2.45g,9.79 mmol ) 、DBA ( 0.70g,4.61 mmol ) ' PCH7DAB ( 2.48g > 6.53 mmol),及二胺化合物 ( 40) ( 0.50g > 2.08 mmol)於 NMP (11.5g)中混合,於 80°C下反應5小時後,加入CBDA(0.64g,3.26 mmol)與 NMP ( 8.50g ),於40 °C下進行6小時反應,而製得聚醯胺 酸溶液。 於所得聚醯胺酸溶液(lO.lg )中加入NMP,稀釋至6 質量%後,加入醯亞胺觸媒之乙酸酐(2.1 5 g ),及吡啶( 1.67g ),使其於90°C下反應3.5小時。將該反應溶液投入 甲醇(3 00ml )中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於100°C下減壓乾燥得聚醯亞胺粉末(0)。該聚 醯亞胺之醯亞胺化率爲80 %,數平均分子量爲16,900、重 量平均分子量爲47,200。 -81 - 200948859 <合成例29> 將 BODA ( 2.49g,9.94 mmol ) 、p - PDA ( 0.50g, 4.64 mmol ) 、PCH7DAB ( 2.52g,6.63 mmol),及二胺 化合物(40) (0.51g,2.11 mmol)於 NMP(11.3g)中混 合,於80°C下反應5小時後,加入CBDA(0.65g,3.31 mmol )與NMP(8.30g),於40 °C下進行6小時反應,而製 得聚醯胺酸溶液。 於所得聚醯胺酸溶液(l〇.〇g )中加入NMP,稀釋至6 質量%後,加入醯亞胺觸媒之乙酸酐(2.16g ),及吡啶( 1.6 7g),使其於90°C下反應3.5小時。將該反應溶液投入 甲醇(310ml)中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於1〇〇 °C下減壓乾燥得聚醯亞胺粉末(P)。該聚 醯亞胺之醯亞胺化率爲79%,數平均分子量爲17,100、重 量平均分子量爲47,900。 <合成例30> 將 BODA ( 2.53g,10.1 mmol ) 、D B A ( 0 · 7 2 g,4 · 7 4 mmol) 、PCH7DAB(2.56g,6.73 mmol),及二胺化合物 (43) (0.49g,2.01 mmol)於 NMP (11.8g)中混合,於 8〇°C下反應5小時後,加入CBDA(0_66g,3.37 mmol)與 NMP ( 8.60g),於40 °C下進行6小時反應,而製得聚醯胺 酸溶液。 於所得聚醯胺酸溶液(10.0g)中加入NMP,稀釋至6 質量%後,加入醯亞胺觸媒之乙酸酐(2.15g ),及吡啶( -82- 200948859 l-65g ),使其於90°C下反應3.5小時。將該反應溶液投入 甲醇(310ml)中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於l〇〇t下減壓乾燥得聚醯亞胺粉末(Q)。該聚 醯亞胺之醯亞胺化率爲81 %,數平均分子量爲17,900、重 量平均分子量爲48,100。 <合成例31> 將 BODA ( 2.49g,9.94 mmol ) 、p — P D A ( 0.5 0 g, 4.64 mmol ) 、PCH7DAB(2.51g,6.63 mmol),及二胺 化合物( 43) ( 0.48 g > 1.98 mmol)於 NMP(10.5g)中混 合,於80°C下反應5小時後,加入CBDA ( 0.65g,3.31 mmol)與NMP ( 8.10g),於4 0 °C下進行6小時反應,而製 得聚醯胺酸溶液。 於所得聚醯胺酸溶液(10.lg)中加入NMP,稀釋至6 質量%後,加入醯亞胺觸媒之乙酸酐(2.18g ),及吡啶( 1.68g),使其於90°C下反應3.5小時。將該反應溶液投入 甲醇(310 ml)中,將所得沉澱物濾除。該沉澱物使用甲 醇洗淨,於l〇(TC下減壓乾燥得聚醯亞胺粉末(R)。該聚 醯亞胺之醯亞胺化率爲80 %,數平均分子量爲17,700、重 量平均分子量爲47,600。 -83- 200948859 表5] 合成例 二胺j 戎份(mmol) 四羧酸成份 (mmol) 醯亞胺化率 (%) 二胺化合物 (A) 二胺化 合物(B) 其他 14 聚醯亞胺粉末 ΓΑ1 化纖4) (3.06) DBA (7.17) PCH7DAB (10.2) CBDA (5.10) BODA (15.3) 55 15 聚醯亞胺粉末 ΓΒ1 化合物(4) (3.06) DBA (7.17) PCH7DAB (10.2) CBDA (5.10) BODA (15.3) 80 16 聚醯亞胺粉末 rci 化合物⑺ (2.72) DBA (9.01) PCH7DAB (1.27) CBDA (3.21) BODA (9.64) 56 17 聚醯亞胺粉末 『D1 化合物⑽ (3.88) DBA (8.55) PCH7DAB (12.2) CBDA (6.12) BODA (18.4) 60 18 聚醯亞胺粉末 ΓΕ1 化合物(10) (3.88) DBA (8.55) PCH7DAB (12.2) CBDA (6.12) BODA (18.4) 83 19 聚醯亞胺粉末 TF1 化合物(14) (3-04) DBA (6.18) PCH7DAB (4.10) CBDA (3.42) BODA (10.3) 55 20 聚醯亞胺粉末 『G1 化合物(16) (3.52) DBA (7.30) PCH7DAB a.97) CBDA (3.31) BODA (9.94) 53 21 聚醯亞胺粉末 ΓΗ1 化合物(19) (1_79) DBA (4.74) PCH7DAB (6.73) CBDA (3.37) BODA (10.1) 55 22 聚醯亞胺粉末 ΓΙ1 化合物(23) (1-96) DBA (4.87) PCH7DAB (6.93) CBDA (3.47) BODA (10-4) 54 23 聚醯亞胺粉末 m 化合物(26) (4.37) DBA (7.30) PCH7DAB (1.31) CBDA (3.31) BODA (9.94) 57 24 聚醯亞胺粉末 ΓΚ1 化合物(29) (1.74) DBA (10.5) PCH7DAB (1.29) CBDA (3.26) BODA (9.79) 55 25 聚醯亞胺粉末 『L1 化合物(34) (3.52) DBA (4.01) PCH7DAB (6.63) CBDA (3.31) BODA (9.94) 55 26 聚醯亞胺粉末 『Ml 化合物(37) (4.46) DBA (8.22) PCH7DAB a 1.7) CBDA (5.86) BODA (17.6) 55 27 聚醯亞胺粉末 [N1 化合物(37) (4.46) DBA (8.22) PCH7DAB (11.7) CBDA (5.86) BODA (17.6) 82 -84- 200948859 [表6] 合成例 二胺成份 (mmol) 四羧酸成份 (mmol) 醯亞胺化率 (%) 28 聚醯亞胺粉末 Γ〇1 化合物(40) (2.08) DBA (4.61) PCH7DAB (6.53) CBDA Ρ·26) BODA (9.79) 80 29 聚醯亞胺粉末 [P1 化合物(4〇) (2.11) p-PDA (4.64) PCH7DAB (6.63) CBDA (3.31) BODA (9.94) 79 30 聚醯亞胺粉末 Γ01 化合物(43) (2.01) DBA (4.74) PCH7DAB (6.73) CBDA (3.37) BODA (10.1) 81 31 聚醯亞胺粉末 叫 化合物(43) (1.98) p一PDA (4.64) PCH7DAB (6.63) CBDA (3.31) BODA (9.94) 80 [液晶配向處理劑之製作·評估] <實施例1> 於合成例14所得之聚醯亞胺粉末[A]( 5.lg)中加入 NMP(22.1g),於70°C下攪拌40小時使其溶解。於該溶液 中加入 NMP(ll.lg) 、BCS(46.8g),在 25 °C 下攪拌 2 小 時,製得液晶配向處理劑[1 ]。該液晶配向處理劑中未發現 混濁或析出等異常,確認樹脂成份均勻地溶解。 [液晶晶胞之製作] 將上述所得之液晶配向處理劑[1 ]旋轉塗佈於貼附3 cm X4cm (長X寬)ITO電極之基板之ITO面上,在熱壓板上以 8 0°C下5分鐘,且在21 0°C之熱風循環式烘箱中進行燒成1 小時,製作膜厚l〇〇nm之聚醯亞胺塗膜。 使該貼附液晶配向膜之基板在輥直徑120mm、嫘縈布 之摩擦裝置中,以旋轉數3 00rpni,輥進行速度20mm/sec, -85- 200948859 擠入量〇.3mm之條件下進行摩擦處理,製得貼附液晶配向 膜之基板。 準備兩片該貼附液晶配向膜之基板,於其一片液晶配 向膜面上散佈6 # m之珠粒隔離材後,自其上印刷密封劑。 使另一片基板成爲液晶配向膜之內測,以摩擦方向成爲反 向之方式貼合後,使密封劑硬化製備空晶胞。藉由減壓注 入法於該空晶胞中注入液晶MLC — 6608 (日本默克公司製 造),製得反向平行配向之向列型液晶晶胞。 [電壓維持率之評價] 在80°C之溫度下對上述所得之液晶晶胞施加60 /z s之 4V電壓,且測定16.67ms及1 667ms後之電壓,計算可以何 種程度保持之電壓作爲電壓維持率。結果列於下表7。 [殘留電荷之緩和評價] 對測定電壓維持率後之液晶晶胞施加1 0V之直流電壓 3〇分鐘’且經短路1秒後,測定1 8 00秒內於液晶晶胞內產 生之電位。且測定50秒後及1 000秒後之殘留電荷。另外, 測定係使用東陽技術公司製造之62 5 4型液晶物性評價裝置 。結果列於下表8。 [高溫放置後之評價] 將測定殘留電荷後之液晶晶胞置於設定在100 °C之高 溫槽中7天後,進行電壓維持率及殘留電荷之測定。結果 200948859 列於下表7及表8。 <實施例2> 於合成例1 5所得之聚醯亞胺粉末[B】(5.0g )中,加入 NMP ( 21.7g),於70 °C下攪拌40小時使其溶解。於此溶液 中加入 NMP (l〇.8g) 、BCS(45.8g),經於25 °C 下攪拌 2 小時後,得液晶配向處理劑[2]。該液晶配向處理劑並未發 現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀態 。使用所得之液晶配向處理劑[2],依實施例1相同方法製 作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電荷 之評估、高溫放置後之評估。其結果,如後述表7及表8所 不° <實施例3> 於合成例16所得之聚醯亞胺粉末[C](4.9g)中加入 NMP ( 29.4g),於70 °C下攪拌40小時使其溶解。於該溶液 中加入 NMP(14.8g) 、BCS(32.5g),經於 25 °C 下攪拌 2 小時後,得液晶配向處理劑[3 ]。該液晶配向處理劑並未發 現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀態 。使用所得之液晶配向處理劑[3],依實施例1相同方法製 作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電荷 之評估、高溫放置後之評估。其結果,如後述表7及表8所 示0 -87- 200948859 <實施例4> 於合成例17所得之聚醯亞胺粉末[D](5.〇g)中加入 NMP (21.6g),於70 °C下攪拌4 0小時使其溶解。於該溶液 中加入 NMP (10.5g) > BCS ( 45.4g ) ’經於 25 °C 下攪拌 2 小時後,得液晶配向處理劑[4]。該液晶配向處理劑並未發 現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀態 。使用所得之液晶配向處理劑[4] ’依實施例1相同方法製 作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電荷 之評估、高溫放置後之評估。其結果’如後述表7及表8所 不 ° <實施例5> 於合成例18所得之聚醯亞胺粉末[E](5.0g)中加入 NMP ( 27.2g ),於70 °C下攪拌40小時使其溶解。於該溶液 中加入 NMP (13.5g) 、BCS(37.6g),經於 25 °C 下攪拌 2 小時後,得液晶配向處理劑[5]。該液晶配向處理劑並未發 現混濁或析出等異常,確認樹脂成份呈現均句之溶解狀態 。使用所得之液晶配向處理劑[5],依實施例1相同方法製 作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電荷 之評估、高溫放置後之評估。其結果,如後述表7及表8所 不。 <實施例6> 於合成例1 9所得之聚醯亞胺粉末[F] ( 5 · 1 g )中加入 -88- .200948859 NMP ( 25.Og),於70 °C下攪拌40小時使其溶解。於該溶液 中加入 NMP(12.5g) ' BCS ( 42.5g ),經於 25 °C 下攪拌 2 小時後,得液晶配向處理劑[6]。該液晶配向處理劑並未發 現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀態 。使用所得之液晶配向處理劑[6],依實施例1相同方法製 作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電荷 之評估、高溫放置後之評估。其結果,如後述表7及表8所 <實施例 於合成例20所得之聚醯亞胺粉末[G] ( 5.0g)中,加入 NMP ( 24.4g),於70 °C下攪拌40小時使其溶解。於該溶液 中加入 NMP(12.2g) 、BCS(41.8g),經於 25 t 下攪拌 2 小時後,得液晶配向處理劑[7]。該液晶配向處理劑並未發 現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀態 。使用所得之液晶配向處理劑[7],依實施例1相同方法製 作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電荷 之評估、高溫放置後之評估。其結果,如後述表7及表8所 示。 <實施例8> 於合成例21所得之聚酿亞胺粉末[H] ( 5.0g)中,加入 NMP ( 30.1g),於70°C下攪拌40小時使其溶解。於該溶液 中加入 NMP (14_7g) 、BCS(33.5g),經於 25 °C 下攪拌 2 -89- 200948859 小時後,得液晶配向處理劑[8]。該液晶配向處理劑並未發 現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀態 。使用所得之液晶配向處理劑[8],依實施例1相同方法製 作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電荷 之評估、高溫放置後之評估。其結果,如後述表7及表8所 不 °醯imination rate (%) = (1-α · x/y)xlOO In the above formula, x is the proton peak estimate derived from the NH group of the proline, y is the reference proton peak estimate α, α is the poly The ratio of the number of protons of one proton relative to the sulfhydryl group of valine (when the imineization rate is 0%) <Synthesis Example 14> BODA ( 3.83g > 15.3 mmol ) , DBA ( 1.0 9 g, 7 1 7 mmol), PCH7DAB ( 3.88 g, 10.2 mmol), and the diamine compound (4) (0.74 g, 3.06 mmol) were mixed in NMP (17.5 g), and reacted at 8 ° C for 5 hours. Thereafter, CBDA (1.00 g, 5.10 mmol) was added and NMP (14.Og)' was reacted at 40 ° C for 6 hours to prepare a polyaminic acid solution. NMP was added to the polyamic acid solution (10.0 g), and after diluting to 6% by mass, acetic anhydride (1.67 g) as a ruthenium amide catalyst and pyridine (〇.90 g) were added thereto to make 90 The reaction was carried out in methanol (130 ml), and the resulting precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (A). The polyimine had a hydrazine imidation ratio of 55%, a number average molecular weight of 18,500, and a weight average molecular weight of 48,200. -73-200948859 <Synthesis Example 1 5> In the polyphthalic acid solution (i〇.0g) obtained in Synthesis Example 14, after adding nmP to 6 mass%, acetic anhydride (2 17 g) was added to the ruthenium catalyst. And pyridine (1.68 g) was allowed to react at 9 (TC for 3.5 hours. The reaction solution was poured into methanol (140 ml), and the resulting precipitate was filtered off. The precipitate was washed with methanol, The polyiminoimine powder (B) was dried under reduced pressure at TC. The polyamidimide had an oxime imidization ratio of 80%, a number average molecular weight of 17,100, and a weight average molecular weight of 46,900. <Synthesis Example 1 6 > BODA (2.41g, 9.64 mmol), DBA (1.37 g, 9.0 1 mmol) 'PBCH7DAB (0.48g » 1.27 mmol), and diamine compound (7) (〇.66g, 2.72 mmol) The mixture was mixed with NMP (9.00 g), and after reacting at 80 ° C for 5 hours, CBDA (0.63 g, 3.21 mmol) and NMP (7.80 g) were added, and the reaction was carried out at 40 ° C for 6 hours to obtain polydecylamine. An acid solution was added to the obtained polyaminic acid solution (10.0 g), and after diluting to 6 mass%, acetic anhydride (1·60 g) and pyridine (〇.90 g) of a quinone imine catalyst were added thereto to make it The reaction was carried out for 3.5 hours at 90 ° C. The reaction solution was poured into methanol (140 ml), and the resulting precipitate was filtered off. The precipitate was washed with methanol and dried under reduced pressure at 10 ° C to obtain a polyimine powder. (C) The polyimine has a ruthenium iodide ratio of 56%, a number average molecular weight of 17,300, and a weight average molecular weight of 46,000. -74- 200948859 <Synthesis Example 17> BODA (4.59 g, 18.4 mmol) , DBA (1 · 30 g, 8.5 5 mmol), PCH7DAB ( 4.66 g, 1 2_2 mmol), and diamine compound (10) (0.94 g, 3.88 mmol) were mixed in NMP (21.5 g) at 8 〇 After reacting for 5 hours at ° C, CBDA (1.20 g, 6.12 mmol) and NMP (17.Og) were added, and the reaction was carried out at 40 ° C for 6 hours to obtain a poly-proline solution. NMP was added to the solution (10.0 g), and after diluting to 6 mass%, acetic anhydride (1.68 g) and pyridine (92 g) of a ruthenium catalyst were added, and the mixture was reacted at 90 ° C for 3.5 hours. The reaction solution was poured into methanol (130 ml), and the resulting precipitate was removed. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (D). The polyamidimide had a hydrazine imidation ratio of 60%, a number average molecular weight of 18,100, and a weight average molecular weight of 47,800. <Synthesis Example 1 8 > NMP was added to the polyamidic acid solution (10.0 g) obtained in Synthesis Example 17, and after diluting to 6 mass%, acetic anhydride (2.16 g) of ruthenium catalyst was added, and pyridine was added. (1.75 g), it was allowed to react at 90 t for 3.5 hours. The reaction solution was poured into methanol (130 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 1 ° C to obtain a polyimine powder (E). The polyimine had an oxime imidization ratio of 83%, a number average molecular weight of 1,7,300, and a weight average molecular weight of 45,900. -75- 200948859 <Synthesis Example 19> BODA (2.56 g, 10.3 mmol), DB A (0.94 g, 6.1 8 mmol), PCH7DAB (1.56 g, 4.10 mmol), and diamine compound (14) (0.74 g) ,3·04 mmol) was mixed in NMP (10.50 g), and after reacting at 80 ° C for 5 hours, CBDA (0.67 g, 3.42 mmol) and NMP (9.00 g) were added, and the reaction was carried out at 40 ° C for 6 hours. And a polyaminic acid solution was prepared. NMP was added to the obtained polyaminic acid solution (l〇.〇g), and after diluting to 6 mass%, acetic anhydride (1·16 6 g) of ruthenium amide and pyridine (〇.88 g) were added thereto. It was reacted at 90 ° C for 3.5 hours. The reaction solution was poured into methanol (140 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 1 ° C to obtain a polyimine powder (F). The polyamidimide had a hydrazine imidation ratio of 55 %, a number average molecular weight of 19,100, and a weight average molecular weight of 49,100. <Synthesis Example 20> BODA (2.49 g, 9.94 mmol), DBA (1.llg, 7.30 mmol) 'PCH7DAB (0.75 g > 1.97 mmol), and diamine compound (16) (0.85 g, 3.52 mmol) After mixing in NMP (9.50 g) and reacting at 80 ° C for 5 hours, CBDA (0.65 g, 3.31 mmol) and NMP ( 8.10 g) were added and reacted at 40 ° C for 6 hours to obtain polyfluorene. Amino acid solution. NMP was added to the obtained polyaminic acid solution (10.0 g), diluted to 6% by mass, and then acetic anhydride (1.12 g) of ruthenium amide was added, and pyridine (-76-200948859 0.9 0g), 80 The reaction was carried out at ° C for 2 hours. The reaction solution was poured into methanol (1 20 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 100 ° C to obtain a polyimine powder (G). The polyimine had a ruthenium iodide ratio of 53%, a number average molecular weight of 18,800, and a weight average molecular weight of 47,900. <Synthesis Example 21> BODA (2.53 g, 10.1 mmol), DBA (0.72 g, 4.74 mmol) 'PCH7DAB ( 2.56 g 1 6.73 mmol), and a diamine compound (19) (0.43 g, 1.79 mmol) After mixing in NMP (12.1 g) and reacting at 8 ° C for 5 hours, CBDA (0.66 g, 3.37 mmol) and NMP ( 9.20 g) were added, and the reaction was carried out at 40 ° C for 6 hours to obtain a poly Proline solution. Adding NMP to the obtained polyaminic acid solution (10.Og), diluting to 6 mass%, adding acetic anhydride (1.16 g) of ruthenium catalyst, and pyridine (1.0 g) The reaction was carried out at 90 ° C for 3.5 hours. The reaction solution was poured into methanol (140 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 10 ° C to obtain a polyimine powder (H). The polyamidimide had a ruthenium iodide ratio of 55%, a number average molecular weight of 16,900, and a weight average molecular weight of 46,500. <Synthesis Example 22> BODA (2_60 g, 10.4 mmol), DBA (0.74 g, 4.87 mmol) 'PCH7DAB ( 2.64 g » 6.93 mmol), and diamine compound -77-200948859 (23) (0.47 g, 1.96 mmol) The mixture was mixed in NMP (ll.lg), and reacted at 8 ° C for 5 hours, then CBDA (0.68 g, 3.47 mmol) and NMP (9.50 g) were added, and the reaction was carried out at 40 ° C for 6 hours. A polyamine solution was obtained. After adding NMP to the obtained polyaminic acid solution (10.g.), and diluting to 6 mass%, acetic anhydride (i.i 5g) and pyridine (l.〇lg) of the quinone imine catalyst were added to make it The reaction was carried out at 90 ° C for 3.5 hours. The reaction solution was poured into methanol (1 20 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol at a reduced pressure at 100 ° C to obtain a polyimide pigment (I). The polyamidimide had a ruthenium iodide ratio of 54%, a number average molecular weight of 18,100, and a weight average molecular weight of 48,100. <Synthesis Example 23> BODA (2.49 g, 9.94 mmol), DBA (1.llg, 7.30 mmol) 'PCH7DAB (0.50 g > 1.31 mmol), and diamine compound (26) (1_06 g, 4.37 mmol) The mixture was mixed in NMP (9.50 g), and reacted at 80 ° C for 5 hours, and then CBDA (0-65 g, 3.31 mmol) and NMP ( 8.10 g) were added and reacted at 40 ° C for 6 hours to obtain a reaction. Polylysine solution. NMP was added to the obtained polyaminic acid solution (1 〇.2g), and after diluting to 6 mass%, acetic anhydride (1.17 g) of ruthenium catalyst and pyridine (〇.99g) were added to make it The reaction was carried out at 90 ° C for 3.5 hours. The reaction solution was poured into methanol (130 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 1 ° C to obtain a polyimine powder (J). The polyamine 200948859 has an imidization ratio of 57%, a number average molecular weight of 18,100, and a weight average molecular weight of 47,000. <Synthesis Example 24> BODA (2.55 g, 9.79 mmol), DBA (1.59 g, 10.5 mmol), PCH7DAB (0.49 g, 1.29 mmol), and a diamine compound (29) (0.42 g, 1.74 mmol) After mixing in NMP (8.50 g) and reacting at 8 ° C for 5 hours, CBDA (0.64 g, 3.26 mmol) and NMP (7.50 g) were added, and the reaction was carried out at 40 ° C for 6 hours to obtain a poly Proline solution. NMP was added to the obtained polyaminic acid solution (l〇.〇g), and after diluting to 6 mass%, acetic anhydride (1·16g) and pyridine (1.0 g) of the quinone imine catalyst were added. It was reacted at 90 ° C for 3.5 hours. The reaction solution was poured into methanol (130 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 1 ° C to obtain a polyimine powder (K). The polyamidimide had a ruthenium iodide ratio of 55%, a number average molecular weight of 1,800, and a weight average molecular weight of 47,900. <Synthesis Example 25> BODA (2.49 g, 9.94 mmol), DBA (0.61 g > 4.0 1 mmol), PCH7DAB (2.52 g, 6.63 mmol), and diamine compound (34) (0.85 g > 3_52 mmol) After mixing in NMP (12.5 g) and reacting at 8 ° C for 5 hours, CBDA (0.65 g, 3.31 mmol) and NMP (10.5 g) were added and reacted at 40 ° C for 6 hours to obtain a reaction. Polyamide-79- 200948859 acid solution. To the obtained polyamic acid solution (10.0 g), NMP was added, and after diluting to 6 mass%, acetic anhydride (1.16 g) of ruthenium catalyst and pyridine (1.0 g) were added thereto at 90 ° C. The reaction was carried out for 3.5 hours. The reaction solution was poured into methanol (150 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 10 ° C to obtain a polyimine powder (L). The polyamidimide had a hydrazine imidation ratio of 55 %, a number average molecular weight of 18,400, and a weight average molecular weight of 47,400. <Synthesis Example 26> B OD A (4.40 g, 1 7.6 mm ο 1 ), DBA (1.25 g, 8.22 mmol) 'PCH7DAB ( 4.46 g 5 11.7 mmol), and diamine compound (3 7 ) (1.08 g > 4.46 mmol) was mixed in NMP (21.0 g), and reacted at 8 ° C for 5 hours, then CBDA ( 1.15 g, 5 - 86 mmol ) and NMP ( 16.5 g ) were added at 40 ° C for 6 hours. The reaction was carried out to prepare a polyaminic acid solution. Add NMP to the obtained polyaminic acid solution (l〇.〇g), dilute to 6 mass%, add acetic anhydride (1.5 g) of ruthenium catalyst, and pyridine ( 1.〇〇8) The reaction mixture was poured into methanol (150 ml), and the resulting precipitate was filtered off. The precipitate was washed with methanol and dried under reduced pressure at 1 ° C. Polyimine powder (M). The polyimine has a hydrazine imidation ratio of 55 %, a number average molecular weight of 19,800, and a weight average molecular weight of 48,800. -80 - 200948859 <Synthesis Example 27> NMP was added to the obtained polyamic acid solution, and after diluting to 6% by mass, acetic anhydride (2.17 g) of ruthenium amide and pyridine (1 - 66 g) were added, and it was reacted at 9 (TC for 3.5 hours). The reaction solution was poured into methanol (31 Oral), and the resulting precipitate was filtered off. The precipitate was washed with methanol and dried under reduced pressure at 10 ° C to obtain a polyimine powder (N). The ruthenium imine has an imidization ratio of 82%, a number average molecular weight of 16,800, and a weight average molecular weight of 46,300. <Synthesis Example 28> BODA ( 2.45 g, 9 .79 mmol ), DBA (0.70 g, 4.61 mmol) 'PCH7DAB ( 2.48 g > 6.53 mmol), and the diamine compound (40) (0.50 g > 2.08 mmol) were mixed in NMP (11.5 g) at 80 After reacting for 5 hours at ° C, CBDA (0.64 g, 3.26 mmol) and NMP (8.50 g) were added and reacted at 40 ° C for 6 hours to obtain a polyaminic acid solution. NMP was added to (lO.lg), and after diluting to 6 mass%, acetic anhydride (2.15 g) of ruthenium catalyst and pyridine (1.77 g) were added, and it was made to react at 90 ° C for 3.5 hours. The reaction solution was poured into methanol (300 ml), and the resulting precipitate was filtered off. The precipitate was washed with methanol and dried under reduced pressure at 100 ° C to obtain a polyimine powder (0). The hydrazine imidation ratio was 80%, the number average molecular weight was 16,900, and the weight average molecular weight was 47,200. -81 - 200948859 <Synthesis Example 29> BODA (2.49 g, 9.94 mmol), p-PDA (0.50 g, 4.64 mmol) , PCH7DAB (2.52g, 6.63 mmol), and diamine compound (40) (0.51 g, 2.11 mmol) were mixed in NMP (11.3 g), and reacted at 80 ° C for 5 hours, then added CBDA ( 0.65 g, 3.31 mmol) and NMP (8.30 g) were reacted at 40 ° C for 6 hours to prepare a polyaminic acid solution. NMP was added to the obtained polyaminic acid solution (l〇.〇g), and after diluting to 6 mass%, acetic anhydride (2.16 g) of ruthenium catalyst and pyridine (1.67 g) were added to make it 90. The reaction was carried out at ° C for 3.5 hours. The reaction solution was poured into methanol (310 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 1 ° C to obtain a polyimine powder (P). The polyamidimide had a ruthenium imidation ratio of 79%, a number average molecular weight of 17,100, and a weight average molecular weight of 47,900. <Synthesis Example 30> BODA (2.53 g, 10.1 mmol), DBA (0 · 7 2 g, 4 · 7 4 mmol), PCH7DAB (2.56 g, 6.73 mmol), and diamine compound (43) (0.49 g) , 2.01 mmol), mixed with NMP (11.8 g), and reacted at 8 ° C for 5 hours, then added CBDA (0-66 g, 3.37 mmol) and NMP ( 8.60 g), and reacted at 40 ° C for 6 hours. A polyaminic acid solution was prepared. NMP was added to the obtained polyaminic acid solution (10.0 g), and after diluting to 6 mass%, acetic anhydride (2.15 g) of a quinone imine catalyst, and pyridine (-82-200948859 l-65 g) were added to make it. The reaction was carried out at 90 ° C for 3.5 hours. The reaction solution was poured into methanol (310 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at 1 Torr to obtain a polyimine powder (Q). The polyamidimide had a ruthenium iodide ratio of 81%, a number average molecular weight of 17,900, and a weight average molecular weight of 48,100. <Synthesis Example 31> BODA (2.49 g, 9.94 mmol), p-PDA (0.50 g, 4.64 mmol), PCH7DAB (2.51 g, 6.63 mmol), and diamine compound (43) (0.48 g > 1.98) Methyl) was mixed with NMP (10.5 g), and reacted at 80 ° C for 5 hours, then CBDA (0.65 g, 3.31 mmol) and NMP ( 8.10 g) were added and reacted at 40 ° C for 6 hours. A polyamine solution was obtained. NMP was added to the obtained polyamic acid solution (10.gg), and after diluting to 6 mass%, acetic anhydride (2.18g) of ruthenium catalyst, and pyridine (1.868g) were added to 90 degreeC. The reaction was carried out for 3.5 hours. The reaction solution was poured into methanol (310 ml), and the obtained precipitate was filtered. The precipitate was washed with methanol, and dried under reduced pressure at TC to give a polyimine powder (R). The polyamidimide had an imidization ratio of 80% and a number average molecular weight of 17,700. The molecular weight is 47,600. -83- 200948859 Table 5] Synthesis Example Diamine j 戎 (mmol) Tetracarboxylic acid component (mmol) 醯 imidization ratio (%) Diamine compound (A) Diamine compound (B) Other 14 Polyimine powder ΓΑ1 chemical fiber 4) (3.06) DBA (7.17) PCH7DAB (10.2) CBDA (5.10) BODA (15.3) 55 15 Polyimine powder ΓΒ1 Compound (4) (3.06) DBA (7.17) PCH7DAB (10.2 CBDA (5.10) BODA (15.3) 80 16 Polyimine powder rci Compound (7) (2.72) DBA (9.01) PCH7DAB (1.27) CBDA (3.21) BODA (9.64) 56 17 Polyimine powder "D1 compound (10) ( 3.88) DBA (8.55) PCH7DAB (12.2) CBDA (6.12) BODA (18.4) 60 18 Polyimine powder ΓΕ1 Compound (10) (3.88) DBA (8.55) PCH7DAB (12.2) CBDA (6.12) BODA (18.4) 83 19 Polyimine powder TF1 Compound (14) (3-04) DBA (6.18) PCH7DAB (4.10) CBDA (3.42) BODA (10.3) 55 20 Polyimine powder "G1 compound (16) (3.52) D BA (7.30) PCH7DAB a.97) CBDA (3.31) BODA (9.94) 53 21 Polyimine powder ΓΗ1 Compound (19) (1_79) DBA (4.74) PCH7DAB (6.73) CBDA (3.37) BODA (10.1) 55 22 Polyimine powder ΓΙ1 Compound (23) (1-96) DBA (4.87) PCH7DAB (6.93) CBDA (3.47) BODA (10-4) 54 23 Polyimine powder m Compound (26) (4.37) DBA ( 7.30) PCH7DAB (1.31) CBDA (3.31) BODA (9.94) 57 24 Polyimine powder ΓΚ1 Compound (29) (1.74) DBA (10.5) PCH7DAB (1.29) CBDA (3.26) BODA (9.79) 55 25 Poly Amine powder "L1 compound (34) (3.52) DBA (4.01) PCH7DAB (6.63) CBDA (3.31) BODA (9.94) 55 26 Polyimine powder "Ml compound (37) (4.46) DBA (8.22) PCH7DAB a 1.7 CBDA (5.86) BODA (17.6) 55 27 Polyimine powder [N1 compound (37) (4.46) DBA (8.22) PCH7DAB (11.7) CBDA (5.86) BODA (17.6) 82 -84- 200948859 [Table 6] Synthesis Example Diamine Component (mmol) Tetracarboxylic Acid Component (mmol) Ruthenium Amination Rate (%) 28 Polyimine Powder Γ〇1 Compound (40) (2.08) DBA (4.61) PCH7DAB (6.53) CBDA Ρ· 26) BODA (9.79) 80 29 Polyimine powder [P1 (4〇) (2.11) p-PDA (4.64) PCH7DAB (6.63) CBDA (3.31) BODA (9.94) 79 30 Polyimine Powder Γ01 Compound (43) (2.01) DBA (4.74) PCH7DAB (6.73) CBDA (3.37) BODA (10.1) 81 31 Polyimine powder is called compound (43) (1.98) p-PDA (4.64) PCH7DAB (6.63) CBDA (3.31) BODA (9.94) 80 [Production and evaluation of liquid crystal alignment agent <Example 1> NMP (22.1 g) was added to the polyimine powder [A] (5.5 g) obtained in Synthesis Example 14, and the mixture was stirred at 70 ° C for 40 hours to be dissolved. NMP (ll.lg) and BCS (46.8 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment treatment agent [1]. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component was uniformly dissolved. [Production of Liquid Crystal Cell] The liquid crystal alignment treatment agent [1] obtained above was spin-coated on the ITO surface of a substrate to which a 3 cm X4 cm (length X width) ITO electrode was attached, and 80° on a hot plate. After 5 minutes at C, the film was fired in a hot air circulating oven at 21 ° C for 1 hour to prepare a polyimide film having a film thickness of 10 nm. The substrate to which the liquid crystal alignment film was attached was rubbed in a friction device having a roll diameter of 120 mm and a crepe cloth at a speed of 30 mm/sec, a roll speed of 20 mm/sec, and -85-200948859. The substrate is attached to the liquid crystal alignment film. Two sheets of the substrate to which the liquid crystal alignment film was attached were prepared, and a 6 # m bead spacer was spread on one of the liquid crystal alignment film faces, and a sealant was printed thereon. The other substrate was subjected to internal measurement of the liquid crystal alignment film, and after the rubbing direction was reversed, the sealing agent was hardened to prepare an empty cell. A liquid crystal MLC-6608 (manufactured by Merck & Co., Ltd.) was injected into the empty cell by a vacuum injection method to prepare an antiparallel aligned nematic liquid crystal cell. [Evaluation of Voltage Holding Rate] A voltage of 4 V of 60 /zs was applied to the liquid crystal cell obtained above at a temperature of 80 ° C, and the voltages after 16.67 ms and 1 667 ms were measured, and the degree of voltage which can be maintained as a voltage was calculated. Maintenance rate. The results are shown in Table 7 below. [Evaluation of Retention of Residual Charge] A DC voltage of 10 V was applied to the liquid crystal cell after the voltage holding ratio was measured for 3 ’ minutes, and after a short circuit for 1 second, the potential generated in the liquid crystal cell was measured in 1 800 sec. The residual charge was measured after 50 seconds and after 1 000 seconds. Further, the measurement was carried out using a 62 5 4 liquid crystal physical property evaluation device manufactured by Dongyang Technology Co., Ltd. The results are shown in Table 8 below. [Evaluation after high-temperature placement] The liquid crystal cell after the measurement of the residual charge was placed in a high-temperature bath set at 100 °C for 7 days, and then the voltage maintenance ratio and the residual charge were measured. Results 200948859 is listed in Tables 7 and 8 below. <Example 2> NMP (21.7 g) was added to the polyimine powder [B] (5.0 g) obtained in Synthesis Example 15, and the mixture was stirred at 70 ° C for 40 hours to be dissolved. NMP (10. 8g) and BCS (45.8 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment treatment agent [2]. The liquid crystal alignment agent did not exhibit abnormalities such as turbidity or precipitation, and it was confirmed that the resin component exhibited a uniform dissolved state. Using the obtained liquid crystal alignment treatment agent [2], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage retention ratio was evaluated, the evaluation of residual charge was relaxed, and the evaluation after high temperature standing was performed. As a result, it is not shown in Table 7 and Table 8 which will be described later. <Example 3> NMP (2.94 g) was added to the polyimine powder [C] (4.9 g) obtained in Synthesis Example 16 at 70 ° C. Stir for 40 hours to dissolve. NMP (14.8 g) and BCS (32.5 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment treatment agent [3]. The liquid crystal alignment agent did not exhibit abnormalities such as turbidity or precipitation, and it was confirmed that the resin component exhibited a uniform dissolved state. Using the obtained liquid crystal alignment treatment agent [3], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage retention ratio was evaluated, the evaluation of residual charge was relaxed, and the evaluation after high temperature standing was performed. As a result, as shown in Table 7 and Table 8 below, 0-87-200948859 <Example 4> NMP (21.6 g) was added to the polyimine powder [D] (5.〇g) obtained in Synthesis Example 17. It was stirred at 70 ° C for 40 hours to dissolve. NMP (10.5 g) > BCS (45.4 g) was added to the solution and stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment treatment agent [4]. The liquid crystal alignment agent did not exhibit abnormalities such as turbidity or precipitation, and it was confirmed that the resin component exhibited a uniform dissolved state. Using the obtained liquid crystal alignment treatment agent [4]', a liquid crystal cell was prepared in the same manner as in Example 1, and the voltage retention ratio was evaluated, the evaluation of residual charge was relaxed, and the evaluation after high temperature standing was performed. The results were as follows: <Example 5> In the polyimine powder [E] (5.0 g) obtained in Synthesis Example 18, NMP (2.72 g) was added at 70 ° C. Stir for 40 hours to dissolve. NMP (13.5 g) and BCS (37.6 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment treatment agent [5]. The liquid crystal alignment agent did not exhibit abnormalities such as turbidity or precipitation, and it was confirmed that the resin component exhibited a dissolution state of the uniform sentence. Using the obtained liquid crystal alignment treatment agent [5], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage retention ratio was evaluated, the evaluation of residual charge was alleviated, and the evaluation after high temperature standing was performed. The results are as shown in Tables 7 and 8 below. <Example 6> Into the polyimine powder [F] (5 · 1 g) obtained in Synthesis Example 19, -88-.200948859 NMP (25.Og) was added, and the mixture was stirred at 70 ° C for 40 hours. It dissolves. NMP (12.5 g) 'BCS (42.5 g) was added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment treatment agent [6]. The liquid crystal alignment agent did not exhibit abnormalities such as turbidity or precipitation, and it was confirmed that the resin component exhibited a uniform dissolved state. Using the obtained liquid crystal alignment treatment agent [6], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage retention ratio was evaluated, the evaluation of residual charge was relaxed, and the evaluation after high temperature standing was performed. As a result, as shown in the following Tables 7 and 8 <Examples, in the polyimine powder [G] (5.0 g) obtained in Synthesis Example 20, NMP (24.4 g) was added, and the mixture was stirred at 70 ° C for 40 hours. Let it dissolve. NMP (12.2 g) and BCS (41.8 g) were added to the solution, and the mixture was stirred at 25 t for 2 hours to obtain a liquid crystal alignment treatment agent [7]. The liquid crystal alignment agent did not exhibit abnormalities such as turbidity or precipitation, and it was confirmed that the resin component exhibited a uniform dissolved state. Using the obtained liquid crystal alignment treatment agent [7], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage retention ratio was evaluated, the evaluation of residual charge was relaxed, and the evaluation after high temperature standing was performed. The results are shown in Tables 7 and 8 below. <Example 8> NMP (30.1 g) was added to the polyacrylonitrile powder [H] (5.0 g) obtained in Synthesis Example 21, and the mixture was stirred at 70 ° C for 40 hours to dissolve. NMP (14_7g) and BCS (33.5g) were added to the solution, and the mixture was stirred at 25 ° C for 2 -89 - 200948859 hours to obtain a liquid crystal alignment treatment agent [8]. The liquid crystal alignment agent did not exhibit abnormalities such as turbidity or precipitation, and it was confirmed that the resin component exhibited a uniform dissolved state. Using the obtained liquid crystal alignment treatment agent [8], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage retention ratio was evaluated, the evaluation of the residual charge was alleviated, and the evaluation after high temperature standing was performed. As a result, it will not be as shown in Table 7 and Table 8 below.
<實施例9> 於合成例22所得之聚醯亞胺粉末[I] ( 5.0g )中,加入 NMP ( 32.7g),於7(TC下攪拌40小時使其溶解。於該溶液 中加入 NMP(16_5g) 、BCS(29.2g),經於 25 °C 下攪拌 2<Example 9> In the polyimine powder [I] (5.0 g) obtained in Synthesis Example 22, NMP (32.7 g) was added, and the mixture was stirred at 7 (TC) for 40 hours to dissolve. NMP (16_5g), BCS (29.2g), stirred at 25 °C 2
小時後,得液晶配向處理劑[9]。該液晶配向處理劑並未發 現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀態 。使用所得之液晶配向處理劑[9],依實施例1相同方法製 作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電荷 之評估、高溫放置後之評估。其結果,如後述表7及表8所 示。 <實施例1〇> 於合成例23所得之聚醯亞胺粉末[J] ( 4.8g )中,加入 NMP ( 3 1.5g) ’於70 °C下攪拌40小時使其溶解。於該溶液 中加入NMP(15.5g) 、BCS(28.1g),經於25。(:下攪拌 2 小時後,得液晶配向處理劑[1 0]。該液晶配向處理劑並未 發現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀 -90- 200948859 態。使用所得之液晶配向處理劑[1 0],依實施例1相同方法 製作液晶晶胞’對其進行電壓保持率之評估、緩和殘留電 荷之評估、高溫放置後之評估。其結果,如後述表7及表8 所示。 <實施例11> 於合成例24所得之聚醯亞胺粉末[κ] ( 5.0g)中,加入 NMP ( 38.3g),於70 °C下攪拌40小時使其溶解。於該溶液 中加入 NMP(19.2g) 、BCS(20.7g),經於 25。(:下攪拌 2 小時後’得液晶配向處理劑[1 1 ]。該液晶配向處理劑並未 發現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀 態。使用所得之液晶配向處理劑[1 1 ],依實施例1相同方法 製作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電 荷之評估、高溫放置後之評估。其結果,如後述表7及表8 所示。 ❹ <實施例12> 於合成例25所得之聚醯亞胺粉末[L]( 4.9g)中,加入 NMP ( 32_2g) ’於70°C下攪拌40小時使其溶解。於該溶液 中加入 NMP (16.1g) 、BCS(28.5g),經於25 t 下攪拌2 小時後’得液晶配向處理劑[1 2 ]。該液晶配向處理劑並未 發現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀 態。使用所得之液晶配向處理劑[1 2 ],依實施例1相同方法 製作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電 -91 - 200948859 荷之評估、高溫放置後之評估。其結果,如後述表7及表8 所示。 <實施例13> 於合成例26所得之聚醯亞胺粉末[M] ( 5.0g )中,加 入NMP (30.0g),於70 °C下攪拌40小時使其溶解。於該溶 液中加入 NMP(14.8g) 、BCS(33.3g),經於 25 °C 下攪 拌2小時後,得液晶配向處理劑[13]。該液晶配向處理劑並 未發現混濁或析出等異常,確認樹脂成份呈現均勻之溶解 狀態。使用所得之液晶配向處理劑[13],依實施例1相同方 法製作液晶晶胞,對其進行電壓保持率之評估、緩和殘留 電荷之評估、高溫放置後之評估。其結果,如後述表7及 表8所示。 <實施例14> 於合成例27所得之聚醯亞胺粉末[N] ( 5.0g)中,加入 NMP ( 32.6g),於70 °C下攪拌40小時使其溶解。於該溶液 中加入 NMP(16.6g) 、BCS(29.2g),經於 25 °C 下攪拌 2 小時後,得液晶配向處理劑[1 4]。該液晶配向處理劑並未 發現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀 態。使用所得之液晶配向處理劑[1 4],依實施例1相同方法 製作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電 荷之評估、高溫放置後之評估。其結果,如後述表7及表8 所示。 -92- 200948859 〈比較例1 > 於合成例28所得之聚醯亞胺粉末[〇] ( 4.5g)中,加入 NMP ( 24.5g),於7(TC下攪拌40小時使其溶解。於該溶液 中加入 NMP (12.3g) 、BCS(33.8g),經於 25。(:下攪拌 2 小時後’得液晶配向處理劑[1 5]。該液晶配向處理劑並未 發現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀 態。使用所得之液晶配向處理劑[1 5 ],依實施例1相同方法 製作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電 荷之評估、高溫放置後之評估。其結果,如後述表7及表8 所示。 <比較例2 > 於合成例29所得之聚醯亞胺粉末[P] ( 4.6g)中,加入 NMP ( 35.3g ),於70 °C下攪拌40小時使其溶解。於該溶液 中加入 NMP(17.6g) 、BCS(19.3g),經於 25 °C 下攪拌 2 小時後,得液晶配向處理劑[1 6]。該液晶配向處理劑並未 發現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀 態。使用所得之液晶配向處理劑[1 6],依實施例1相同方法 製作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電 荷之評估、高溫放置後之評估。其結果,如後述表7及表8 所示。 〈比較例3 > -93- 200948859 於合成例30所得之聚醯亞胺粉末[Q] ( 4.5g)中,加入 NMP ( 27.lg),於70 °C下攪拌40小時使其溶解。於該溶液 中加入 NMP (13.3g) 、BCS(30.1g),經於 25 °C 下攪拌 2 小時後,得液晶配向處理劑[1 7]。該液晶配向處理劑並未 發現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀 態。使用所得之液晶配向處理劑[1 7],依實施例1相同方法 製作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電 荷之評估、高溫放置後之評估。其結果,如後述表7及表8 <比較例4> 於合成例31所得之聚醯亞胺粉末[R] ( 4.5 g)中,加入 NMP ( 37.lg),於70 °C下攪拌40小時使其溶解。於該溶液 中加入 NMP(18_5g) 、BCS(35.0g),經於 25。(:下攪拌 2 小時後,得液晶配向處理劑[1 8]。該液晶配向處理劑並未 發現混濁或析出等異常,確認樹脂成份呈現均勻之溶解狀 態。使用所得之液晶配向處理劑[1 8],依實施例1相同方法 製作液晶晶胞,對其進行電壓保持率之評估、緩和殘留電 荷之評估、高溫放置後之評估。其結果,如後述表7及表8 所示。 -94- 200948859 表7]After a few hours, a liquid crystal alignment treatment agent [9] was obtained. The liquid crystal alignment agent did not exhibit abnormalities such as turbidity or precipitation, and it was confirmed that the resin component exhibited a uniform dissolved state. Using the obtained liquid crystal alignment treating agent [9], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage holding ratio was evaluated, the evaluation of residual charge was relaxed, and the evaluation after high temperature standing was performed. The results are shown in Tables 7 and 8 below. <Example 1 〇> In the polyimine powder [J] (4.8 g) obtained in Synthesis Example 23, NMP (3 1.5 g) was added and stirred at 70 ° C for 40 hours to dissolve. NMP (15.5 g) and BCS (28.1 g) were added to the solution, and the mixture was passed through 25. (After stirring for 2 hours, a liquid crystal alignment treatment agent [10] was obtained. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment treatment agent, and it was confirmed that the resin component exhibited a uniform dissolution state - 90-200948859. The alignment treatment agent [10] was prepared in the same manner as in Example 1 to evaluate the voltage retention rate, to evaluate the residual charge, and to evaluate after the high temperature deposition. The results are shown in Tables 7 and 8 below. <Example 11> In the polyimine powder [κ] (5.0 g) obtained in Synthesis Example 24, NMP (38.3 g) was added, and the mixture was stirred at 70 ° C for 40 hours to dissolve. NMP (19.2 g) and BCS (20.7 g) were added to the solution at 25 (after stirring for 2 hours) to obtain a liquid crystal alignment treatment agent [1 1 ]. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment treatment agent. It was confirmed that the resin component exhibited a uniform dissolved state. Using the obtained liquid crystal alignment treatment agent [1 1 ], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage retention ratio was evaluated, the residual charge was evaluated, and the high temperature was placed. Post evaluation. The result, Table 7 and Table 8 which will be described later. ❹ <Example 12> In the polyimine powder [L] (4.9 g) obtained in Synthesis Example 25, NMP (32_2 g) was added and stirred at 70 ° C for 40 hours. To the solution, NMP (16.1 g) and BCS (28.5 g) were added, and after stirring for 2 hours at 25 t, the liquid crystal alignment treatment agent [1 2 ] was obtained. No turbidity was observed in the liquid crystal alignment treatment agent. Or an abnormality such as precipitation, and it was confirmed that the resin component exhibited a uniform dissolved state. Using the obtained liquid crystal alignment treatment agent [1 2 ], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage retention ratio was evaluated to relax the residual electricity. 91 - 200948859 Evaluation of the charge and evaluation after high temperature deposition. The results are shown in Tables 7 and 8 below. <Example 13> Polyimine powder obtained in Synthesis Example 26 [M] (5.0 g) NMP (30.0 g) was added and the mixture was stirred at 70 ° C for 40 hours to dissolve. NMP (14.8 g) and BCS (33.3 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours. Liquid crystal alignment treatment agent [13]. The liquid crystal alignment treatment agent did not detect abnormalities such as turbidity or precipitation, and confirmed that the resin composition was present. The liquid crystal cell was prepared in the same manner as in Example 1 using the obtained liquid crystal alignment treatment agent [13], and the voltage retention rate was evaluated, the residual charge was evaluated, and the evaluation was performed after the high temperature was placed. As shown in the following Tables 7 and 8. [Example 14] In the polyimine powder [N] (5.0 g) obtained in Synthesis Example 27, NMP (32.6 g) was added, and the mixture was stirred at 70 ° C. It was dissolved in 40 hours. NMP (16.6 g) and BCS (29.2 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment treatment agent [1 4]. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component exhibited a uniform dissolution state. Using the obtained liquid crystal alignment treatment agent [1 4], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage holding ratio was evaluated, the residual charge was evaluated, and the evaluation after high temperature standing was performed. The results are shown in Tables 7 and 8 below. -92-200948859 <Comparative Example 1 > In the polyimine powder [〇] (4.5 g) obtained in Synthesis Example 28, NMP (24.5 g) was added, and the mixture was stirred at 7 (TC) for 40 hours to dissolve. NMP (12.3g) and BCS (33.8g) were added to the solution, and the liquid crystal alignment treatment agent [15] was obtained after stirring for 2 hours. The liquid crystal alignment treatment agent was not found to be turbid or precipitated. Abnormally, it was confirmed that the resin component exhibited a uniform dissolved state. Using the obtained liquid crystal alignment treatment agent [1 5 ], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage retention rate was evaluated, the residual charge was evaluated, and the temperature was elevated. The evaluation was carried out, and the results are shown in Tables 7 and 8 below. <Comparative Example 2 > In the polyimine powder [P] (4.6 g) obtained in Synthesis Example 29, NMP (35.3 g) was added. The solution was dissolved by stirring at 70 ° C for 40 hours. NMP (17.6 g) and BCS (19.3 g) were added to the solution, and the mixture was stirred at 25 ° C for 2 hours to obtain a liquid crystal alignment treatment agent [1 6 No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment agent, and it was confirmed that the resin component exhibited a uniform dissolved state. Using the obtained liquid crystal alignment treatment agent [6 6], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage retention ratio was evaluated, the evaluation of the residual charge was relaxed, and the evaluation after the high temperature was placed. The result is as follows. 7 and Table 8. <Comparative Example 3 > -93- 200948859 In the polyimine powder [Q] (4.5 g) obtained in Synthesis Example 30, NMP (27 g) was added at 70 ° C After stirring for 40 hours, NMP (13.3 g) and BCS (30.1 g) were added to the solution, and after stirring at 25 ° C for 2 hours, a liquid crystal alignment treatment agent [17] was obtained. The liquid crystal alignment treatment agent No abnormality such as turbidity or precipitation was observed, and it was confirmed that the resin component was uniformly dissolved. Using the obtained liquid crystal alignment treatment agent [17], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage retention ratio was evaluated. The evaluation of the residual charge was evaluated, and the evaluation was carried out after the high-temperature standing. As a result, Table 7 and Table 8 described later <Comparative Example 4> In the polyimine powder [R] (4.5 g) obtained in Synthesis Example 31, NMP was added. (37.lg), dissolved at 70 ° C for 40 hours to dissolve. Add this solution NMP (18_5g) and BCS (35.0g) were obtained at 25. After stirring for 2 hours, a liquid crystal alignment treatment agent [18] was obtained. No abnormality such as turbidity or precipitation was observed in the liquid crystal alignment treatment agent, and the resin composition was confirmed. A uniform dissolved state was exhibited. Using the obtained liquid crystal alignment treatment agent [8 8], a liquid crystal cell was produced in the same manner as in Example 1, and the voltage holding ratio was evaluated, the evaluation of residual charge was relaxed, and the evaluation after high temperature standing was performed. The results are shown in Tables 7 and 8 below. -94- 200948859 Table 7]
液晶配向 處理劑 電壓保持率(%) 液晶晶胞製作時 高溫放置後 16.67ms 1667ms 16.67ms 1667ms 實施例1 [1] 97.8 64.5 97.7 64.2 實施例2 [2] 98.2 66.7 98.1 66.5 實施例3 [3] 97.7 64.6 97.5 64.7 實施例4 [4] 97.9 64.4 97.9 64.3 實施例5 [5] 98.3 66.9 98.3 66.8 實施例6 [6] 97.5 64.3 97.4 64.2 實施例7 [7] 97.2 64.1 97.0 63.9 實施例8 [8] 97.3 64.1 97.2 64.0 實施例9 [9] 97.6 64.5 97.5 64.3 實施例10 [10] 97.9 64.9 97.8 64.8 實施例11 [11] 97.3 64.5 97.6 64.2 實施例12 [12] 97.3 64.3 97.3 64.1 實施例13 [13] 97.4 64.4 97.5 64.4 實施例14 『141 98.3 66.7 98.2 66.5 比較例1 [15] 97.6 66.1 97.1 64.8 比較例2 [16] 97.2 66.2 96.4 64.0 比較例3 [17] 97.1 65.4 96.1 63.8 比較例4 Γ181 96.9 65.1 96.2 63.2Liquid crystal alignment treatment agent voltage retention ratio (%) 16.67 ms 1667 ms 16.67 ms 1667 ms after liquid crystal cell fabrication at a high temperature. Example 1 [1] 97.8 64.5 97.7 64.2 Example 2 [2] 98.2 66.7 98.1 66.5 Example 3 [3] 97.7 64.6 97.5 64.7 Example 4 [4] 97.9 64.4 97.9 64.3 Example 5 [5] 98.3 66.9 98.3 66.8 Example 6 [6] 97.5 64.3 97.4 64.2 Example 7 [7] 97.2 64.1 97.0 63.9 Example 8 [8] 97.3 64.1 97.2 64.0 Example 9 [9] 97.6 64.5 97.5 64.3 Example 10 [10] 97.9 64.9 97.8 64.8 Example 11 [11] 97.3 64.5 97.6 64.2 Example 12 [12] 97.3 64.3 97.3 64.1 Example 13 [13] 97.4 64.4 97.5 64.4 Example 14 『141 98.3 66.7 98.2 66.5 Comparative Example 1 [15] 97.6 66.1 97.1 64.8 Comparative Example 2 [16] 97.2 66.2 96.4 64.0 Comparative Example 3 [17] 97.1 65.4 96.1 63.8 Comparative Example 4 Γ181 96.9 65.1 96.2 63.2
-95- 200948859 表8] 液晶配向 處理劑 緩和殘留1 1 荷(V) 液晶晶胞製作時 高雛置後 50秒後 1000秒後 50秒後 1000秒後 實施例1 [1] 1.78 0.21 1.82 0.23 實施例2 [2] 3.85 0.72 3.83 0.73 實施例3 [3] 1.12 0.15 1.14 0.16 實施例4 [4] 2.01 0.31 2.12 0.31 實施例5 [5] 3.94 0.88 3.99 0.92 實施例6 [6] 1.45 0.18 1.48 0.21 實施例7 [7] 1.24 0.14 1.22 0.14 實施例8 [8] 1.84 0.24 1.90 0.32 實施例9 [9] 1.88 0.23 1.85 0.26 實施例10 [1〇] 1.19 0.12 1.21 0.15 實施例11 [Π] 1.15 0.11 1.17 0.12 實施例12 [12] 1.84 0.29 1.88 0.33 實施例13 [13] 2.12 0.40 2.20 0.42 實施例14 『141 3.94 0.76 3.99 0.78 比較例1 [15] 3.98 1.56 4.13 1.89 比較例2 [16] 4.15 1.85 4.29 2.01 比較例3 [17] 4.03 1.78 4.22 1.99 比較例4 「181 4.28 1.93 4.39 2.12 [產業上之利用性] 本發明之液晶配向處理劑於成爲液晶配向膜時,可得 到電壓保持率高且即使且於長時間暴露於高溫下之後亦可 加速緩和由直流電壓引起之累積殘留電荷之液晶配向膜。 另外可提供可耐在過度嚴苛之使用環境下長期使用之信賴 性高之液晶顯示元件。其結果,可用於TN元件、STN元件 、TFT液晶元件,進而可用於垂直配向型或水平配向型( IPS)之液晶顯示元件等。 -96- 200948859 又,2008年1月25日申請之日本特願2008 — 0 1 4970號 之說明書、申請專利範圍,及摘要之全部內容均被引用, 且倂入本發明之說明書之揭示內容中。-95- 200948859 Table 8] Liquid crystal alignment agent to alleviate residual 1 1 charge (V) After liquid crystal cell fabrication, after 50 seconds, 1000 seconds, 50 seconds, and 1000 seconds later, Example 1 [1] 1.78 0.21 1.82 0.23 Example 2 [2] 3.85 0.72 3.83 0.73 Example 3 [3] 1.12 0.15 1.14 0.16 Example 4 [4] 2.01 0.31 2.12 0.31 Example 5 [5] 3.94 0.88 3.99 0.92 Example 6 [6] 1.45 0.18 1.48 0.21 Example 7 [7] 1.24 0.14 1.22 0.14 Example 8 [8] 1.84 0.24 1.90 0.32 Example 9 [9] 1.88 0.23 1.85 0.26 Example 10 [1〇] 1.19 0.12 1.21 0.15 Example 11 [Π] 1.15 0.11 1.17 0.12 Example 12 [12] 1.84 0.29 1.88 0.33 Example 13 [13] 2.12 0.40 2.20 0.42 Example 14 『141 3.94 0.76 3.99 0.78 Comparative Example 1 [15] 3.98 1.56 4.13 1.89 Comparative Example 2 [16] 4.15 1.85 4.29 2.01 Comparative Example 3 [17] 4.03 1.78 4.22 1.99 Comparative Example 4 "181 4.28 1.93 4.39 2.12 [Industrial Applicability] When the liquid crystal alignment treatment agent of the present invention is used as a liquid crystal alignment film, a voltage holding ratio can be obtained even if After prolonged exposure to high temperatures, it can also accelerate the mitigation by straight A liquid crystal alignment film which accumulates residual charge due to a flow voltage. It is also provided with a highly reliable liquid crystal display element which can withstand long-term use in an excessively harsh environment. As a result, it can be used for a TN element, an STN element, and a TFT liquid crystal element. Further, it can be used for a vertical alignment type or a horizontal alignment type (IPS) liquid crystal display element, etc. -96- 200948859 Also, the specification and patent application scope of the Japanese Patent Application No. 2008-0181, filed on January 25, 2008, The entire contents of the Abstract are incorporated herein by reference.
-97--97-
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008014970 | 2008-01-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200948859A true TW200948859A (en) | 2009-12-01 |
TWI449727B TWI449727B (en) | 2014-08-21 |
Family
ID=40901210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW098103118A TWI449727B (en) | 2008-01-25 | 2009-01-23 | A liquid crystal alignment agent, and a liquid crystal display device using the liquid crystal display device |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5240207B2 (en) |
KR (1) | KR101514861B1 (en) |
CN (1) | CN101925849B (en) |
TW (1) | TWI449727B (en) |
WO (1) | WO2009093707A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103261956A (en) * | 2010-10-19 | 2013-08-21 | 日产化学工业株式会社 | Liquid crystal aligning agent suitable for photo-lignment process, and liquid crystal alignment film using same |
TWI427104B (en) * | 2010-10-26 | 2014-02-21 | Chi Mei Corp | Liquid crystal alignment agent, liquid crystal alignment film and a liquid crystal display comprising said liquid crystal alignment film |
TWI494374B (en) * | 2009-12-25 | 2015-08-01 | Nissan Chemical Ind Ltd | A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101626900B1 (en) * | 2009-12-21 | 2016-06-03 | 삼성디스플레이 주식회사 | Vertical alignment layer and liquid crystal display including the same |
JP5643985B2 (en) * | 2010-08-19 | 2014-12-24 | Jnc株式会社 | Diamine, liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element |
JP5655439B2 (en) * | 2010-08-31 | 2015-01-21 | 日産化学工業株式会社 | Novel liquid crystal aligning agent with photo-alignment and novel diamine compound |
JP5537345B2 (en) * | 2010-09-03 | 2014-07-02 | 株式会社ジャパンディスプレイ | Liquid crystal display |
CN102445790B (en) * | 2010-10-06 | 2016-05-18 | 株式会社日本显示器 | Alignment films, composition for forming alignment film and liquid crystal indicator |
JP5999107B2 (en) * | 2012-01-18 | 2016-09-28 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
JP5949070B2 (en) | 2012-04-03 | 2016-07-06 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
TWI520985B (en) * | 2012-07-18 | 2016-02-11 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liguid crystal display element |
JP6269098B2 (en) * | 2013-04-26 | 2018-01-31 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
TWI527844B (en) * | 2014-06-06 | 2016-04-01 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device |
CN105087018B (en) * | 2014-07-21 | 2018-01-19 | 中节能万润股份有限公司 | Aligning agent for liquid crystal, liquid crystal orientation film and its liquid crystal display cells |
TWI534203B (en) * | 2014-07-24 | 2016-05-21 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device |
JP6701635B2 (en) * | 2014-10-08 | 2020-05-27 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device |
JP6620428B2 (en) * | 2015-05-29 | 2019-12-18 | 三菱瓦斯化学株式会社 | Polyimide resin |
WO2018047872A1 (en) * | 2016-09-07 | 2018-03-15 | 日産化学工業株式会社 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element |
JP7256472B2 (en) * | 2017-10-25 | 2023-04-12 | 日産化学株式会社 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
JP7302305B2 (en) * | 2019-06-04 | 2023-07-04 | Dic株式会社 | Liquid crystal composition and liquid crystal display element |
CN110734771B (en) * | 2019-09-27 | 2022-12-20 | 江苏三月科技股份有限公司 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005097377A (en) * | 2003-09-24 | 2005-04-14 | Fuji Photo Film Co Ltd | Alignment layer, polymer, retardation plate using it, its preparing method and liquid crystal display device |
CN101085867A (en) * | 2006-06-05 | 2007-12-12 | 大立高分子工业股份有限公司 | Polyamic acid composition, and liquid crystal aligning agent and aligning film prepared from the same |
TWI406838B (en) * | 2006-08-04 | 2013-09-01 | Jnc Corp | Diamide,liquid crystal alignment agent,liquid crystal alignment film and liquid crystal display |
JP5077558B2 (en) * | 2007-02-15 | 2012-11-21 | Jsr株式会社 | Liquid crystal aligning agent and liquid crystal display element |
-
2009
- 2009-01-23 TW TW098103118A patent/TWI449727B/en active
- 2009-01-23 CN CN2009801031911A patent/CN101925849B/en active Active
- 2009-01-23 WO PCT/JP2009/051114 patent/WO2009093707A1/en active Application Filing
- 2009-01-23 JP JP2009550581A patent/JP5240207B2/en active Active
- 2009-01-23 KR KR1020107016447A patent/KR101514861B1/en active IP Right Grant
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI494374B (en) * | 2009-12-25 | 2015-08-01 | Nissan Chemical Ind Ltd | A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same |
CN103261956A (en) * | 2010-10-19 | 2013-08-21 | 日产化学工业株式会社 | Liquid crystal aligning agent suitable for photo-lignment process, and liquid crystal alignment film using same |
CN103261956B (en) * | 2010-10-19 | 2016-03-16 | 日产化学工业株式会社 | Be applicable to the aligning agent for liquid crystal of light orientation process method and use the liquid crystal orientation film of this aligning agent for liquid crystal |
TWI427104B (en) * | 2010-10-26 | 2014-02-21 | Chi Mei Corp | Liquid crystal alignment agent, liquid crystal alignment film and a liquid crystal display comprising said liquid crystal alignment film |
US8673177B2 (en) | 2010-10-26 | 2014-03-18 | Chi Mei Corporation | Liquid crystal alignment agent, and liquid crystal alignment film and liquid crystal display element formed from the liquid crystal alignment agent |
Also Published As
Publication number | Publication date |
---|---|
KR101514861B1 (en) | 2015-04-23 |
JPWO2009093707A1 (en) | 2011-05-26 |
WO2009093707A1 (en) | 2009-07-30 |
KR20100103637A (en) | 2010-09-27 |
TWI449727B (en) | 2014-08-21 |
CN101925849B (en) | 2012-07-18 |
CN101925849A (en) | 2010-12-22 |
JP5240207B2 (en) | 2013-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200948859A (en) | Liquid-crystal alignment material and liquid-crystal display element made with the same | |
JP5663876B2 (en) | Liquid crystal aligning agent and liquid crystal display element using the same | |
TWI638009B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
TWI477478B (en) | Diamine compounds, polyamic acid, polyimide and liquid crystal alignment treatment agent | |
TWI457368B (en) | Using the same liquid crystal alignment treating agent to the liquid crystal display element | |
TWI471655B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element | |
TWI480647B (en) | A liquid crystal alignment agent, and a liquid crystal display device using the liquid crystal display device | |
WO2009093709A1 (en) | Liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element | |
JP2017116940A (en) | Diamine compound | |
TW201527846A (en) | Liquid crystal aligning agent and liquid crystal display element using same | |
WO2013161984A1 (en) | Diamine, polymer, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
TWI343413B (en) | Liquid crystal alignment agent and liquid crystal display element | |
JP6183616B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TW201627354A (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element using same | |
TWI494374B (en) | A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same | |
WO2016140302A1 (en) | Polyimide precursor, and liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element having precursor |